SEC Info - GoHealth, Inc. - ‘10-K’ for 12/31/20

SEC Info℠

Home

My Interests

Help

Please Sign In

GoHealth, Inc. – ‘10-K’ for 12/31/20 – ‘JSON’

On: Tuesday, 3/16/21, at 4:25pm ET · For: 12/31/20 · Accession #: 1808220-21-10 · File #: 1-39390

Previous ‘10-K’: None · Next: ‘10-K’ on 3/16/22 for 12/31/21 · Latest: ‘10-K’ on 3/14/24 for 12/31/23 · 12 References:

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/16/21  GoHealth, Inc.                    10-K       12/31/20   93:12M

Annual Report — Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.61M 
 2: EX-4.2      Instrument Defining the Rights of Security Holders  HTML     49K 
 3: EX-21.1     Subsidiaries List                                   HTML     26K 
 4: EX-23.1     Consent of Expert or Counsel                        HTML     25K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     29K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     29K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     27K 
 8: EX-32.2     Certification -- §906 - SOA'02                      HTML     27K 
15: R1          Cover                                               HTML     92K 
16: R2          Consolidated Statements of Operations               HTML    104K 
17: R3          Consolidated Statements of Comprehensive Income     HTML     52K 
                (Loss)                                                           
18: R4          Consolidated Balance Sheets                         HTML    145K 
19: R5          Consolidated Balance Sheets (Parenthetical)         HTML     48K 
20: R6          Consolidated Statements of Changes in               HTML    150K 
                Stockholders' / Members' Equity                                  
21: R7          Consolidated Statements of Cash Flows               HTML    156K 
22: R8          Description of Business and Significant Accounting  HTML     92K 
                Policies                                                         
23: R9          Acquisitions                                        HTML     45K 
24: R10         Balance Sheet Accounts                              HTML     62K 
25: R11         Fair Value Measurements                             HTML     39K 
26: R12         Goodwill And Intangible Assets, Net                 HTML     66K 
27: R13         Long-Term Debt                                      HTML     54K 
28: R14         Stockholders' Equity and Members' Equity            HTML     40K 
29: R15         Share-Based Compensation Plans                      HTML     94K 
30: R16         Net Loss Per Share                                  HTML     41K 
31: R17         Income Taxes                                        HTML    112K 
32: R18         Revenue                                             HTML     72K 
33: R19         Commitments and Contingencies                       HTML     42K 
34: R20         Related Party Transactions                          HTML     31K 
35: R21         Operating Segments and Significant Customers        HTML     95K 
36: R22         Subsequent Events                                   HTML     28K 
37: R23         Description of Business and Significant Accounting  HTML    146K 
                Policies (Policies)                                              
38: R24         Description of Business and Significant Accounting  HTML     41K 
                Policies (Tables)                                                
39: R25         Acquisitions (Tables)                               HTML     42K 
40: R26         Balance Sheet Accounts (Tables)                     HTML     67K 
41: R27         Fair Value Measurements (Tables)                    HTML     33K 
42: R28         Goodwill And Intangible Assets, Net (Tables)        HTML     89K 
43: R29         Long-Term Debt (Tables)                             HTML     45K 
44: R30         Share-Based Compensation Plans (Tables)             HTML     95K 
45: R31         Net Loss Per Share (Tables)                         HTML     40K 
46: R32         Income Taxes (Tables)                               HTML    108K 
47: R33         Revenue (Tables)                                    HTML     65K 
48: R34         Commitment and Contingencies (Tables)               HTML     55K 
49: R35         Operating Segments and Significant Customers        HTML     89K 
                (Tables)                                                         
50: R36         Description of Business and Significant Accounting  HTML    145K 
                Policies - Narrative (Details)                                   
51: R37         Acquisitions - Narrative (Details)                  HTML     84K 
52: R38         Acquisitions - Summary of Purchase Consideration    HTML     38K 
                (Details)                                                        
53: R39         Acquisitions - Summary of Allocation of Purchase    HTML     58K 
                Price (Details)                                                  
54: R40         Balance Sheet Accounts - Commissions Receivable     HTML     49K 
                (Details)                                                        
55: R41         Balance Sheet Accounts - Summary of Property,       HTML     44K 
                Equipment and Capitalized Software, Net (Details)                
56: R42         Balance Sheet Accounts - Narrative (Details)        HTML     30K 
57: R43         Balance Sheet Accounts - Summary of Accrued         HTML     40K 
                Liabilities (Details)                                            
58: R44         Fair Value Measurements - Narrative (Details)       HTML     31K 
59: R45         Fair Value Measurements - Summary of Fair value of  HTML     39K 
                the Contingent Consideration (Details)                           
60: R46         Goodwill And Intangible Assets, Net - Narrative     HTML     50K 
                (Details)                                                        
61: R47         Goodwill And Intangible Assets, Net - Summary of    HTML     48K 
                Definite-lived and Indefinite-lived Intangible                   
                Assets (Details)                                                 
62: R48         Goodwill and Intangible Assets, Net - Summary of    HTML     50K 
                Expected Future Amortization Expense Related to                  
                Intangible Assets (Details)                                      
63: R49         Long-Term Debt - Summary of Long-Term Debt          HTML     38K 
                (Details)                                                        
64: R50         Long-Term Debt - Maturities of Long-term Debt       HTML     41K 
                (Details)                                                        
65: R51         Long-Term Debt - Narrative (Details)                HTML    127K 
66: R52         Stockholders' Equity and Members' Equity (Details)  HTML     59K 
67: R53         Share-Based Compensation Plans - Summary of         HTML     41K 
                Share-Based Compensation Expenses by Operating                   
                Function (Details)                                               
68: R54         Share-Based Compensation Plans - Narrative          HTML    125K 
                (Details)                                                        
69: R55         Share-Based Compensation Plans - Summary of Profit  HTML     62K 
                Units and RSUs Issued to Employees (Details)                     
70: R56         Share-Based Compensation Plans - Summary of         HTML     37K 
                Valuation Assumptions, Profit Units (Details)                    
71: R57         Share-Based Compensation Plans - Summary of Stock   HTML     63K 
                Options Issued to Employees (Details)                            
72: R58         Share-Based Compensation Plans - Summary of         HTML     44K 
                Valuation Assumptions, Options (Details)                         
73: R59         Net Loss Per Share - Reconciliation of the          HTML     54K 
                Numerator and Denominator Used in the Calculation                
                of Basic and Diluted Net Loss Per Share (Details)                
74: R60         Net Loss Per Share - Antidilutive Securities        HTML     32K 
                (Details)                                                        
75: R61         Income Taxes - Components of Income (Loss) Before   HTML     38K 
                Income Taxes (Details)                                           
76: R62         Income Taxes - Components of Income Tax Expense     HTML     58K 
                (Benefit) (Details)                                              
77: R63         Income Taxes - Reconciliation of Statutory Tax      HTML     49K 
                Rate to Our Effective Tax Rate (Details)                         
78: R64         Income Taxes - Deferred Tax Assets and Liabilities  HTML     57K 
                (Details)                                                        
79: R65         Income Taxes - Narrative (Details)                  HTML     47K 
80: R66         Revenue - Narrative (Details)                       HTML     30K 
81: R67         Revenue - Summary of Disaggregation of Revenue      HTML     68K 
                (Details)                                                        
82: R68         Commitments and Contingencies - Narrative           HTML     38K 
                (Details)                                                        
83: R69         Commitments and Contingencies - Future Minimum      HTML     67K 
                Lease Payments Under Non-cancelable Capital and                  
                Operating Leases (Details)                                       
84: R70         Related Party Transactions (Details)                HTML     50K 
85: R71         Operating Segments and Significant Customers -      HTML     30K 
                Narrative (Details)                                              
86: R72         Operating Segments and Significant Customers -      HTML     94K 
                Summary of Reconciliation of Operating Profit                    
                (Loss) from Segments to Consolidated (Details)                   
87: R73         Operating Segments and Significant Customers -      HTML     40K 
                Summary of Revenue by Major Customers by Reporting               
                Segments (Details)                                               
88: R74         Subsequent Events (Details)                         HTML     39K 
89: R9999       Uncategorized Items - goco-20201231.htm             HTML     34K 
91: XML         IDEA XML File -- Filing Summary                      XML    166K 
14: XML         XBRL Instance -- goco-20201231_htm                   XML   2.73M 
90: EXCEL       IDEA Workbook of Financial Reports                  XLSX    134K 
10: EX-101.CAL  XBRL Calculations -- goco-20201231_cal               XML    317K 
11: EX-101.DEF  XBRL Definitions -- goco-20201231_def                XML   1.08M 
12: EX-101.LAB  XBRL Labels -- goco-20201231_lab                     XML   2.23M 
13: EX-101.PRE  XBRL Presentations -- goco-20201231_pre              XML   1.37M 
 9: EX-101.SCH  XBRL Schema -- goco-20201231                         XSD    219K 
92: JSON        XBRL Instance as JSON Data -- MetaLinks              486±   737K 
93: ZIP         XBRL Zipped Folder -- 0001808220-21-000010-xbrl      Zip    625K

‘JSON’ — XBRL Instance as JSON Data — MetaLinks

This File is an XBRL Instance as JavaScript Object Notation (JSON) Data.

{
"instance":  {
    "goco-20201231.htm":  {
        "axisCustom":  1,
        "axisStandard":  37,
        "contextCount":  342,
        "dts":  {
            "calculationLink":  {
                "local":  [
                    "goco-20201231_cal.xml"
                    ]
                },
            "definitionLink":  {
                "local":  [
                    "goco-20201231_def.xml"
                    ],
                "remote":  [
                    "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
                    "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
                    ]
                },
            "inline":  {
                "local":  [
                    "goco-20201231.htm"
                    ]
                },
            "labelLink":  {
                "local":  [
                    "goco-20201231_lab.xml"
                    ],
                "remote":  [
                    "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
                    "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
                    ]
                },
            "presentationLink":  {
                "local":  [
                    "goco-20201231_pre.xml"
                    ]
                },
            "referenceLink":  {
                "remote":  [
                    "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
                    "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
                    ]
                },
            "schema":  {
                "local":  [
                    "goco-20201231.xsd"
                    ],
                "remote":  [
                    "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
                    "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
                    "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
                    "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
                    "http://www.xbrl.org/2005/xbrldt-2005.xsd",
                    "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
                    "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
                    "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
                    "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
                    "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
                    "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
                    "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
                    "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
                    "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
                    "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
                    "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
                    "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
                    "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
                    ]
                }
            },
        "elementCount":  743,
        "entityCount":  1,
        "hidden":  {
            "http://fasb.org/us-gaap/2020-01-31":  8,
            "http://www.gohealth.com/20201231":  2,
            "http://xbrl.sec.gov/dei/2020-01-31":  4,
            "total":  14
            },
        "keyCustom":  76,
        "keyStandard":  443,
        "memberCustom":  68,
        "memberStandard":  43,
        "nsprefix":  "goco",
        "nsuri":  "http://www.gohealth.com/20201231",
        "report":  {
            "R1":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "dei:DocumentType",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "document",
                "isDefault":  "true",
                "longName":  "0001001 - Document - Cover",
                "role":  "http://www.gohealth.com/role/Cover",
                "shortName":  "Cover",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "dei:DocumentType",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R10":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2110103 - Disclosure - Balance Sheet Accounts",
                "role":  "http://www.gohealth.com/role/BalanceSheetAccounts",
                "shortName":  "Balance Sheet Accounts",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R11":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FairValueDisclosuresTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2116104 - Disclosure - Fair Value Measurements",
                "role":  "http://www.gohealth.com/role/FairValueMeasurements",
                "shortName":  "Fair Value Measurements",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FairValueDisclosuresTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R12":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2120105 - Disclosure - Goodwill And Intangible Assets, Net",
                "role":  "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNet",
                "shortName":  "Goodwill And Intangible Assets, Net",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R13":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LongTermDebtTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2125106 - Disclosure - Long-Term Debt",
                "role":  "http://www.gohealth.com/role/LongTermDebt",
                "shortName":  "Long-Term Debt",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LongTermDebtTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R14":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2130107 - Disclosure - Stockholders' Equity and Members' Equity",
                "role":  "http://www.gohealth.com/role/StockholdersEquityandMembersEquity",
                "shortName":  "Stockholders' Equity and Members' Equity",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R15":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2132108 - Disclosure - Share-Based Compensation Plans",
                "role":  "http://www.gohealth.com/role/ShareBasedCompensationPlans",
                "shortName":  "Share-Based Compensation Plans",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R16":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:EarningsPerShareTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2140109 - Disclosure - Net Loss Per Share",
                "role":  "http://www.gohealth.com/role/NetLossPerShare",
                "shortName":  "Net Loss Per Share",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:EarningsPerShareTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R17":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:IncomeTaxDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2144110 - Disclosure - Income Taxes",
                "role":  "http://www.gohealth.com/role/IncomeTaxes",
                "shortName":  "Income Taxes",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:IncomeTaxDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R18":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RevenueFromContractWithCustomerTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2151111 - Disclosure - Revenue",
                "role":  "http://www.gohealth.com/role/Revenue",
                "shortName":  "Revenue",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RevenueFromContractWithCustomerTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R19":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2155112 - Disclosure - Commitments and Contingencies",
                "role":  "http://www.gohealth.com/role/CommitmentsandContingencies",
                "shortName":  "Commitments and Contingencies",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R2":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "ibb836458412d494f842f757175a54e88_D20190101-20190912",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FinancialDesignationPredecessorAndSuccessorFixedList",
                    "reportCount":  1,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "1001002 - Statement - Consolidated Statements of Operations",
                "role":  "http://www.gohealth.com/role/ConsolidatedStatementsofOperations",
                "shortName":  "Consolidated Statements of Operations",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i4076ace195c04c6b9b9407bf01234550_D20190913-20191231",
                    "decimals":  "-3",
                    "lang":  "en-US",
                    "name":  "us-gaap:CostOfRevenue",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R20":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2159113 - Disclosure - Related Party Transactions",
                "role":  "http://www.gohealth.com/role/RelatedPartyTransactions",
                "shortName":  "Related Party Transactions",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R21":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SegmentReportingDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2161114 - Disclosure - Operating Segments and Significant Customers",
                "role":  "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomers",
                "shortName":  "Operating Segments and Significant Customers",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SegmentReportingDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R22":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SubsequentEventsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2166115 - Disclosure - Subsequent Events",
                "role":  "http://www.gohealth.com/role/SubsequentEvents",
                "shortName":  "Subsequent Events",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SubsequentEventsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R23":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2202201 - Disclosure - Description of Business and Significant Accounting Policies (Policies)",
                "role":  "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesPolicies",
                "shortName":  "Description of Business and Significant Accounting Policies (Policies)",
                "subGroupType":  "policies",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R24":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PropertyPlantAndEquipmentTextBlock",
                    "reportCount":  1,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2303301 - Disclosure - Description of Business and Significant Accounting Policies (Tables)",
                "role":  "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesTables",
                "shortName":  "Description of Business and Significant Accounting Policies (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  null
                },
            "R25":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "goco:BusinessCombinationComponentsOfPurchaseConsiderationTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2306302 - Disclosure - Acquisitions (Tables)",
                "role":  "http://www.gohealth.com/role/AcquisitionsTables",
                "shortName":  "Acquisitions (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "goco:BusinessCombinationComponentsOfPurchaseConsiderationTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R26":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2311303 - Disclosure - Balance Sheet Accounts (Tables)",
                "role":  "http://www.gohealth.com/role/BalanceSheetAccountsTables",
                "shortName":  "Balance Sheet Accounts (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R27":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2317304 - Disclosure - Fair Value Measurements (Tables)",
                "role":  "http://www.gohealth.com/role/FairValueMeasurementsTables",
                "shortName":  "Fair Value Measurements (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R28":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2321305 - Disclosure - Goodwill And Intangible Assets, Net (Tables)",
                "role":  "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetTables",
                "shortName":  "Goodwill And Intangible Assets, Net (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R29":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2326306 - Disclosure - Long-Term Debt (Tables)",
                "role":  "http://www.gohealth.com/role/LongTermDebtTables",
                "shortName":  "Long-Term Debt (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R3":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "ibb836458412d494f842f757175a54e88_D20190101-20190912",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FinancialDesignationPredecessorAndSuccessorFixedList",
                    "reportCount":  1,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "1002003 - Statement - Consolidated Statements of Comprehensive Income (Loss)",
                "role":  "http://www.gohealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
                "shortName":  "Consolidated Statements of Comprehensive Income (Loss)",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i4076ace195c04c6b9b9407bf01234550_D20190913-20191231",
                    "decimals":  "-3",
                    "lang":  "en-US",
                    "name":  "us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R30":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2333307 - Disclosure - Share-Based Compensation Plans (Tables)",
                "role":  "http://www.gohealth.com/role/ShareBasedCompensationPlansTables",
                "shortName":  "Share-Based Compensation Plans (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R31":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2341308 - Disclosure - Net Loss Per Share (Tables)",
                "role":  "http://www.gohealth.com/role/NetLossPerShareTables",
                "shortName":  "Net Loss Per Share (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R32":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2345309 - Disclosure - Income Taxes (Tables)",
                "role":  "http://www.gohealth.com/role/IncomeTaxesTables",
                "shortName":  "Income Taxes (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R33":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DisaggregationOfRevenueTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2352310 - Disclosure - Revenue (Tables)",
                "role":  "http://www.gohealth.com/role/RevenueTables",
                "shortName":  "Revenue (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DisaggregationOfRevenueTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R34":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2356311 - Disclosure - Commitment and Contingencies (Tables)",
                "role":  "http://www.gohealth.com/role/CommitmentandContingenciesTables",
                "shortName":  "Commitment and Contingencies (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R35":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2362312 - Disclosure - Operating Segments and Significant Customers (Tables)",
                "role":  "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersTables",
                "shortName":  "Operating Segments and Significant Customers (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R36":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i4076ace195c04c6b9b9407bf01234550_D20190913-20191231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ProceedsFromIssuanceInitialPublicOffering",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2404401 - Disclosure - Description of Business and Significant Accounting Policies - Narrative (Details)",
                "role":  "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails",
                "shortName":  "Description of Business and Significant Accounting Policies - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "if3338f0efdcd4186ab1bf53ff6b5a0e4_D20200717-20200717",
                    "decimals":  "-5",
                    "lang":  "en-US",
                    "name":  "goco:PaymentsToAcquireNoncontrollingInterests",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R37":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "ic6aec12007ce4716a1d69cba723a16a4_I20191231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:BusinessCombinationContingentConsiderationLiability",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2407402 - Disclosure - Acquisitions - Narrative (Details)",
                "role":  "http://www.gohealth.com/role/AcquisitionsNarrativeDetails",
                "shortName":  "Acquisitions - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i12bb71eba1424550b16118270fef136a_D20190101-20191231",
                    "decimals":  "-5",
                    "lang":  "en-US",
                    "name":  "us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R38":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "goco:BusinessCombinationComponentsOfPurchaseConsiderationTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i563f9e5412684cf59f5498db88b4b9a5_D20190913-20190913",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PaymentsToAcquireBusinessesGross",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2408403 - Disclosure - Acquisitions - Summary of Purchase Consideration (Details)",
                "role":  "http://www.gohealth.com/role/AcquisitionsSummaryofPurchaseConsiderationDetails",
                "shortName":  "Acquisitions - Summary of Purchase Consideration (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "goco:BusinessCombinationComponentsOfPurchaseConsiderationTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i563f9e5412684cf59f5498db88b4b9a5_D20190913-20190913",
                    "decimals":  "-3",
                    "lang":  "en-US",
                    "name":  "us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R39":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i81de0d82273a4c5ebc6ced2b0e4ff535_I20201231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:Goodwill",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2409404 - Disclosure - Acquisitions - Summary of Allocation of Purchase Price (Details)",
                "role":  "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails",
                "shortName":  "Acquisitions - Summary of Allocation of Purchase Price (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "ix:continuation",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i37909f0786274164b3d4b2e27d950e3a_I20190913",
                    "decimals":  "-3",
                    "lang":  "en-US",
                    "name":  "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R4":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i81de0d82273a4c5ebc6ced2b0e4ff535_I20201231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CashAndCashEquivalentsAtCarryingValue",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "1003004 - Statement - Consolidated Balance Sheets",
                "role":  "http://www.gohealth.com/role/ConsolidatedBalanceSheets",
                "shortName":  "Consolidated Balance Sheets",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i81de0d82273a4c5ebc6ced2b0e4ff535_I20201231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CashAndCashEquivalentsAtCarryingValue",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R40":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "ibb836458412d494f842f757175a54e88_D20190101-20190912",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FinancialDesignationPredecessorAndSuccessorFixedList",
                    "reportCount":  1,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2412405 - Disclosure - Balance Sheet Accounts - Commissions Receivable (Details)",
                "role":  "http://www.gohealth.com/role/BalanceSheetAccountsCommissionsReceivableDetails",
                "shortName":  "Balance Sheet Accounts - Commissions Receivable (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i04ee6a9b5f2d4c938eb8be8580c54172_D20190913-20191231",
                    "decimals":  "-3",
                    "lang":  "en-US",
                    "name":  "us-gaap:ProceedsFromCommissionsReceived",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R41":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i81de0d82273a4c5ebc6ced2b0e4ff535_I20201231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2413406 - Disclosure - Balance Sheet Accounts - Summary of Property, Equipment and Capitalized Software, Net (Details)",
                "role":  "http://www.gohealth.com/role/BalanceSheetAccountsSummaryofPropertyEquipmentandCapitalizedSoftwareNetDetails",
                "shortName":  "Balance Sheet Accounts - Summary of Property, Equipment and Capitalized Software, Net (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i81de0d82273a4c5ebc6ced2b0e4ff535_I20201231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R42":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i4076ace195c04c6b9b9407bf01234550_D20190913-20191231",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:Depreciation",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2414407 - Disclosure - Balance Sheet Accounts - Narrative (Details)",
                "role":  "http://www.gohealth.com/role/BalanceSheetAccountsNarrativeDetails",
                "shortName":  "Balance Sheet Accounts - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i4076ace195c04c6b9b9407bf01234550_D20190913-20191231",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:Depreciation",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R43":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i81de0d82273a4c5ebc6ced2b0e4ff535_I20201231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "goco:AccruedBonusesAndCommissionsCurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2415408 - Disclosure - Balance Sheet Accounts - Summary of Accrued Liabilities (Details)",
                "role":  "http://www.gohealth.com/role/BalanceSheetAccountsSummaryofAccruedLiabilitiesDetails",
                "shortName":  "Balance Sheet Accounts - Summary of Accrued Liabilities (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i81de0d82273a4c5ebc6ced2b0e4ff535_I20201231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "goco:AccruedBonusesAndCommissionsCurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R44":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "id086c1c0075b45e1a963507ef5c637ad_D20200717-20200717",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2418409 - Disclosure - Fair Value Measurements - Narrative (Details)",
                "role":  "http://www.gohealth.com/role/FairValueMeasurementsNarrativeDetails",
                "shortName":  "Fair Value Measurements - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  null
                },
            "R45":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "ix:continuation",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i47b729be5c6447d9a64506a0890ed77e_I20191231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2419410 - Disclosure - Fair Value Measurements - Summary of Fair value of the Contingent Consideration (Details)",
                "role":  "http://www.gohealth.com/role/FairValueMeasurementsSummaryofFairvalueoftheContingentConsiderationDetails",
                "shortName":  "Fair Value Measurements - Summary of Fair value of the Contingent Consideration (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "ix:continuation",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i47b729be5c6447d9a64506a0890ed77e_I20191231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R46":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:NumberOfReportingUnits",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "reporting_unit",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2422411 - Disclosure - Goodwill And Intangible Assets, Net - Narrative (Details)",
                "role":  "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails",
                "shortName":  "Goodwill And Intangible Assets, Net - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:NumberOfReportingUnits",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "reporting_unit",
                    "xsiNil":  "false"
                    }
                },
            "R47":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
                        "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i81de0d82273a4c5ebc6ced2b0e4ff535_I20201231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FiniteLivedIntangibleAssetsGross",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2423412 - Disclosure - Goodwill And Intangible Assets, Net - Summary of Definite-lived and Indefinite-lived Intangible Assets (Details)",
                "role":  "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetSummaryofDefinitelivedandIndefinitelivedIntangibleAssetsDetails",
                "shortName":  "Goodwill And Intangible Assets, Net - Summary of Definite-lived and Indefinite-lived Intangible Assets (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
                        "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i81de0d82273a4c5ebc6ced2b0e4ff535_I20201231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FiniteLivedIntangibleAssetsGross",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R48":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i81de0d82273a4c5ebc6ced2b0e4ff535_I20201231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2424413 - Disclosure - Goodwill and Intangible Assets, Net - Summary of Expected Future Amortization Expense Related to Intangible Assets (Details)",
                "role":  "http://www.gohealth.com/role/GoodwillandIntangibleAssetsNetSummaryofExpectedFutureAmortizationExpenseRelatedtoIntangibleAssetsDetails",
                "shortName":  "Goodwill and Intangible Assets, Net - Summary of Expected Future Amortization Expense Related to Intangible Assets (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i81de0d82273a4c5ebc6ced2b0e4ff535_I20201231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R49":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i81de0d82273a4c5ebc6ced2b0e4ff535_I20201231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DebtInstrumentCarryingAmount",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2427414 - Disclosure - Long-Term Debt - Summary of Long-Term Debt (Details)",
                "role":  "http://www.gohealth.com/role/LongTermDebtSummaryofLongTermDebtDetails",
                "shortName":  "Long-Term Debt - Summary of Long-Term Debt (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i81de0d82273a4c5ebc6ced2b0e4ff535_I20201231",
                    "decimals":  "-3",
                    "lang":  "en-US",
                    "name":  "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R5":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i81de0d82273a4c5ebc6ced2b0e4ff535_I20201231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "1004005 - Statement - Consolidated Balance Sheets (Parenthetical)",
                "role":  "http://www.gohealth.com/role/ConsolidatedBalanceSheetsParenthetical",
                "shortName":  "Consolidated Balance Sheets (Parenthetical)",
                "subGroupType":  "parenthetical",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i81de0d82273a4c5ebc6ced2b0e4ff535_I20201231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R50":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i81de0d82273a4c5ebc6ced2b0e4ff535_I20201231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2428415 - Disclosure - Long-Term Debt - Maturities of Long-term Debt (Details)",
                "role":  "http://www.gohealth.com/role/LongTermDebtMaturitiesofLongtermDebtDetails",
                "shortName":  "Long-Term Debt - Maturities of Long-term Debt (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i81de0d82273a4c5ebc6ced2b0e4ff535_I20201231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R51":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:StockIssuedDuringPeriodValueNewIssues",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2429416 - Disclosure - Long-Term Debt - Narrative (Details)",
                "role":  "http://www.gohealth.com/role/LongTermDebtNarrativeDetails",
                "shortName":  "Long-Term Debt - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i2b711c3a2ade44ada48d876c5dcf57f0_D20200101-20201231",
                    "decimals":  "INF",
                    "lang":  "en-US",
                    "name":  "goco:MandatoryPrepaymentAsAPercentageOfAssetsSold",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "number",
                    "xsiNil":  "false"
                    }
                },
            "R52":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "ieff25bbec0e245fd9ee2e26598032d86_I20200731",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PreferredStockSharesAuthorized",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2431417 - Disclosure - Stockholders' Equity and Members' Equity (Details)",
                "role":  "http://www.gohealth.com/role/StockholdersEquityandMembersEquityDetails",
                "shortName":  "Stockholders' Equity and Members' Equity (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "ieff25bbec0e245fd9ee2e26598032d86_I20200731",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PreferredStockSharesAuthorized",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    }
                },
            "R53":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "ibb836458412d494f842f757175a54e88_D20190101-20190912",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FinancialDesignationPredecessorAndSuccessorFixedList",
                    "reportCount":  1,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2434418 - Disclosure - Share-Based Compensation Plans - Summary of Share-Based Compensation Expenses by Operating Function (Details)",
                "role":  "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofShareBasedCompensationExpensesbyOperatingFunctionDetails",
                "shortName":  "Share-Based Compensation Plans - Summary of Share-Based Compensation Expenses by Operating Function (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i732c2e4ed46a4788a9269a3c0ad4d642_D20190913-20191231",
                    "decimals":  "-3",
                    "lang":  "en-US",
                    "name":  "us-gaap:AllocatedShareBasedCompensationExpense",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R54":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "if3338f0efdcd4186ab1bf53ff6b5a0e4_D20200717-20200717",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "goco:NumberOfSharesOfLLCInterestsToClassBCommonStockRatio",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "number",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2435419 - Disclosure - Share-Based Compensation Plans - Narrative (Details)",
                "role":  "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails",
                "shortName":  "Share-Based Compensation Plans - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "if3338f0efdcd4186ab1bf53ff6b5a0e4_D20200717-20200717",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "goco:NumberOfSharesOfLLCInterestsToClassBCommonStockRatio",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "number",
                    "xsiNil":  "false"
                    }
                },
            "R55":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i38e91b2f0be84c0aa1ff1fc481228936_I20191231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2436420 - Disclosure - Share-Based Compensation Plans - Summary of Profit Units and RSUs Issued to Employees (Details)",
                "role":  "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofProfitUnitsandRSUsIssuedtoEmployeesDetails",
                "shortName":  "Share-Based Compensation Plans - Summary of Profit Units and RSUs Issued to Employees (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i38e91b2f0be84c0aa1ff1fc481228936_I20191231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    }
                },
            "R56":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "goco:ScheduleOfShareBasedPaymentAwardValuationAssumptionsExcludingOptionTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i39aba3a33e3f45db887428212082b173_D20190913-20191231",
                    "decimals":  "4",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "number",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2437421 - Disclosure - Share-Based Compensation Plans - Summary of Valuation Assumptions, Profit Units (Details)",
                "role":  "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofValuationAssumptionsProfitUnitsDetails",
                "shortName":  "Share-Based Compensation Plans - Summary of Valuation Assumptions, Profit Units (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "goco:ScheduleOfShareBasedPaymentAwardValuationAssumptionsExcludingOptionTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i39aba3a33e3f45db887428212082b173_D20190913-20191231",
                    "decimals":  "4",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "number",
                    "xsiNil":  "false"
                    }
                },
            "R57":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "ic6aec12007ce4716a1d69cba723a16a4_I20191231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                    "reportCount":  1,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2438422 - Disclosure - Share-Based Compensation Plans - Summary of Stock Options Issued to Employees (Details)",
                "role":  "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofStockOptionsIssuedtoEmployeesDetails",
                "shortName":  "Share-Based Compensation Plans - Summary of Stock Options Issued to Employees (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  "-3",
                    "lang":  "en-US",
                    "name":  "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    }
                },
            "R58":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i8d9b9e48460449309cab4479883ec286_D20200101-20201231",
                    "decimals":  "4",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "number",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2439423 - Disclosure - Share-Based Compensation Plans - Summary of Valuation Assumptions, Options (Details)",
                "role":  "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofValuationAssumptionsOptionsDetails",
                "shortName":  "Share-Based Compensation Plans - Summary of Valuation Assumptions, Options (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i8d9b9e48460449309cab4479883ec286_D20200101-20201231",
                    "decimals":  "4",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "number",
                    "xsiNil":  "false"
                    }
                },
            "R59":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i4076ace195c04c6b9b9407bf01234550_D20190913-20191231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ProfitLoss",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2442424 - Disclosure - Net Loss Per Share - Reconciliation of the Numerator and Denominator Used in the Calculation of Basic and Diluted Net Loss Per Share (Details)",
                "role":  "http://www.gohealth.com/role/NetLossPerShareReconciliationoftheNumeratorandDenominatorUsedintheCalculationofBasicandDilutedNetLossPerShareDetails",
                "shortName":  "Net Loss Per Share - Reconciliation of the Numerator and Denominator Used in the Calculation of Basic and Diluted Net Loss Per Share (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  "-3",
                    "lang":  "en-US",
                    "name":  "goco:NetIncomeLossAttributableToParentSubsequentToReorganizationTransactions",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R6":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i3cebd7635f4f4b6d92a3eb49d7424a36_D20180101-20181231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FinancialDesignationPredecessorAndSuccessorFixedList",
                    "reportCount":  1,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "1005006 - Statement - Consolidated Statements of Changes in Stockholders' / Members' Equity",
                "role":  "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity",
                "shortName":  "Consolidated Statements of Changes in Stockholders' / Members' Equity",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "ieb002fd76496499a87a25e649a7e55df_I20171231",
                    "decimals":  "-3",
                    "lang":  "en-US",
                    "name":  "us-gaap:MembersEquity",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R60":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i1329406d851a444db21b6b5128bff155_D20200101-20201231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2443425 - Disclosure - Net Loss Per Share - Antidilutive Securities (Details)",
                "role":  "http://www.gohealth.com/role/NetLossPerShareAntidilutiveSecuritiesDetails",
                "shortName":  "Net Loss Per Share - Antidilutive Securities (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i1329406d851a444db21b6b5128bff155_D20200101-20201231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    }
                },
            "R61":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "ibb836458412d494f842f757175a54e88_D20190101-20190912",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FinancialDesignationPredecessorAndSuccessorFixedList",
                    "reportCount":  1,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2446426 - Disclosure - Income Taxes - Components of Income (Loss) Before Income Taxes (Details)",
                "role":  "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeLossBeforeIncomeTaxesDetails",
                "shortName":  "Income Taxes - Components of Income (Loss) Before Income Taxes (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i4076ace195c04c6b9b9407bf01234550_D20190913-20191231",
                    "decimals":  "-3",
                    "lang":  "en-US",
                    "name":  "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R62":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "ibb836458412d494f842f757175a54e88_D20190101-20190912",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FinancialDesignationPredecessorAndSuccessorFixedList",
                    "reportCount":  1,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2447427 - Disclosure - Income Taxes - Components of Income Tax Expense (Benefit) (Details)",
                "role":  "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails",
                "shortName":  "Income Taxes - Components of Income Tax Expense (Benefit) (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i4076ace195c04c6b9b9407bf01234550_D20190913-20191231",
                    "decimals":  "-3",
                    "lang":  "en-US",
                    "name":  "us-gaap:CurrentFederalTaxExpenseBenefit",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R63":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "ibb836458412d494f842f757175a54e88_D20190101-20190912",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FinancialDesignationPredecessorAndSuccessorFixedList",
                    "reportCount":  1,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2448428 - Disclosure - Income Taxes - Reconciliation of Statutory Tax Rate to Our Effective Tax Rate (Details)",
                "role":  "http://www.gohealth.com/role/IncomeTaxesReconciliationofStatutoryTaxRatetoOurEffectiveTaxRateDetails",
                "shortName":  "Income Taxes - Reconciliation of Statutory Tax Rate to Our Effective Tax Rate (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i4076ace195c04c6b9b9407bf01234550_D20190913-20191231",
                    "decimals":  "3",
                    "lang":  "en-US",
                    "name":  "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "number",
                    "xsiNil":  "false"
                    }
                },
            "R64":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i81de0d82273a4c5ebc6ced2b0e4ff535_I20201231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DeferredTaxAssetsInvestments",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2449429 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)",
                "role":  "http://www.gohealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
                "shortName":  "Income Taxes - Deferred Tax Assets and Liabilities (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i81de0d82273a4c5ebc6ced2b0e4ff535_I20201231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DeferredTaxAssetsInvestments",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R65":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i4076ace195c04c6b9b9407bf01234550_D20190913-20191231",
                    "decimals":  "3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
                    "reportCount":  1,
                    "unitRef":  "number",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2450430 - Disclosure - Income Taxes - Narrative (Details)",
                "role":  "http://www.gohealth.com/role/IncomeTaxesNarrativeDetails",
                "shortName":  "Income Taxes - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "ic6aec12007ce4716a1d69cba723a16a4_I20191231",
                    "decimals":  "INF",
                    "lang":  "en-US",
                    "name":  "us-gaap:UnrecognizedTaxBenefits",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R66":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2453431 - Disclosure - Revenue - Narrative (Details)",
                "role":  "http://www.gohealth.com/role/RevenueNarrativeDetails",
                "shortName":  "Revenue - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R67":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "ibb836458412d494f842f757175a54e88_D20190101-20190912",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FinancialDesignationPredecessorAndSuccessorFixedList",
                    "reportCount":  1,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2454432 - Disclosure - Revenue - Summary of Disaggregation of Revenue (Details)",
                "role":  "http://www.gohealth.com/role/RevenueSummaryofDisaggregationofRevenueDetails",
                "shortName":  "Revenue - Summary of Disaggregation of Revenue (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:DisaggregationOfRevenueTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i88b67c5a0f484bf9895295d41876d46a_D20190913-20191231",
                    "decimals":  "-3",
                    "lang":  "en-US",
                    "name":  "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R68":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i81de0d82273a4c5ebc6ced2b0e4ff535_I20201231",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CapitalLeasedAssetsGross",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2457433 - Disclosure - Commitments and Contingencies - Narrative (Details)",
                "role":  "http://www.gohealth.com/role/CommitmentsandContingenciesNarrativeDetails",
                "shortName":  "Commitments and Contingencies - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i81de0d82273a4c5ebc6ced2b0e4ff535_I20201231",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CapitalLeasedAssetsGross",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R69":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
                        "us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i81de0d82273a4c5ebc6ced2b0e4ff535_I20201231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CapitalLeasesFutureMinimumPaymentsDueCurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2458434 - Disclosure - Commitments and Contingencies - Future Minimum Lease Payments Under Non-cancelable Capital and Operating Leases (Details)",
                "role":  "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails",
                "shortName":  "Commitments and Contingencies - Future Minimum Lease Payments Under Non-cancelable Capital and Operating Leases (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
                        "us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i81de0d82273a4c5ebc6ced2b0e4ff535_I20201231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CapitalLeasesFutureMinimumPaymentsDueCurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R7":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "ibb836458412d494f842f757175a54e88_D20190101-20190912",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FinancialDesignationPredecessorAndSuccessorFixedList",
                    "reportCount":  1,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "1006007 - Statement - Consolidated Statements of Cash Flows",
                "role":  "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows",
                "shortName":  "Consolidated Statements of Cash Flows",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i4076ace195c04c6b9b9407bf01234550_D20190913-20191231",
                    "decimals":  "-3",
                    "lang":  "en-US",
                    "name":  "us-gaap:ShareBasedCompensation",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R70":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i4076ace195c04c6b9b9407bf01234550_D20190913-20191231",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "goco:RelatedPartyTransactionLeasePayments",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2460435 - Disclosure - Related Party Transactions (Details)",
                "role":  "http://www.gohealth.com/role/RelatedPartyTransactionsDetails",
                "shortName":  "Related Party Transactions (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i4076ace195c04c6b9b9407bf01234550_D20190913-20191231",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "goco:RelatedPartyTransactionLeasePayments",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R71":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:NumberOfOperatingSegments",
                    "reportCount":  1,
                    "unitRef":  "segment",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2463436 - Disclosure - Operating Segments and Significant Customers - Narrative (Details)",
                "role":  "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersNarrativeDetails",
                "shortName":  "Operating Segments and Significant Customers - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:NumberOfOperatingSegments",
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  "INF",
                    "lang":  "en-US",
                    "name":  "us-gaap:NumberOfReportableSegments",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "segment",
                    "xsiNil":  "false"
                    }
                },
            "R72":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "ibb836458412d494f842f757175a54e88_D20190101-20190912",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FinancialDesignationPredecessorAndSuccessorFixedList",
                    "reportCount":  1,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2464437 - Disclosure - Operating Segments and Significant Customers - Summary of Reconciliation of Operating Profit (Loss) from Segments to Consolidated (Details)",
                "role":  "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
                "shortName":  "Operating Segments and Significant Customers - Summary of Reconciliation of Operating Profit (Loss) from Segments to Consolidated (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i4076ace195c04c6b9b9407bf01234550_D20190913-20191231",
                    "decimals":  "-3",
                    "lang":  "en-US",
                    "name":  "goco:CorporateExpense",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R73":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "ibb836458412d494f842f757175a54e88_D20190101-20190912",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FinancialDesignationPredecessorAndSuccessorFixedList",
                    "reportCount":  1,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2465438 - Disclosure - Operating Segments and Significant Customers - Summary of Revenue by Major Customers by Reporting Segments (Details)",
                "role":  "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofRevenuebyMajorCustomersbyReportingSegmentsDetails",
                "shortName":  "Operating Segments and Significant Customers - Summary of Revenue by Major Customers by Reporting Segments (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i731b36b817764a718e67f76e9724a3bb_D20190913-20191231",
                    "decimals":  "2",
                    "lang":  "en-US",
                    "name":  "us-gaap:ConcentrationRiskPercentage1",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "number",
                    "xsiNil":  "false"
                    }
                },
            "R74":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "if3338f0efdcd4186ab1bf53ff6b5a0e4_D20200717-20200717",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "goco:InitialPublicOfferingLockUpPeriod",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2467439 - Disclosure - Subsequent Events (Details)",
                "role":  "http://www.gohealth.com/role/SubsequentEventsDetails",
                "shortName":  "Subsequent Events (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "if3338f0efdcd4186ab1bf53ff6b5a0e4_D20200717-20200717",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "goco:InitialPublicOfferingLockUpPeriod",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R8":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2101101 - Disclosure - Description of Business and Significant Accounting Policies",
                "role":  "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPolicies",
                "shortName":  "Description of Business and Significant Accounting Policies",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R9":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:BusinessCombinationDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2105102 - Disclosure - Acquisitions",
                "role":  "http://www.gohealth.com/role/Acquisitions",
                "shortName":  "Acquisitions",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "goco-20201231.htm",
                    "contextRef":  "i9b92f34a71b64fd68fc986d09039c027_D20200101-20201231",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:BusinessCombinationDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R9999":  {
                "firstAnchor":  null,
                "groupType":  "",
                "isDefault":  "false",
                "longName":  "Uncategorized Items - goco-20201231.htm",
                "role":  "http://xbrl.sec.gov/role/uncategorizedFacts",
                "shortName":  "Uncategorized Items - goco-20201231.htm",
                "subGroupType":  "",
                "uniqueAnchor":  null
                }
            },
        "segmentCount":  117,
        "tag":  {
            "dei_AmendmentFlag":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
                            "label":  "Amendment Flag",
                            "terseLabel":  "Amendment Flag"
                            }
                        }
                    },
                "localname":  "AmendmentFlag",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_CityAreaCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Area code of city",
                            "label":  "City Area Code",
                            "terseLabel":  "City Area Code"
                            }
                        }
                    },
                "localname":  "CityAreaCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_CoverAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Cover page.",
                            "label":  "Cover [Abstract]"
                            }
                        }
                    },
                "localname":  "CoverAbstract",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "dei_CurrentFiscalYearEndDate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "End date of current fiscal year in the format --MM-DD.",
                            "label":  "Current Fiscal Year End Date",
                            "terseLabel":  "Current Fiscal Year End Date"
                            }
                        }
                    },
                "localname":  "CurrentFiscalYearEndDate",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "gMonthDayItemType"
                },
            "dei_DocumentAnnualReport":  {
                "auth_ref":  [
                    "r592",
                    "r593",
                    "r594"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a form used as an annual report.",
                            "label":  "Document Annual Report",
                            "terseLabel":  "Document Annual Report"
                            }
                        }
                    },
                "localname":  "DocumentAnnualReport",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentFiscalPeriodFocus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Fiscal period values are FY, Q1, Q2, and Q3.   1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
                            "label":  "Document Fiscal Period Focus",
                            "terseLabel":  "Document Fiscal Period Focus"
                            }
                        }
                    },
                "localname":  "DocumentFiscalPeriodFocus",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "fiscalPeriodItemType"
                },
            "dei_DocumentFiscalYearFocus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "This is focus fiscal year of the document report in YYYY format.  For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus.  Example: 2006.",
                            "label":  "Document Fiscal Year Focus",
                            "terseLabel":  "Document Fiscal Year Focus"
                            }
                        }
                    },
                "localname":  "DocumentFiscalYearFocus",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "gYearItemType"
                },
            "dei_DocumentInformationLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Document Information [Line Items]",
                            "terseLabel":  "Document Information [Line Items]"
                            }
                        }
                    },
                "localname":  "DocumentInformationLineItems",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "stringItemType"
                },
            "dei_DocumentInformationTable":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
                            "label":  "Document Information [Table]",
                            "terseLabel":  "Document Information [Table]"
                            }
                        }
                    },
                "localname":  "DocumentInformationTable",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "stringItemType"
                },
            "dei_DocumentPeriodEndDate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The end date of the period reflected on the cover page if a periodic report.  For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date.  The format of the date is YYYY-MM-DD.",
                            "label":  "Document Period End Date",
                            "terseLabel":  "Document Period End Date"
                            }
                        }
                    },
                "localname":  "DocumentPeriodEndDate",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "dateItemType"
                },
            "dei_DocumentTransitionReport":  {
                "auth_ref":  [
                    "r595"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a form used as a transition report.",
                            "label":  "Document Transition Report",
                            "terseLabel":  "Document Transition Report"
                            }
                        }
                    },
                "localname":  "DocumentTransitionReport",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentType":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc).  The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
                            "label":  "Document Type",
                            "terseLabel":  "Document Type"
                            }
                        }
                    },
                "localname":  "DocumentType",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "submissionTypeItemType"
                },
            "dei_DocumentsIncorporatedByReferenceTextBlock":  {
                "auth_ref":  [
                    "r590"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Documents incorporated by reference.",
                            "label":  "Documents Incorporated by Reference [Text Block]",
                            "terseLabel":  "Documents Incorporated by Reference"
                            }
                        }
                    },
                "localname":  "DocumentsIncorporatedByReferenceTextBlock",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "dei_EntityAddressAddressLine1":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Address Line 1 such as Attn, Building Name, Street Name",
                            "label":  "Entity Address, Address Line One",
                            "terseLabel":  "Entity Address, Address Line One"
                            }
                        }
                    },
                "localname":  "EntityAddressAddressLine1",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressCityOrTown":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Name of the City or Town",
                            "label":  "Entity Address, City or Town",
                            "terseLabel":  "Entity Address, City or Town"
                            }
                        }
                    },
                "localname":  "EntityAddressCityOrTown",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressPostalZipCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Code for the postal or zip code",
                            "label":  "Entity Address, Postal Zip Code",
                            "terseLabel":  "Entity Address, Postal Zip Code"
                            }
                        }
                    },
                "localname":  "EntityAddressPostalZipCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressStateOrProvince":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Name of the state or province.",
                            "label":  "Entity Address, State or Province",
                            "terseLabel":  "Entity Address, State or Province"
                            }
                        }
                    },
                "localname":  "EntityAddressStateOrProvince",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "stateOrProvinceItemType"
                },
            "dei_EntityCentralIndexKey":  {
                "auth_ref":  [
                    "r596"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC.  It is commonly abbreviated as CIK.",
                            "label":  "Entity Central Index Key",
                            "terseLabel":  "Entity Central Index Key"
                            }
                        }
                    },
                "localname":  "EntityCentralIndexKey",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "centralIndexKeyItemType"
                },
            "dei_EntityCommonStockSharesOutstanding":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report.  Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
                            "label":  "Entity Common Stock, Shares Outstanding",
                            "terseLabel":  "Entity Common Stock, Shares Outstanding"
                            }
                        }
                    },
                "localname":  "EntityCommonStockSharesOutstanding",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "dei_EntityCurrentReportingStatus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days.  This information should be based on the registrant's current or most recent filing containing the related disclosure.",
                            "label":  "Entity Current Reporting Status",
                            "terseLabel":  "Entity Current Reporting Status"
                            }
                        }
                    },
                "localname":  "EntityCurrentReportingStatus",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_EntityDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "All the names of the entities being reported upon in a document.  Any legal structure used to conduct activities or to hold assets.  Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts.  This item does not include business and geographical segments which are included in the geographical or business segments domains.",
                            "label":  "Entity [Domain]",
                            "terseLabel":  "Entity [Domain]"
                            }
                        }
                    },
                "localname":  "EntityDomain",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails",
                    "http://www.gohealth.com/role/AcquisitionsSummaryofPurchaseConsiderationDetails",
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails",
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails",
                    "http://www.gohealth.com/role/StockholdersEquityandMembersEquityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "dei_EntityEmergingGrowthCompany":  {
                "auth_ref":  [
                    "r596"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate if registrant meets the emerging growth company criteria.",
                            "label":  "Entity Emerging Growth Company",
                            "terseLabel":  "Entity Emerging Growth Company"
                            }
                        }
                    },
                "localname":  "EntityEmergingGrowthCompany",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityExTransitionPeriod":  {
                "auth_ref":  [
                    "r598"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
                            "label":  "Entity Ex Transition Period",
                            "terseLabel":  "Entity Ex Transition Period"
                            }
                        }
                    },
                "localname":  "EntityExTransitionPeriod",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityFileNumber":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Commission file number.  The field allows up to 17 characters.  The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
                            "label":  "Entity File Number",
                            "terseLabel":  "Entity File Number"
                            }
                        }
                    },
                "localname":  "EntityFileNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "fileNumberItemType"
                },
            "dei_EntityFilerCategory":  {
                "auth_ref":  [
                    "r596"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate whether the registrant is one of the following:  Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer.  Definitions of these categories are stated in Rule 12b-2 of the Exchange Act.  This information should be based on the registrant's current or most recent filing containing the related disclosure.",
                            "label":  "Entity Filer Category",
                            "terseLabel":  "Entity Filer Category"
                            }
                        }
                    },
                "localname":  "EntityFilerCategory",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "filerCategoryItemType"
                },
            "dei_EntityIncorporationStateCountryCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Two-character EDGAR code representing the state or country of incorporation.",
                            "label":  "Entity Incorporation, State or Country Code",
                            "terseLabel":  "Entity Incorporation, State or Country Code"
                            }
                        }
                    },
                "localname":  "EntityIncorporationStateCountryCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "edgarStateCountryItemType"
                },
            "dei_EntityInteractiveDataCurrent":  {
                "auth_ref":  [
                    "r597"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
                            "label":  "Entity Interactive Data Current",
                            "terseLabel":  "Entity Interactive Data Current"
                            }
                        }
                    },
                "localname":  "EntityInteractiveDataCurrent",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_EntityRegistrantName":  {
                "auth_ref":  [
                    "r596"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
                            "label":  "Entity Registrant Name",
                            "terseLabel":  "Entity Registrant Name"
                            }
                        }
                    },
                "localname":  "EntityRegistrantName",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityShellCompany":  {
                "auth_ref":  [
                    "r596"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
                            "label":  "Entity Shell Company",
                            "terseLabel":  "Entity Shell Company"
                            }
                        }
                    },
                "localname":  "EntityShellCompany",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntitySmallBusiness":  {
                "auth_ref":  [
                    "r596"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicates that the company is a Smaller Reporting Company (SRC).",
                            "label":  "Entity Small Business",
                            "terseLabel":  "Entity Small Business"
                            }
                        }
                    },
                "localname":  "EntitySmallBusiness",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityTaxIdentificationNumber":  {
                "auth_ref":  [
                    "r596"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
                            "label":  "Entity Tax Identification Number",
                            "terseLabel":  "Entity Tax Identification Number"
                            }
                        }
                    },
                "localname":  "EntityTaxIdentificationNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "employerIdItemType"
                },
            "dei_EntityVoluntaryFilers":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
                            "label":  "Entity Voluntary Filers",
                            "terseLabel":  "Entity Voluntary Filers"
                            }
                        }
                    },
                "localname":  "EntityVoluntaryFilers",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_EntityWellKnownSeasonedIssuer":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
                            "label":  "Entity Well-known Seasoned Issuer",
                            "terseLabel":  "Entity Well-known Seasoned Issuer"
                            }
                        }
                    },
                "localname":  "EntityWellKnownSeasonedIssuer",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_IcfrAuditorAttestationFlag":  {
                "auth_ref":  [
                    "r592",
                    "r593",
                    "r594"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "ICFR Auditor Attestation Flag",
                            "terseLabel":  "ICFR Auditor Attestation Flag"
                            }
                        }
                    },
                "localname":  "IcfrAuditorAttestationFlag",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_LegalEntityAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The set of legal entities associated with a report.",
                            "label":  "Legal Entity [Axis]",
                            "terseLabel":  "Legal Entity [Axis]"
                            }
                        }
                    },
                "localname":  "LegalEntityAxis",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails",
                    "http://www.gohealth.com/role/AcquisitionsSummaryofPurchaseConsiderationDetails",
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails",
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails",
                    "http://www.gohealth.com/role/StockholdersEquityandMembersEquityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "dei_LocalPhoneNumber":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Local phone number for entity.",
                            "label":  "Local Phone Number",
                            "terseLabel":  "Local Phone Number"
                            }
                        }
                    },
                "localname":  "LocalPhoneNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_Security12bTitle":  {
                "auth_ref":  [
                    "r589"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Title of a 12(b) registered security.",
                            "label":  "Title of 12(b) Security",
                            "terseLabel":  "Title of 12(b) Security"
                            }
                        }
                    },
                "localname":  "Security12bTitle",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "securityTitleItemType"
                },
            "dei_SecurityExchangeName":  {
                "auth_ref":  [
                    "r591"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Name of the Exchange on which a security is registered.",
                            "label":  "Security Exchange Name",
                            "terseLabel":  "Security Exchange Name"
                            }
                        }
                    },
                "localname":  "SecurityExchangeName",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "edgarExchangeCodeItemType"
                },
            "dei_TradingSymbol":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Trading symbol of an instrument as listed on an exchange.",
                            "label":  "Trading Symbol",
                            "terseLabel":  "Trading Symbol"
                            }
                        }
                    },
                "localname":  "TradingSymbol",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Cover"
                    ],
                "xbrltype":  "tradingSymbolItemType"
                },
            "goco_A2019EarnoutMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "2019 Earnout",
                            "label":  "2019 Earnout [Member]",
                            "terseLabel":  "2019 Earnout"
                            }
                        }
                    },
                "localname":  "A2019EarnoutMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails",
                    "http://www.gohealth.com/role/FairValueMeasurementsSummaryofFairvalueoftheContingentConsiderationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_A2020EarnoutMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "2020 Earnout",
                            "label":  "2020 Earnout [Member]",
                            "terseLabel":  "2020 Earnout"
                            }
                        }
                    },
                "localname":  "A2020EarnoutMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails",
                    "http://www.gohealth.com/role/FairValueMeasurementsNarrativeDetails",
                    "http://www.gohealth.com/role/FairValueMeasurementsSummaryofFairvalueoftheContingentConsiderationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_APICShareBasedPaymentArrangementIncreaseForCostRecognitionPriorToTheTransactions":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Prior To The Transactions",
                            "label":  "APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Prior To The Transactions",
                            "terseLabel":  "Share-based compensation expense prior to the Transactions"
                            }
                        }
                    },
                "localname":  "APICShareBasedPaymentArrangementIncreaseForCostRecognitionPriorToTheTransactions",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_APICShareBasedPaymentArrangementIncreaseForCostRecognitionSubsequentToTheTransactions":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Subsequent To The Transactions",
                            "label":  "APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Subsequent To The Transactions",
                            "terseLabel":  "Share-based compensation expense subsequent to the Transactions"
                            }
                        }
                    },
                "localname":  "APICShareBasedPaymentArrangementIncreaseForCostRecognitionSubsequentToTheTransactions",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_AccruedBonusesAndCommissionsCurrent":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/BalanceSheetAccountsSummaryofAccruedLiabilitiesDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrued Bonuses And Commissions, Current",
                            "label":  "Accrued Bonuses And Commissions, Current",
                            "terseLabel":  "Bonuses and commissions"
                            }
                        }
                    },
                "localname":  "AccruedBonusesAndCommissionsCurrent",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsSummaryofAccruedLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_AdjustmentsToAdditionalPaidInCapitalSettlementOfContingentConsiderationLiability":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Adjustments To Additional Paid In Capital, Settlement Of Contingent Consideration Liability",
                            "label":  "Adjustments To Additional Paid In Capital, Settlement Of Contingent Consideration Liability",
                            "terseLabel":  "Assumption of contingent consideration liability by significant shareholder"
                            }
                        }
                    },
                "localname":  "AdjustmentsToAdditionalPaidInCapitalSettlementOfContingentConsiderationLiability",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_AlternateBaseRateMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Alternate Base Rate [Member]",
                            "terseLabel":  "Alternate Base Rate"
                            }
                        }
                    },
                "localname":  "AlternateBaseRateMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_AncillaryMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Ancillary member.",
                            "label":  "Ancillary [Member]",
                            "terseLabel":  "Ancillary"
                            }
                        }
                    },
                "localname":  "AncillaryMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/RevenueSummaryofDisaggregationofRevenueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_AnthemMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Anthem [Member]",
                            "terseLabel":  "Anthem"
                            }
                        }
                    },
                "localname":  "AnthemMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofRevenuebyMajorCustomersbyReportingSegmentsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_BlizzardMidcoLLCMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Blizzard Midco, LLC",
                            "label":  "Blizzard Midco, LLC [Member]",
                            "terseLabel":  "Blizzard Midco"
                            }
                        }
                    },
                "localname":  "BlizzardMidcoLLCMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_BlockerCompanyMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Blocker Company",
                            "label":  "Blocker Company [Member]",
                            "terseLabel":  "Blocker Company"
                            }
                        }
                    },
                "localname":  "BlockerCompanyMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_BlockerMergerMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Blocker Merger [Member]",
                            "terseLabel":  "Blocker Merger"
                            }
                        }
                    },
                "localname":  "BlockerMergerMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_BusinessCombinationComponentsOfPurchaseConsiderationLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Business combination components of purchase consideration [Line Items].",
                            "label":  "Business Combination Components Of Purchase Consideration [Line Items]",
                            "terseLabel":  "Business Combination Components of Purchase Consideration [Line Items]"
                            }
                        }
                    },
                "localname":  "BusinessCombinationComponentsOfPurchaseConsiderationLineItems",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsSummaryofPurchaseConsiderationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "goco_BusinessCombinationComponentsOfPurchaseConsiderationTable":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Business combination components of purchase consideration [Table].",
                            "label":  "Business Combination Components Of Purchase Consideration [Table]",
                            "terseLabel":  "Business Combination Components of Purchase Consideration [Table]"
                            }
                        }
                    },
                "localname":  "BusinessCombinationComponentsOfPurchaseConsiderationTable",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsSummaryofPurchaseConsiderationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "goco_BusinessCombinationComponentsOfPurchaseConsiderationTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Business combination components of purchase consideration [Table text block].",
                            "label":  "Business Combination Components Of Purchase Consideration [Table Text Block]",
                            "terseLabel":  "Summary of Purchase Consideration"
                            }
                        }
                    },
                "localname":  "BusinessCombinationComponentsOfPurchaseConsiderationTableTextBlock",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "goco_BusinessCombinationContingentConsiderationArrangementsSettlementPeriod":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Business Combination, Contingent Consideration Arrangements, Settlement Period",
                            "label":  "Business Combination, Contingent Consideration Arrangements, Settlement Period",
                            "terseLabel":  "Contingent consideration, settlement period"
                            }
                        }
                    },
                "localname":  "BusinessCombinationContingentConsiderationArrangementsSettlementPeriod",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "goco_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCommissionReceivableNonCurrent":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Business combination recognized identifiable assets acquired and liabilities assumed commission receivable non current.",
                            "label":  "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Commission Receivable, Non Current",
                            "terseLabel":  "Commissions receivable - non-current"
                            }
                        }
                    },
                "localname":  "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCommissionReceivableNonCurrent",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesContractWithCustomerLiabilityDeferredRevenue":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails":  {
                        "order":  8.0,
                        "parentTag":  "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Contract With Customer, Liability, Deferred Revenue",
                            "label":  "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Contract With Customer, Liability, Deferred Revenue",
                            "negatedTerseLabel":  "Deferred revenue"
                            }
                        }
                    },
                "localname":  "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesContractWithCustomerLiabilityDeferredRevenue",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesContractWithCustomerLiabilityCommissionsPayable":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails":  {
                        "order":  9.0,
                        "parentTag":  "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Contract With Customer, Liability, Commissions Payable",
                            "label":  "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Contract With Customer, Liability, Commissions Payable",
                            "negatedLabel":  "Commissions payable - non-current"
                            }
                        }
                    },
                "localname":  "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesContractWithCustomerLiabilityCommissionsPayable",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_BusinessCombinationSettlementOfContingentConsiderationSharesIssuedValue":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Business combination settlement of contingent consideration shares issued.",
                            "label":  "Business Combination, Settlement Of Contingent Consideration, Shares Issued, Value",
                            "terseLabel":  "Settlement of contingent consideration, shares issued, value"
                            }
                        }
                    },
                "localname":  "BusinessCombinationSettlementOfContingentConsiderationSharesIssuedValue",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_CapitalLeasesFutureMinimumPaymentsInterestAndTaxesIncludedInPayments":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Capital Leases, Future Minimum Payments, Interest And Taxes Included in Payments",
                            "label":  "Capital Leases, Future Minimum Payments, Interest And Taxes Included in Payments",
                            "negatedTerseLabel":  "Less: amounts representing interest and taxes"
                            }
                        }
                    },
                "localname":  "CapitalLeasesFutureMinimumPaymentsInterestAndTaxesIncludedInPayments",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_ClassACommonUnitsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Class a common units.",
                            "label":  "Class A Common Units [Member]",
                            "terseLabel":  "Class A Common Units"
                            }
                        }
                    },
                "localname":  "ClassACommonUnitsMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_ClassBCommonUnitsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Class b common units.",
                            "label":  "Class B Common Units [Member]",
                            "terseLabel":  "Class\u00a0B Common Units"
                            }
                        }
                    },
                "localname":  "ClassBCommonUnitsMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_ClassCIncentivePlanMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Class C Incentive Plan",
                            "label":  "Class C Incentive Plan [Member]",
                            "terseLabel":  "Class C Incentive Plan"
                            }
                        }
                    },
                "localname":  "ClassCIncentivePlanMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_CommissionMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Commission",
                            "label":  "Commission [Member]",
                            "terseLabel":  "Commission"
                            }
                        }
                    },
                "localname":  "CommissionMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsCommissionsReceivableDetails",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations",
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails",
                    "http://www.gohealth.com/role/RevenueSummaryofDisaggregationofRevenueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_CommonEarnoutStockMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Common earnout stock.",
                            "label":  "Common Earnout Stock [Member]",
                            "terseLabel":  "Common earnout stock"
                            }
                        }
                    },
                "localname":  "CommonEarnoutStockMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_CommonStockNumberOfVotesPerShareHeld":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Common Stock, Number Of Votes Per Share Held",
                            "label":  "Common Stock, Number Of Votes Per Share Held",
                            "terseLabel":  "Number of votes per common share held"
                            }
                        }
                    },
                "localname":  "CommonStockNumberOfVotesPerShareHeld",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails",
                    "http://www.gohealth.com/role/StockholdersEquityandMembersEquityDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "goco_CommonUnitHeld":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Common Unit, Held",
                            "label":  "Common Unit, Held",
                            "terseLabel":  "LLC interests held (in shares)"
                            }
                        }
                    },
                "localname":  "CommonUnitHeld",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "goco_ComputerEquipmentAndSoftwareMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Computer Equipment and Software",
                            "label":  "Computer Equipment and Software [Member]",
                            "terseLabel":  "Computer equipment and software"
                            }
                        }
                    },
                "localname":  "ComputerEquipmentAndSoftwareMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_ContingentConsiderationMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Contingent consideration [Member].",
                            "label":  "Contingent Consideration [Member]",
                            "terseLabel":  "Contingent consideration"
                            }
                        }
                    },
                "localname":  "ContingentConsiderationMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/FairValueMeasurementsNarrativeDetails",
                    "http://www.gohealth.com/role/FairValueMeasurementsSummaryofFairvalueoftheContingentConsiderationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_ContinuingEquityOwnersAndPermittedTransfereesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Continuing Equity Owners And Permitted Transferees",
                            "label":  "Continuing Equity Owners And Permitted Transferees [Member]",
                            "terseLabel":  "Continuing Equity Owners and permitted transferees"
                            }
                        }
                    },
                "localname":  "ContinuingEquityOwnersAndPermittedTransfereesMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/StockholdersEquityandMembersEquityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_ContinuingEquityOwnersMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Continuing Equity Owners",
                            "label":  "Continuing Equity Owners [Member]",
                            "terseLabel":  "Continuing Equity Owners"
                            }
                        }
                    },
                "localname":  "ContinuingEquityOwnersMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_ContractWithCustomerAssetRollForward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Contract with Customer, Asset",
                            "label":  "Contract with Customer, Asset [Roll Forward]",
                            "terseLabel":  "Contract with Customer, Asset [Roll Forward]"
                            }
                        }
                    },
                "localname":  "ContractWithCustomerAssetRollForward",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsCommissionsReceivableDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "goco_ContractWithCustomerLiabilityCurrentCommissionsPayable":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Contract With Customer, Liability, Current, Commissions Payable",
                            "label":  "Contract With Customer, Liability, Current, Commissions Payable",
                            "terseLabel":  "Commissions payable - current"
                            }
                        }
                    },
                "localname":  "ContractWithCustomerLiabilityCurrentCommissionsPayable",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_ContractWithCustomerLiabilityCurrentDeferredRevenue":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Contract With Customer, Liability, Current, Deferred Revenue",
                            "label":  "Contract With Customer, Liability, Current, Deferred Revenue",
                            "terseLabel":  "Deferred revenue"
                            }
                        }
                    },
                "localname":  "ContractWithCustomerLiabilityCurrentDeferredRevenue",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_ContractWithCustomerLiabilityNoncurrentCommissionsPayable":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LiabilitiesNoncurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Contract With Customer, Liability, Noncurrent, Commissions Payable",
                            "label":  "Contract With Customer, Liability, Noncurrent, Commissions Payable",
                            "terseLabel":  "Commissions payable - non-current"
                            }
                        }
                    },
                "localname":  "ContractWithCustomerLiabilityNoncurrentCommissionsPayable",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_CorporateExpense":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Corporate expense",
                            "label":  "Corporate Expense",
                            "terseLabel":  "Corporate expense"
                            }
                        }
                    },
                "localname":  "CorporateExpense",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_CouponRateOnSeniorPreferredSecurities":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Coupon rate on senior preferred securities.",
                            "label":  "Coupon Rate On Senior Preferred Securities",
                            "terseLabel":  "Coupon rate"
                            }
                        }
                    },
                "localname":  "CouponRateOnSeniorPreferredSecurities",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "goco_CurrentAndFormerEmployeesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Current And Former Employees",
                            "label":  "Current And Former Employees [Member]",
                            "terseLabel":  "Current and former employees"
                            }
                        }
                    },
                "localname":  "CurrentAndFormerEmployeesMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_CustomerCareAndEnrollmentMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Customer care and enrollment [Member].",
                            "label":  "Customer Care and Enrollment [Member]",
                            "terseLabel":  "Customer care and enrollment"
                            }
                        }
                    },
                "localname":  "CustomerCareAndEnrollmentMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofShareBasedCompensationExpensesbyOperatingFunctionDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_CustomerCareAndEnrollmentPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Customer Care And Enrollment, Policy",
                            "label":  "Customer Care And Enrollment, Policy [Policy Text Block]",
                            "terseLabel":  "Customer Care and Enrollment"
                            }
                        }
                    },
                "localname":  "CustomerCareAndEnrollmentPolicyPolicyTextBlock",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "goco_DebtInstrumentPeriodicPaymentPaymentPercentage":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Debt instrument periodic payment payment percentage.",
                            "label":  "Debt Instrument Periodic Payment Payment Percentage",
                            "terseLabel":  "Debt instrument periodic payment percentage"
                            }
                        }
                    },
                "localname":  "DebtInstrumentPeriodicPaymentPaymentPercentage",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "goco_DirectPartnerCampaignsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Direct Partner Campaigns",
                            "label":  "Direct Partner Campaigns [Member]",
                            "terseLabel":  "Direct Partner Campaigns"
                            }
                        }
                    },
                "localname":  "DirectPartnerCampaignsMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/RevenueSummaryofDisaggregationofRevenueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_EffectOfMergerShares":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Effect Of Merger, Shares",
                            "label":  "Effect Of Merger, Shares",
                            "terseLabel":  "Effect of the Blocker Merger (in shares)"
                            }
                        }
                    },
                "localname":  "EffectOfMergerShares",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "goco_EffectOfMergerValue":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Effect Of Merger, Value",
                            "label":  "Effect Of Merger, Value",
                            "negatedTerseLabel":  "Effect of the Blocker Merger"
                            }
                        }
                    },
                "localname":  "EffectOfMergerValue",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_EnterpriseMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Enterprise",
                            "label":  "Enterprise [Member]",
                            "terseLabel":  "Enterprise"
                            }
                        }
                    },
                "localname":  "EnterpriseMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations",
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails",
                    "http://www.gohealth.com/role/RevenueSummaryofDisaggregationofRevenueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_EnterpriseOtherMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Enterprise, Other",
                            "label":  "Enterprise, Other [Member]",
                            "terseLabel":  "Other"
                            }
                        }
                    },
                "localname":  "EnterpriseOtherMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/RevenueSummaryofDisaggregationofRevenueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_FiveCustomersMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Five Customers",
                            "label":  "Five Customers [Member]",
                            "terseLabel":  "Five customers"
                            }
                        }
                    },
                "localname":  "FiveCustomersMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_FixedIndemnityMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Fixed indemnity member.",
                            "label":  "Fixed Indemnity [Member]",
                            "terseLabel":  "Fixed Indemnity"
                            }
                        }
                    },
                "localname":  "FixedIndemnityMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/RevenueSummaryofDisaggregationofRevenueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_FourCustomersMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Four Customers",
                            "label":  "Four Customers [Member]",
                            "terseLabel":  "Four customers"
                            }
                        }
                    },
                "localname":  "FourCustomersMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_GoHealthHoldingsLLCMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "GoHealth Holdings, LLC",
                            "label":  "GoHealth Holdings, LLC [Member]",
                            "terseLabel":  "GHH, LLC"
                            }
                        }
                    },
                "localname":  "GoHealthHoldingsLLCMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails",
                    "http://www.gohealth.com/role/AcquisitionsSummaryofPurchaseConsiderationDetails",
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails",
                    "http://www.gohealth.com/role/StockholdersEquityandMembersEquityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_HumanaMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Humana [Member]",
                            "terseLabel":  "Humana"
                            }
                        }
                    },
                "localname":  "HumanaMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofRevenuebyMajorCustomersbyReportingSegmentsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_IncentiveSharePlanMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Incentive Share Plan",
                            "label":  "Incentive Share Plan [Member]",
                            "terseLabel":  "Incentive Share Plan"
                            }
                        }
                    },
                "localname":  "IncentiveSharePlanMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_IncreaseDecreaseInContractWithCustomerLiabilityCommissionsPayable":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  14.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Increase (Decrease) In Contract With Customer, Liability, Commissions Payable",
                            "label":  "Increase (Decrease) In Contract With Customer, Liability, Commissions Payable",
                            "verboseLabel":  "Commissions payable"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInContractWithCustomerLiabilityCommissionsPayable",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_IncreaseDecreaseInContractWithCustomerLiabilityDeferredRevenue":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  13.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Increase (Decrease) In Contract With Customer, Liability, Deferred Revenue",
                            "label":  "Increase (Decrease) In Contract With Customer, Liability, Deferred Revenue",
                            "terseLabel":  "Deferred revenue"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInContractWithCustomerLiabilityDeferredRevenue",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_IncrementalNo3RevolvingCreditFacilityMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Incremental no.\u00a03 revolving credit facility [Member].",
                            "label":  "Incremental No3 Revolving Credit Facility [Member]",
                            "terseLabel":  "Incremental No.3 Revolving Credit Facility"
                            }
                        }
                    },
                "localname":  "IncrementalNo3RevolvingCreditFacilityMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_IncrementalRevolvingCreditFacilityMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Incremental revolving credit facility [Member].",
                            "label":  "Incremental Revolving Credit Facility [Member]",
                            "terseLabel":  "Incremental Revolving Credit Facility"
                            }
                        }
                    },
                "localname":  "IncrementalRevolvingCreditFacilityMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_IncrementalTermLoanFacilityMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Incremental term loan facility [Member].",
                            "label":  "Incremental Term Loan Facility [Member]",
                            "terseLabel":  "Incremental Term Loan Facility"
                            }
                        }
                    },
                "localname":  "IncrementalTermLoanFacilityMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_IndividualAndFamilyPlanAndOtherExternalSegmentMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Individual And Family Plan And Other External Segment",
                            "label":  "Individual And Family Plan And Other External Segment [Member]",
                            "terseLabel":  "External channel"
                            }
                        }
                    },
                "localname":  "IndividualAndFamilyPlanAndOtherExternalSegmentMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_IndividualAndFamilyPlanAndOtherInternalSegmentMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Individual And Family Plan And Other Internal Segment",
                            "label":  "Individual And Family Plan And Other Internal Segment [Member]",
                            "terseLabel":  "Internal channel"
                            }
                        }
                    },
                "localname":  "IndividualAndFamilyPlanAndOtherInternalSegmentMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_IndividualAndFamilyPlanAndOtherMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Individual and Family Plan and Other [Member]",
                            "terseLabel":  "Individual and Family Plan and Other"
                            }
                        }
                    },
                "localname":  "IndividualAndFamilyPlanAndOtherMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_IndividualAndFamilyPlanMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Individual and family plan member.",
                            "label":  "Individual And Family Plan [Member]",
                            "terseLabel":  "Individual and Family Plan"
                            }
                        }
                    },
                "localname":  "IndividualAndFamilyPlanMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/RevenueSummaryofDisaggregationofRevenueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_InitialPublicOfferingLockUpPeriod":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Initial Public Offering, Lock-Up Period",
                            "label":  "Initial Public Offering, Lock-Up Period",
                            "terseLabel":  "Lock-up period"
                            }
                        }
                    },
                "localname":  "InitialPublicOfferingLockUpPeriod",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/SubsequentEventsDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "goco_IssuanceOfCommonEarnoutUnitsUnits":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Issuance of common earnout units units.",
                            "label":  "Issuance Of Common Earnout Units Units",
                            "verboseLabel":  "Issuance of common units (in shares)"
                            }
                        }
                    },
                "localname":  "IssuanceOfCommonEarnoutUnitsUnits",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "goco_IssuanceOfCommonEarnoutUnitsValue":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Issuance of common earnout units value.",
                            "label":  "Issuance Of Common Earnout Units Value",
                            "terseLabel":  "Issuance of Common Earnout Units"
                            }
                        }
                    },
                "localname":  "IssuanceOfCommonEarnoutUnitsValue",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_IssuanceOfCommonUnitsDuringThePeriodValue":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Issuance of common units during the period value.",
                            "label":  "Issuance Of Common Units During The Period Value",
                            "terseLabel":  "Issuance of common units"
                            }
                        }
                    },
                "localname":  "IssuanceOfCommonUnitsDuringThePeriodValue",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_IssuanceOfSeniorPreferredEarnoutUnitsUnits":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Issuance of senior preferred earnout units, units.",
                            "label":  "Issuance Of Senior Preferred Earnout Units Units",
                            "verboseLabel":  "Issuance of Senior Preferred Earnout Units (in shares)"
                            }
                        }
                    },
                "localname":  "IssuanceOfSeniorPreferredEarnoutUnitsUnits",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "goco_IssuanceOfSeniorPreferredEarnoutUnitsValue":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Issuance of senior preferred earnout units, value.",
                            "label":  "Issuance Of Senior Preferred Earnout Units Value",
                            "terseLabel":  "Issuance of Senior Preferred Earnout units"
                            }
                        }
                    },
                "localname":  "IssuanceOfSeniorPreferredEarnoutUnitsValue",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_LimitedLiabilityCompanyUnitsRedeemedShares":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Limited Liability Company Units Redeemed, Shares",
                            "label":  "Limited Liability Company Units Redeemed, Shares",
                            "terseLabel":  "LLC Interests Redeemed (in shares)"
                            }
                        }
                    },
                "localname":  "LimitedLiabilityCompanyUnitsRedeemedShares",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "goco_LineOfCreditBorrowingCapacityAsAPercentageOfTradeReceivables":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line of credit borrowing capacity as a percentage of trade receivables.",
                            "label":  "Line Of Credit Borrowing Capacity As A Percentage Of Trade Receivables",
                            "terseLabel":  "Line of credit current borrowing capacity as a percentage of trade receivables"
                            }
                        }
                    },
                "localname":  "LineOfCreditBorrowingCapacityAsAPercentageOfTradeReceivables",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "goco_LineOfCreditCurrentBorrowingCapacityAsAPercentageOfEnrollmentFeesEarned":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line of credit current borrowing capacity as a percentage of enrollment fees earned.",
                            "label":  "Line Of Credit Current Borrowing Capacity As A Percentage Of Enrollment Fees Earned",
                            "terseLabel":  "Line of credit current borrowing capacity as a percentage of enrollment/commission fees earned"
                            }
                        }
                    },
                "localname":  "LineOfCreditCurrentBorrowingCapacityAsAPercentageOfEnrollmentFeesEarned",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "goco_LineOfCreditFacilityMandatoryPrepaymentNotRequiredProceedsInvestedOrCommittedToBeInvestedPeriodPostReceiptOfProceeds":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line Of Credit Facility, Mandatory Prepayment Not Required, Proceeds Invested Or Committed To Be Invested, Period Post Receipt Of Proceeds",
                            "label":  "Line Of Credit Facility, Mandatory Prepayment Not Required, Proceeds Invested Or Committed To Be Invested, Period Post Receipt Of Proceeds",
                            "terseLabel":  "Mandatory prepayment, no prepayment required if net proceeds are invested (or committed to be invested), period post receipt of net proceeds"
                            }
                        }
                    },
                "localname":  "LineOfCreditFacilityMandatoryPrepaymentNotRequiredProceedsInvestedOrCommittedToBeInvestedPeriodPostReceiptOfProceeds",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "goco_LiquidationConditionMinimumVotingInterestRequiredAfterMerger":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Liquidation Condition, Minimum Voting Interest Required after Merger.",
                            "label":  "Liquidation Condition Minimum Voting Interest Required after Merger",
                            "verboseLabel":  "Percentage voting rights of common stock (less than)"
                            }
                        }
                    },
                "localname":  "LiquidationConditionMinimumVotingInterestRequiredAfterMerger",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/StockholdersEquityandMembersEquityDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "goco_MajorMedicalMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Major medical member.",
                            "label":  "Major Medical [Member]",
                            "terseLabel":  "Major Medical"
                            }
                        }
                    },
                "localname":  "MajorMedicalMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/RevenueSummaryofDisaggregationofRevenueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_MandatoryPrepaymentAsAPercentageOfAmountRaisedOnDebtIssue":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Mandatory prepayment as a percentage of amount raised on debt issue.",
                            "label":  "Mandatory Prepayment As A Percentage Of Amount Raised On Debt Issue",
                            "terseLabel":  "Mandatory prepayment as a percentage of amount raised on debt issue"
                            }
                        }
                    },
                "localname":  "MandatoryPrepaymentAsAPercentageOfAmountRaisedOnDebtIssue",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "goco_MandatoryPrepaymentAsAPercentageOfAssetsSold":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Mandatory prepayment as a percentage of assets sold.",
                            "label":  "Mandatory Prepayment As A Percentage Of Assets Sold",
                            "terseLabel":  "Mandatory prepayment as a percentage of assets sold"
                            }
                        }
                    },
                "localname":  "MandatoryPrepaymentAsAPercentageOfAssetsSold",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "goco_MandatoryPrepaymentPercentageTermLoanAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Mandatory Prepayment Percentage Term Loan [Axis]",
                            "terseLabel":  "Mandatory Prepayment Percentage Term Loan [Axis]"
                            }
                        }
                    },
                "localname":  "MandatoryPrepaymentPercentageTermLoanAxis",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "goco_MandatoryPrepaymentPercentageTermLoanDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Mandatory Prepayment Percentage Term Loan [Domain]",
                            "terseLabel":  "Mandatory Prepayment Percentage Term Loan [Domain]"
                            }
                        }
                    },
                "localname":  "MandatoryPrepaymentPercentageTermLoanDomain",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_MarketingAndAdvertisingPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Marketing And Advertising, Policy",
                            "label":  "Marketing And Advertising, Policy [Policy Text Block]",
                            "terseLabel":  "Marketing and Advertising"
                            }
                        }
                    },
                "localname":  "MarketingAndAdvertisingPolicyPolicyTextBlock",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "goco_MedicalAdvantageMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Medical advantage member.",
                            "label":  "Medical Advantage [Member]",
                            "terseLabel":  "Medicare Advantage"
                            }
                        }
                    },
                "localname":  "MedicalAdvantageMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/RevenueSummaryofDisaggregationofRevenueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_MedicareExternalSegmentMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Medicare External Segment",
                            "label":  "Medicare External Segment [Member]",
                            "terseLabel":  "External channel",
                            "verboseLabel":  "Medicare\u2014External"
                            }
                        }
                    },
                "localname":  "MedicareExternalSegmentMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails",
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_MedicareInternalSegmentMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Medicare Internal Segment",
                            "label":  "Medicare Internal Segment [Member]",
                            "terseLabel":  "Internal channel",
                            "verboseLabel":  "Medicare\u2014Internal"
                            }
                        }
                    },
                "localname":  "MedicareInternalSegmentMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails",
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_MedicareMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Medicare [Member]",
                            "terseLabel":  "Medicare"
                            }
                        }
                    },
                "localname":  "MedicareMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
                    "http://www.gohealth.com/role/RevenueSummaryofDisaggregationofRevenueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_MedicareSupplementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Medicare supplement member.",
                            "label":  "Medicare Supplement [Member]",
                            "terseLabel":  "Medicare Supplement"
                            }
                        }
                    },
                "localname":  "MedicareSupplementMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/RevenueSummaryofDisaggregationofRevenueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_NetDebtToLeverageRatio":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Net debt to leverage ratio.",
                            "label":  "Net debt to leverage ratio",
                            "terseLabel":  "Net debt to leverage ratio"
                            }
                        }
                    },
                "localname":  "NetDebtToLeverageRatio",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "pureItemType"
                },
            "goco_NetIncomeLossAttributableToParentSubsequentToReorganizationTransactions":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Net Income (Loss) Attributable to Parent, Subsequent To Reorganization Transactions",
                            "label":  "Net Income (Loss) Attributable to Parent, Subsequent To Reorganization Transactions",
                            "terseLabel":  "Net loss attributable to GoHealth, Inc."
                            }
                        }
                    },
                "localname":  "NetIncomeLossAttributableToParentSubsequentToReorganizationTransactions",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/NetLossPerShareReconciliationoftheNumeratorandDenominatorUsedintheCalculationofBasicandDilutedNetLossPerShareDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestPriorToTheTransactions":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Prior To The Transactions",
                            "label":  "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Prior To The Transactions",
                            "terseLabel":  "Net loss prior to the Transactions",
                            "verboseLabel":  "Less:  Net loss attributable to GoHealth, Inc. prior to the IPO"
                            }
                        }
                    },
                "localname":  "NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestPriorToTheTransactions",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity",
                    "http://www.gohealth.com/role/NetLossPerShareReconciliationoftheNumeratorandDenominatorUsedintheCalculationofBasicandDilutedNetLossPerShareDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestSubsequentToTheTransactions":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Subsequent To TheTransactions",
                            "label":  "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Subsequent To TheTransactions",
                            "terseLabel":  "Net loss subsequent to the Transactions"
                            }
                        }
                    },
                "localname":  "NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestSubsequentToTheTransactions",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_NoncontrollingInterestDecreaseFromRedemptionsOrPurchaseOfInterestsShares":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests, Shares",
                            "label":  "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests, Shares",
                            "negatedTerseLabel":  "Effect of purchase of LLC Interests (in shares)"
                            }
                        }
                    },
                "localname":  "NoncontrollingInterestDecreaseFromRedemptionsOrPurchaseOfInterestsShares",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "goco_NoncontrollingInterestIncreaseFromVestingOfProfitUnits":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Noncontrolling Interest, Increase From Vesting Of Profit Units",
                            "label":  "Noncontrolling Interest, Increase From Vesting Of Profit Units",
                            "terseLabel":  "Share-based compensation expense upon vesting of performance-based profit units"
                            }
                        }
                    },
                "localname":  "NoncontrollingInterestIncreaseFromVestingOfProfitUnits",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_NoncontrollingInterestsDecreaseFromSettlementOfSeniorPreferredEarnoutUnits":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Noncontrolling Interests, Decrease From Settlement Of Senior Preferred Earnout Units",
                            "label":  "Noncontrolling Interests, Decrease From Settlement Of Senior Preferred Earnout Units",
                            "negatedTerseLabel":  "Settlement of Senior Preferred Earnout Units"
                            }
                        }
                    },
                "localname":  "NoncontrollingInterestsDecreaseFromSettlementOfSeniorPreferredEarnoutUnits",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_NonexclusiveAircraftDryLeaseAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Non-Exclusive Aircraft Dry Lease Agreement",
                            "label":  "NonExclusive Aircraft Dry Lease Agreement [Member]",
                            "terseLabel":  "Non-Exclusive Aircraft Dry Lease Agreement"
                            }
                        }
                    },
                "localname":  "NonexclusiveAircraftDryLeaseAgreementMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_NorvaxLLCMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Norvax, LLC",
                            "label":  "Norvax, LLC [Member]",
                            "terseLabel":  "Norvax"
                            }
                        }
                    },
                "localname":  "NorvaxLLCMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails",
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails",
                    "http://www.gohealth.com/role/AcquisitionsSummaryofPurchaseConsiderationDetails",
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails",
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_NumberOfSharesOfLLCInterestsToClassBCommonStockRatio":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number Of Shares Of LLC Interests To Class B Common Stock, Ratio",
                            "label":  "Number Of Shares Of LLC Interests To Class B Common Stock, Ratio",
                            "terseLabel":  "Ratio of LLC Interests to Class B common stock"
                            }
                        }
                    },
                "localname":  "NumberOfSharesOfLLCInterestsToClassBCommonStockRatio",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails"
                    ],
                "xbrltype":  "pureItemType"
                },
            "goco_OfficeEquipmentAndFurnitureMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Office Equipment And Furniture",
                            "label":  "Office Equipment And Furniture [Member]",
                            "terseLabel":  "Office equipment and furniture"
                            }
                        }
                    },
                "localname":  "OfficeEquipmentAndFurnitureMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsSummaryofPropertyEquipmentandCapitalizedSoftwareNetDetails",
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPriorToTheTransactions":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Prior To The Transactions",
                            "label":  "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Prior To The Transactions",
                            "terseLabel":  "Foreign currency translation adjustment prior to the Transactions"
                            }
                        }
                    },
                "localname":  "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPriorToTheTransactions",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxSubsequentToTheTransactions":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Subsequent To The Transactions",
                            "label":  "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Subsequent To The Transactions",
                            "terseLabel":  "Foreign currency translation adjustment subsequent to the Transactions"
                            }
                        }
                    },
                "localname":  "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxSubsequentToTheTransactions",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_PartnerMarketingAndEnrollmentServicesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Partner Marketing And Enrollment Services",
                            "label":  "Partner Marketing And Enrollment Services [Member]",
                            "terseLabel":  "Partner Marketing and Enrollment Services"
                            }
                        }
                    },
                "localname":  "PartnerMarketingAndEnrollmentServicesMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/RevenueSummaryofDisaggregationofRevenueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_PaymentsForAdvanceToAffiliateFinancingActivities":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  14.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Payments For Advance To Affiliate, Financing Activities",
                            "label":  "Payments For Advance To Affiliate, Financing Activities",
                            "negatedTerseLabel":  "Advancement to NVX Holdings, Inc."
                            }
                        }
                    },
                "localname":  "PaymentsForAdvanceToAffiliateFinancingActivities",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_PaymentsForConsiderationForMergerFinancingActivities":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Payments For Consideration For Merger, Financing Activities",
                            "label":  "Payments For Consideration For Merger, Financing Activities",
                            "negatedTerseLabel":  "Payment of partial consideration to Blocker Shareholders in the Blocker Merger",
                            "terseLabel":  "Payment of partial consideration of the Blocker Merger"
                            }
                        }
                    },
                "localname":  "PaymentsForConsiderationForMergerFinancingActivities",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows",
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_PaymentsForRelatedPartyDistribution":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Payments For Related Party Distribution",
                            "label":  "Payments For Related Party Distribution",
                            "terseLabel":  "One-time tax distributions"
                            }
                        }
                    },
                "localname":  "PaymentsForRelatedPartyDistribution",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_PaymentsToAcquireNoncontrollingInterests":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Payments To Acquire Noncontrolling Interests",
                            "label":  "Payments To Acquire Noncontrolling Interests",
                            "negatedTerseLabel":  "Purchase of LLC Interests from Continuing Equity Owners",
                            "terseLabel":  "Payments to redeem LLC Interests"
                            }
                        }
                    },
                "localname":  "PaymentsToAcquireNoncontrollingInterests",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows",
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_PerformanceVestingUnitsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Performance-Vesting Units [Member]",
                            "label":  "Performance Vesting Units [Member]",
                            "terseLabel":  "Performance-Vesting Units"
                            }
                        }
                    },
                "localname":  "PerformanceVestingUnitsMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofProfitUnitsandRSUsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_PredecessorCreditFacilityMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Predecessor Credit Facility",
                            "label":  "Predecessor Credit Facility [Member]",
                            "terseLabel":  "Predecessor Credit Facility"
                            }
                        }
                    },
                "localname":  "PredecessorCreditFacilityMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_PreferredUnitsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Preferred units.",
                            "label":  "Preferred Units [Member]",
                            "terseLabel":  "Preferred Units"
                            }
                        }
                    },
                "localname":  "PreferredUnitsMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_PrepaymentAsAPercentageOfPrincipalAmountOutstanding":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Prepayment as a percentage of principal amount outstanding.",
                            "label":  "Prepayment As A Percentage Of Principal Amount Outstanding",
                            "terseLabel":  "Prepayment as a percentage of principal amount outstanding"
                            }
                        }
                    },
                "localname":  "PrepaymentAsAPercentageOfPrincipalAmountOutstanding",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "goco_PrepaymentPercentageOneMemberMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "prepayment percentage one member.",
                            "label":  "Prepayment Percentage One [Member]",
                            "terseLabel":  "Prepayment Percentage One"
                            }
                        }
                    },
                "localname":  "PrepaymentPercentageOneMemberMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_PrepaymentPercentageThreeMemberMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Prepayment percentage three member.",
                            "label":  "Prepayment Percentage Three Member [Member]",
                            "terseLabel":  "Prepayment Percentage Three"
                            }
                        }
                    },
                "localname":  "PrepaymentPercentageThreeMemberMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_PrepaymentPercentageTwoMemberMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Prepayment percentage two member.",
                            "label":  "Prepayment Percentage Two Member [Member]",
                            "terseLabel":  "Prepayment Percentage Two"
                            }
                        }
                    },
                "localname":  "PrepaymentPercentageTwoMemberMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_PrescriptionDrugPlansMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Prescription Drug Plans [Member]",
                            "terseLabel":  "Prescription Drug Plans"
                            }
                        }
                    },
                "localname":  "PrescriptionDrugPlansMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/RevenueSummaryofDisaggregationofRevenueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_ProfitUnitsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Profit Units [Member]",
                            "label":  "Profit Units [Member]",
                            "terseLabel":  "Profit Units"
                            }
                        }
                    },
                "localname":  "ProfitUnitsMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofValuationAssumptionsProfitUnitsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_PropertyPlantAndEquipmentExcludingCapitalizedComputerSoftwareMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Property, Plant, And Equipment Excluding Capitalized Computer Software",
                            "label":  "Property, Plant, And Equipment Excluding Capitalized Computer Software [Member]",
                            "terseLabel":  "Property and equipment"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentExcludingCapitalizedComputerSoftwareMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsSummaryofPropertyEquipmentandCapitalizedSoftwareNetDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_RelatedPartyTransactionLeasePayments":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Related Party Transaction, Lease Payments",
                            "label":  "Related Party Transaction, Lease Payments",
                            "terseLabel":  "Lease payments"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionLeasePayments",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_RelatedPartyTransactionRequiredPaymentForUseOfAircraftAmountPerFlightHour":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Related Party Transaction, Required Payment For Use Of Aircraft, Amount Per Flight Hour",
                            "label":  "Related Party Transaction, Required Payment For Use Of Aircraft, Amount Per Flight Hour",
                            "terseLabel":  "Amount required to pay per flight hour for use of aircraft"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionRequiredPaymentForUseOfAircraftAmountPerFlightHour",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_RelatedPartyTransactionTerminationWithoutCausePeriodOfRequiredWrittenNotice":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Related Party Transaction, Termination Without Cause, Period Of Required Written Notice",
                            "label":  "Related Party Transaction, Termination Without Cause, Period Of Required Written Notice",
                            "terseLabel":  "Agreement terminable without cause by either party, period of required prior written notice"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionTerminationWithoutCausePeriodOfRequiredWrittenNotice",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "goco_RestrictedStockUnitsAndOptionsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Restricted Stock Units and Options",
                            "label":  "Restricted Stock Units and Options [Member]",
                            "terseLabel":  "RSUs and Stock options"
                            }
                        }
                    },
                "localname":  "RestrictedStockUnitsAndOptionsMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_RevenueFromContractWithCustomerPaymentTerms":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Revenue From Contract with Customer, Payment Terms",
                            "label":  "Revenue From Contract with Customer, Payment Terms",
                            "terseLabel":  "Payment terms"
                            }
                        }
                    },
                "localname":  "RevenueFromContractWithCustomerPaymentTerms",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "goco_ScheduleOfShareBasedPaymentAwardValuationAssumptionsExcludingOptionTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule of Share-based Payment Award, Valuation Assumptions, Excluding Option",
                            "label":  "Schedule of Share-based Payment Award, Valuation Assumptions, Excluding Option [Table Text Block]",
                            "terseLabel":  "Schedule of Profit Unit Valuation Assumptions"
                            }
                        }
                    },
                "localname":  "ScheduleOfShareBasedPaymentAwardValuationAssumptionsExcludingOptionTableTextBlock",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "goco_SeasonalityPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Seasonality",
                            "label":  "Seasonality [Policy Text Block]",
                            "terseLabel":  "Seasonality"
                            }
                        }
                    },
                "localname":  "SeasonalityPolicyTextBlock",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "goco_SeniorPreferredEarnoutStockMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Senior preferred earnout stock.",
                            "label":  "Senior Preferred Earnout Stock [Member]",
                            "terseLabel":  "Senior preferred earnout stock"
                            }
                        }
                    },
                "localname":  "SeniorPreferredEarnoutStockMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_SeniorSecuredRevolvingCreditFacilityMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Senior Secured Revolving Credit Facility",
                            "label":  "Senior Secured Revolving Credit Facility [Member]",
                            "terseLabel":  "Revolving Credit Facility"
                            }
                        }
                    },
                "localname":  "SeniorSecuredRevolvingCreditFacilityMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_SettlementOfContingentConsiderationLiability":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Settlement Of Contingent Consideration Liability",
                            "label":  "Settlement Of Contingent Consideration Liability",
                            "terseLabel":  "Settlement of contingent consideration liability"
                            }
                        }
                    },
                "localname":  "SettlementOfContingentConsiderationLiability",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_ShareBasedCompensationAndTransactionBonusesAndCostsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-based Compensation And Transaction Bonuses And Costs",
                            "label":  "Share-based Compensation And Transaction Bonuses And Costs [Member]",
                            "terseLabel":  "Share-based compensation and transaction bonuses and costs"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationAndTransactionBonusesAndCostsMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Grant Date Fair Value",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Grant Date Fair Value",
                            "terseLabel":  "Exercisable, Weighted Average Grant Date Fair Value (in dollars per share)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofStockOptionsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "goco_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-based Compensation Arrangement By Share-based Payment Award, Options, Exercises In Period, Weighted Average Grant Date Fair Value",
                            "label":  "Share-based Compensation Arrangement By Share-based Payment Award, Options, Exercises In Period, Weighted Average Grant Date Fair Value",
                            "terseLabel":  "Exercised (in dollars per share)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofStockOptionsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "goco_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Forfeited In Period, Weighted Average Grant Date Fair Value",
                            "label":  "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Forfeited In Period, Weighted Average Grant Date Fair Value",
                            "terseLabel":  "Forfeited (in dollars per share)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofStockOptionsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "goco_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Grant Date Fair Value",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Grant Date Fair Value",
                            "periodEndLabel":  "Outstanding at end of period (in dollars per share)",
                            "periodStartLabel":  "Outstanding at beginning of period (in dollars per share)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofStockOptionsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "goco_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueRollForward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Grant Date Fair Value",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Grant Date Fair Value [Roll Forward]",
                            "terseLabel":  "Weighted Average Grant Date Fair Value"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueRollForward",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofStockOptionsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "goco_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingRightsPercentageOfAward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-Based Compensation Arrangement By Share-Based Payment Award, Vesting Rights, Percentage Of Award",
                            "label":  "Share-Based Compensation Arrangement By Share-Based Payment Award, Vesting Rights, Percentage Of Award",
                            "terseLabel":  "Percentage of award"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingRightsPercentageOfAward",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "goco_ShareBasedPaymentArrangementOptionsAndRestrictedStockUnitsRSUsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-Based Payment Arrangement, Options And Restricted Stock Units (RSUs)",
                            "label":  "Share-Based Payment Arrangement, Options And Restricted Stock Units (RSUs) [Member]",
                            "terseLabel":  "Stock options and RSUs"
                            }
                        }
                    },
                "localname":  "ShareBasedPaymentArrangementOptionsAndRestrictedStockUnitsRSUsMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/NetLossPerShareAntidilutiveSecuritiesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_ShareBasedPaymentArrangementTrancheFiveMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-Based Payment Arrangement, Tranche Five",
                            "label":  "Share-Based Payment Arrangement, Tranche Five [Member]",
                            "terseLabel":  "Vesting Installment Five"
                            }
                        }
                    },
                "localname":  "ShareBasedPaymentArrangementTrancheFiveMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_ShareBasedPaymentArrangementTrancheFourMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-Based Payment Arrangement, Tranche Four",
                            "label":  "Share-Based Payment Arrangement, Tranche Four [Member]",
                            "terseLabel":  "Vesting Installment Four"
                            }
                        }
                    },
                "localname":  "ShareBasedPaymentArrangementTrancheFourMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_ShortTermMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Short term member.",
                            "label":  "Short Term [Member]",
                            "terseLabel":  "Short-term"
                            }
                        }
                    },
                "localname":  "ShortTermMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/RevenueSummaryofDisaggregationofRevenueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_SmallGroupMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Small group member.",
                            "label":  "Small Group [Member]",
                            "terseLabel":  "Small Group"
                            }
                        }
                    },
                "localname":  "SmallGroupMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/RevenueSummaryofDisaggregationofRevenueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_StockholdersEquityChangeInReportingEntityShares":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stockholders' Equity, Change in Reporting Entity, Shares",
                            "label":  "Stockholders' Equity, Change in Reporting Entity, Shares",
                            "terseLabel":  "Effect of the Transactions (in shares)"
                            }
                        }
                    },
                "localname":  "StockholdersEquityChangeInReportingEntityShares",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "goco_StockholdersEquityNoteCommonStockConversionRatio":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stockholders' Equity Note, Common Stock, Conversion Ratio",
                            "label":  "Stockholders' Equity Note, Common Stock, Conversion Ratio",
                            "terseLabel":  "Common stock conversion ratio"
                            }
                        }
                    },
                "localname":  "StockholdersEquityNoteCommonStockConversionRatio",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/SubsequentEventsDetails"
                    ],
                "xbrltype":  "pureItemType"
                },
            "goco_StockholdersEquityNoteLLCInterestsToNewlyIssuedClassACommonStockConversionRatio":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stockholders' Equity Note, LLC Interests To Newly Issued Class A Common Stock, Conversion Ratio",
                            "label":  "Stockholders' Equity Note, LLC Interests To Newly Issued Class A Common Stock, Conversion Ratio",
                            "terseLabel":  "LLC Interests to newly issued Class A common stock, conversion ratio"
                            }
                        }
                    },
                "localname":  "StockholdersEquityNoteLLCInterestsToNewlyIssuedClassACommonStockConversionRatio",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/StockholdersEquityandMembersEquityDetails"
                    ],
                "xbrltype":  "pureItemType"
                },
            "goco_StockholdersEquityNoteNumberOfSharesOfClassACommonStockIssuedToNumberOfLLCInterestsOwnedRequiredRatio":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stockholders' Equity Note, Number Of Shares Of Class A Common Stock Issued To Number Of LLC Interests Owned, Required Ratio",
                            "label":  "Stockholders' Equity Note, Number Of Shares Of Class A Common Stock Issued To Number Of LLC Interests Owned, Required Ratio",
                            "terseLabel":  "Ratio between the number of shares of Class A common stock issued and the number of LLC Interests owned"
                            }
                        }
                    },
                "localname":  "StockholdersEquityNoteNumberOfSharesOfClassACommonStockIssuedToNumberOfLLCInterestsOwnedRequiredRatio",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/StockholdersEquityandMembersEquityDetails"
                    ],
                "xbrltype":  "pureItemType"
                },
            "goco_StockholdersEquityNoteNumberOfSharesOfClassBCommonStockOwnedToNumberOfLLCInterestsOwnedRequiredRatio":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stockholders' Equity Note, Number Of Shares Of Class B Common Stock Owned To Number Of LLC Interests Owned, Required Ratio",
                            "label":  "Stockholders' Equity Note, Number Of Shares Of Class B Common Stock Owned To Number Of LLC Interests Owned, Required Ratio",
                            "terseLabel":  "Ratio between the number of shares of Class B common stock owned and the number of LLC Interests owned"
                            }
                        }
                    },
                "localname":  "StockholdersEquityNoteNumberOfSharesOfClassBCommonStockOwnedToNumberOfLLCInterestsOwnedRequiredRatio",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/StockholdersEquityandMembersEquityDetails"
                    ],
                "xbrltype":  "pureItemType"
                },
            "goco_TaxDistributionToClassAAndClassBUnitHoldersPercent":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tax Distribution To Class A And Class B Unit Holders, Percent",
                            "label":  "Tax Distribution To Class A And Class B Unit Holders, Percent",
                            "terseLabel":  "Tax distribution to Class A and Class B unit holders, percent"
                            }
                        }
                    },
                "localname":  "TaxDistributionToClassAAndClassBUnitHoldersPercent",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/StockholdersEquityandMembersEquityDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "goco_TaxReceivableAgreementLiability":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tax Receivable Agreement, Liability",
                            "label":  "Tax Receivable Agreement, Liability",
                            "terseLabel":  "Tax Receivable Agreement, liability"
                            }
                        }
                    },
                "localname":  "TaxReceivableAgreementLiability",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_TaxReceivableAgreementPaymentAmountPercentOfRealizedOrRealizableIncomeTaxBenefits":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tax Receivable Agreement, Payment Amount, Percent Of Realized Or Realizable Income Tax Benefits",
                            "label":  "Tax Receivable Agreement, Payment Amount, Percent Of Realized Or Realizable Income Tax Benefits",
                            "terseLabel":  "Tax Receivable Agreement, payment, percent of amount of tax benefits realized or deemed to realize"
                            }
                        }
                    },
                "localname":  "TaxReceivableAgreementPaymentAmountPercentOfRealizedOrRealizableIncomeTaxBenefits",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesNarrativeDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "goco_TaxReceivableAgreementRemainingPercentOfTaxBenefitsThatMayBeRealized":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tax Receivable Agreement, Remaining Percent Of Tax Benefits That May Be Realized",
                            "label":  "Tax Receivable Agreement, Remaining Percent Of Tax Benefits That May Be Realized",
                            "terseLabel":  "Tax Receivable Agreement, percent of tax benefits that the Company may actually realize"
                            }
                        }
                    },
                "localname":  "TaxReceivableAgreementRemainingPercentOfTaxBenefitsThatMayBeRealized",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesNarrativeDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "goco_TechnologyPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Technology, Policy",
                            "label":  "Technology, Policy [Policy Text Block]",
                            "terseLabel":  "Technology"
                            }
                        }
                    },
                "localname":  "TechnologyPolicyPolicyTextBlock",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "goco_TermLoanFacilityMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Term loan facility [Member].",
                            "label":  "Term Loan Facility [Member]",
                            "terseLabel":  "Term Loan Facility"
                            }
                        }
                    },
                "localname":  "TermLoanFacilityMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_TimeVestingUnitsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Time based units [Member]",
                            "label":  "Time Vesting Units [Member]",
                            "terseLabel":  "Time-Vesting Units"
                            }
                        }
                    },
                "localname":  "TimeVestingUnitsMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofProfitUnitsandRSUsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_TransactionCost":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations":  {
                        "order":  8.0,
                        "parentTag":  "us-gaap_CostsAndExpenses",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Transaction cost.",
                            "label":  "Transaction Cost",
                            "terseLabel":  "Acquisition related transaction costs",
                            "verboseLabel":  "Acquisition related transaction costs"
                            }
                        }
                    },
                "localname":  "TransactionCost",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations",
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "goco_TwentyTwentyIncentiveAwardPlanMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Twenty Twenty Incentive Award Plan [Member]",
                            "terseLabel":  "2020 Incentive Award Plan"
                            }
                        }
                    },
                "localname":  "TwentyTwentyIncentiveAwardPlanMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_UnitedMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "United [Member]",
                            "terseLabel":  "United"
                            }
                        }
                    },
                "localname":  "UnitedMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofRevenuebyMajorCustomersbyReportingSegmentsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "goco_WilsonTechFiveMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Wilson tech five.",
                            "label":  "Wilson Tech Five [Member]",
                            "terseLabel":  "Wilson Tech Five"
                            }
                        }
                    },
                "localname":  "WilsonTechFiveMember",
                "nsuri":  "http://www.gohealth.com/20201231",
                "presentation":  [
                    "http://www.gohealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_ConsolidationItemsAxis":  {
                "auth_ref":  [
                    "r180",
                    "r192",
                    "r193",
                    "r194",
                    "r195",
                    "r196",
                    "r198",
                    "r202"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Consolidation Items [Axis]",
                            "terseLabel":  "Consolidation Items [Axis]"
                            }
                        }
                    },
                "localname":  "ConsolidationItemsAxis",
                "nsuri":  "http://fasb.org/srt/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_ConsolidationItemsDomain":  {
                "auth_ref":  [
                    "r180",
                    "r192",
                    "r193",
                    "r194",
                    "r195",
                    "r196",
                    "r198",
                    "r202"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Consolidation Items [Domain]",
                            "terseLabel":  "Consolidation Items [Domain]"
                            }
                        }
                    },
                "localname":  "ConsolidationItemsDomain",
                "nsuri":  "http://fasb.org/srt/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_CounterpartyNameAxis":  {
                "auth_ref":  [
                    "r58",
                    "r118"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Counterparty Name [Axis]",
                            "terseLabel":  "Counterparty Name [Axis]"
                            }
                        }
                    },
                "localname":  "CounterpartyNameAxis",
                "nsuri":  "http://fasb.org/srt/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails",
                    "http://www.gohealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_EquityMethodInvesteeNameDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Investment, Name [Domain]",
                            "terseLabel":  "Investment, Name [Domain]"
                            }
                        }
                    },
                "localname":  "EquityMethodInvesteeNameDomain",
                "nsuri":  "http://fasb.org/srt/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_MajorCustomersAxis":  {
                "auth_ref":  [
                    "r207",
                    "r312",
                    "r318",
                    "r564"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Customer [Axis]",
                            "terseLabel":  "Customer [Axis]"
                            }
                        }
                    },
                "localname":  "MajorCustomersAxis",
                "nsuri":  "http://fasb.org/srt/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails",
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofRevenuebyMajorCustomersbyReportingSegmentsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_MaximumMember":  {
                "auth_ref":  [
                    "r330",
                    "r332",
                    "r505",
                    "r506",
                    "r507",
                    "r508",
                    "r509",
                    "r510",
                    "r511",
                    "r562",
                    "r565"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Maximum [Member]",
                            "terseLabel":  "Maximum"
                            }
                        }
                    },
                "localname":  "MaximumMember",
                "nsuri":  "http://fasb.org/srt/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofValuationAssumptionsOptionsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_MinimumMember":  {
                "auth_ref":  [
                    "r330",
                    "r332",
                    "r505",
                    "r506",
                    "r507",
                    "r508",
                    "r509",
                    "r510",
                    "r511",
                    "r562",
                    "r565"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Minimum [Member]",
                            "terseLabel":  "Minimum"
                            }
                        }
                    },
                "localname":  "MinimumMember",
                "nsuri":  "http://fasb.org/srt/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofValuationAssumptionsOptionsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_NameOfMajorCustomerDomain":  {
                "auth_ref":  [
                    "r207",
                    "r312",
                    "r318",
                    "r564"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Customer [Domain]",
                            "terseLabel":  "Customer [Domain]"
                            }
                        }
                    },
                "localname":  "NameOfMajorCustomerDomain",
                "nsuri":  "http://fasb.org/srt/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails",
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofRevenuebyMajorCustomersbyReportingSegmentsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_OwnershipAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Ownership [Axis]",
                            "terseLabel":  "Ownership [Axis]"
                            }
                        }
                    },
                "localname":  "OwnershipAxis",
                "nsuri":  "http://fasb.org/srt/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_OwnershipDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Ownership [Domain]",
                            "terseLabel":  "Ownership [Domain]"
                            }
                        }
                    },
                "localname":  "OwnershipDomain",
                "nsuri":  "http://fasb.org/srt/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_ProductOrServiceAxis":  {
                "auth_ref":  [
                    "r204",
                    "r312",
                    "r316",
                    "r512",
                    "r561",
                    "r563"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Product and Service [Axis]",
                            "terseLabel":  "Product and Service [Axis]"
                            }
                        }
                    },
                "localname":  "ProductOrServiceAxis",
                "nsuri":  "http://fasb.org/srt/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsCommissionsReceivableDetails",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations",
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails",
                    "http://www.gohealth.com/role/RevenueSummaryofDisaggregationofRevenueDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_ProductsAndServicesDomain":  {
                "auth_ref":  [
                    "r204",
                    "r312",
                    "r316",
                    "r512",
                    "r561",
                    "r563"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Product and Service [Domain]",
                            "terseLabel":  "Product and Service [Domain]"
                            }
                        }
                    },
                "localname":  "ProductsAndServicesDomain",
                "nsuri":  "http://fasb.org/srt/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsCommissionsReceivableDetails",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations",
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails",
                    "http://www.gohealth.com/role/RevenueSummaryofDisaggregationofRevenueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_RangeAxis":  {
                "auth_ref":  [
                    "r324",
                    "r330",
                    "r332",
                    "r505",
                    "r506",
                    "r507",
                    "r508",
                    "r509",
                    "r510",
                    "r511",
                    "r562",
                    "r565"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statistical Measurement [Axis]",
                            "terseLabel":  "Statistical Measurement [Axis]"
                            }
                        }
                    },
                "localname":  "RangeAxis",
                "nsuri":  "http://fasb.org/srt/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails",
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofValuationAssumptionsOptionsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_RangeMember":  {
                "auth_ref":  [
                    "r324",
                    "r330",
                    "r332",
                    "r505",
                    "r506",
                    "r507",
                    "r508",
                    "r509",
                    "r510",
                    "r511",
                    "r562",
                    "r565"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statistical Measurement [Domain]",
                            "terseLabel":  "Statistical Measurement [Domain]"
                            }
                        }
                    },
                "localname":  "RangeMember",
                "nsuri":  "http://fasb.org/srt/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails",
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofValuationAssumptionsOptionsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_RepurchaseAgreementCounterpartyNameDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Counterparty Name [Domain]",
                            "terseLabel":  "Counterparty Name [Domain]"
                            }
                        }
                    },
                "localname":  "RepurchaseAgreementCounterpartyNameDomain",
                "nsuri":  "http://fasb.org/srt/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails",
                    "http://www.gohealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_RestatementAxis":  {
                "auth_ref":  [
                    "r126",
                    "r127",
                    "r128",
                    "r129",
                    "r130",
                    "r131",
                    "r134",
                    "r135",
                    "r136",
                    "r139",
                    "r140",
                    "r141",
                    "r142",
                    "r143",
                    "r156",
                    "r220",
                    "r221",
                    "r369",
                    "r401",
                    "r568",
                    "r569",
                    "r570",
                    "r571",
                    "r572",
                    "r573",
                    "r574",
                    "r575",
                    "r576",
                    "r577"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Revision of Prior Period [Axis]",
                            "terseLabel":  "Revision of Prior Period [Axis]"
                            }
                        }
                    },
                "localname":  "RestatementAxis",
                "nsuri":  "http://fasb.org/srt/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_RestatementDomain":  {
                "auth_ref":  [
                    "r126",
                    "r127",
                    "r128",
                    "r129",
                    "r130",
                    "r131",
                    "r134",
                    "r135",
                    "r136",
                    "r139",
                    "r140",
                    "r141",
                    "r142",
                    "r143",
                    "r156",
                    "r220",
                    "r221",
                    "r369",
                    "r401",
                    "r568",
                    "r569",
                    "r570",
                    "r571",
                    "r572",
                    "r573",
                    "r574",
                    "r575",
                    "r576",
                    "r577"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Revision of Prior Period [Domain]",
                            "terseLabel":  "Revision of Prior Period [Domain]"
                            }
                        }
                    },
                "localname":  "RestatementDomain",
                "nsuri":  "http://fasb.org/srt/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember":  {
                "auth_ref":  [
                    "r130",
                    "r131",
                    "r136",
                    "r220",
                    "r221",
                    "r369",
                    "r401",
                    "r568",
                    "r569",
                    "r570",
                    "r571",
                    "r572",
                    "r573",
                    "r574",
                    "r575",
                    "r576",
                    "r577"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Revision of Prior Period, Accounting Standards Update, Adjustment [Member]",
                            "verboseLabel":  "Cumulative effect of adoption of ASC 606"
                            }
                        }
                    },
                "localname":  "RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember",
                "nsuri":  "http://fasb.org/srt/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_ScenarioPreviouslyReportedMember":  {
                "auth_ref":  [
                    "r126",
                    "r128",
                    "r129",
                    "r130",
                    "r131",
                    "r134",
                    "r135",
                    "r136",
                    "r139",
                    "r140",
                    "r142",
                    "r143",
                    "r156",
                    "r220",
                    "r221",
                    "r369",
                    "r401",
                    "r568",
                    "r569",
                    "r570",
                    "r571",
                    "r572",
                    "r573",
                    "r574",
                    "r575",
                    "r576",
                    "r577"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Previously Reported [Member]",
                            "terseLabel":  "Previously reported"
                            }
                        }
                    },
                "localname":  "ScenarioPreviouslyReportedMember",
                "nsuri":  "http://fasb.org/srt/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis":  {
                "auth_ref":  [
                    "r214"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Investment, Name [Axis]",
                            "terseLabel":  "Investment, Name [Axis]"
                            }
                        }
                    },
                "localname":  "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
                "nsuri":  "http://fasb.org/srt/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_WeightedAverageMember":  {
                "auth_ref":  [
                    "r505",
                    "r507",
                    "r510"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Weighted Average [Member]",
                            "terseLabel":  "Weighted average"
                            }
                        }
                    },
                "localname":  "WeightedAverageMember",
                "nsuri":  "http://fasb.org/srt/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AccountingPoliciesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accounting Policies [Abstract]"
                            }
                        }
                    },
                "localname":  "AccountingPoliciesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AccountingStandardsUpdateExtensibleList":  {
                "auth_ref":  [
                    "r130",
                    "r131",
                    "r132",
                    "r133",
                    "r216",
                    "r217",
                    "r218",
                    "r219",
                    "r220",
                    "r221",
                    "r362",
                    "r363",
                    "r364",
                    "r365",
                    "r366",
                    "r367",
                    "r368",
                    "r369",
                    "r400",
                    "r401",
                    "r566",
                    "r567",
                    "r568",
                    "r569",
                    "r570",
                    "r571",
                    "r572",
                    "r573",
                    "r574",
                    "r575",
                    "r576",
                    "r577"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicates amendment to accounting standards.",
                            "label":  "Accounting Standards Update [Extensible List]",
                            "terseLabel":  "Accounting Standards Update [Extensible List]"
                            }
                        }
                    },
                "localname":  "AccountingStandardsUpdateExtensibleList",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "extensibleListItemType"
                },
            "us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis":  {
                "auth_ref":  [
                    "r55"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by billing status of receivables.",
                            "label":  "Billing Status, Type [Axis]",
                            "terseLabel":  "Billing Status, Type [Axis]"
                            }
                        }
                    },
                "localname":  "AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AccountsPayableCurrent":  {
                "auth_ref":  [
                    "r41"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accounts Payable, Current",
                            "terseLabel":  "Accounts payable"
                            }
                        }
                    },
                "localname":  "AccountsPayableCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccountsReceivableMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Due from customers or clients for goods or services that have been delivered or sold.",
                            "label":  "Accounts Receivable [Member]",
                            "terseLabel":  "Accounts receivable"
                            }
                        }
                    },
                "localname":  "AccountsReceivableMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AccountsReceivableNetCurrent":  {
                "auth_ref":  [
                    "r3",
                    "r25",
                    "r209",
                    "r210"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
                            "label":  "Accounts Receivable, after Allowance for Credit Loss, Current",
                            "terseLabel":  "Accounts receivable, net of allowance for doubtful accounts of $1,045 in 2020 and $904 in 2019",
                            "verboseLabel":  "Accounts receivable"
                            }
                        }
                    },
                "localname":  "AccountsReceivableNetCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets",
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedLiabilitiesCurrent":  {
                "auth_ref":  [
                    "r44"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/BalanceSheetAccountsSummaryofAccruedLiabilitiesDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        },
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.  Examples include taxes, interest, rent and utilities.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accrued Liabilities, Current",
                            "terseLabel":  "Accrued liabilities",
                            "totalLabel":  "Accrued liabilities"
                            }
                        }
                    },
                "localname":  "AccruedLiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsSummaryofAccruedLiabilitiesDetails",
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedMarketingCostsCurrent":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/BalanceSheetAccountsSummaryofAccruedLiabilitiesDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services.   Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accrued Marketing Costs, Current",
                            "terseLabel":  "Marketing costs"
                            }
                        }
                    },
                "localname":  "AccruedMarketingCostsCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsSummaryofAccruedLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedSalariesCurrent":  {
                "auth_ref":  [
                    "r7",
                    "r8",
                    "r44"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/BalanceSheetAccountsSummaryofAccruedLiabilitiesDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accrued Salaries, Current",
                            "terseLabel":  "Payroll"
                            }
                        }
                    },
                "localname":  "AccruedSalariesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsSummaryofAccruedLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment":  {
                "auth_ref":  [
                    "r39",
                    "r250"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
                            "label":  "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
                            "negatedTerseLabel":  "Less:  Accumulated depreciation and amortization"
                            }
                        }
                    },
                "localname":  "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsSummaryofPropertyEquipmentandCapitalizedSoftwareNetDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax":  {
                "auth_ref":  [
                    "r28",
                    "r62",
                    "r63",
                    "r64",
                    "r549",
                    "r573",
                    "r577"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end.  Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.  Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
                            "label":  "Accumulated Other Comprehensive Income (Loss), Net of Tax",
                            "terseLabel":  "Accumulated other comprehensive income (loss)"
                            }
                        }
                    },
                "localname":  "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccumulatedOtherComprehensiveIncomeMember":  {
                "auth_ref":  [
                    "r61",
                    "r64",
                    "r65",
                    "r126",
                    "r127",
                    "r129",
                    "r452",
                    "r568",
                    "r569"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent.  Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
                            "label":  "AOCI Attributable to Parent [Member]",
                            "terseLabel":  "Accumulated Other Comprehensive Income (Loss)"
                            }
                        }
                    },
                "localname":  "AccumulatedOtherComprehensiveIncomeMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AdditionalPaidInCapital":  {
                "auth_ref":  [
                    "r26",
                    "r369"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.  Includes adjustments to additional paid in capital.  Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees.  Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock.  For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock.  For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
                            "label":  "Additional Paid in Capital",
                            "terseLabel":  "Additional paid-in capital"
                            }
                        }
                    },
                "localname":  "AdditionalPaidInCapital",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdditionalPaidInCapitalMember":  {
                "auth_ref":  [
                    "r126",
                    "r127",
                    "r129",
                    "r366",
                    "r367",
                    "r368"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
                            "label":  "Additional Paid-in Capital [Member]",
                            "terseLabel":  "Additional Paid-In Capital"
                            }
                        }
                    },
                "localname":  "AdditionalPaidInCapitalMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue":  {
                "auth_ref":  [
                    "r334",
                    "r336",
                    "r372",
                    "r373"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
                            "label":  "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
                            "terseLabel":  "Share-based compensation expense"
                            }
                        }
                    },
                "localname":  "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
                            "terseLabel":  "Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:"
                            }
                        }
                    },
                "localname":  "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AdvertisingExpense":  {
                "auth_ref":  [
                    "r376"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
                            "label":  "Advertising Expense",
                            "terseLabel":  "Advertising expenses"
                            }
                        }
                    },
                "localname":  "AdvertisingExpense",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AllocatedShareBasedCompensationExpense":  {
                "auth_ref":  [
                    "r336",
                    "r359",
                    "r371"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of expense for award under share-based payment arrangement.  Excludes amount capitalized.",
                            "label":  "Share-based Payment Arrangement, Expense",
                            "terseLabel":  "Share-based compensation expense",
                            "verboseLabel":  "Total share-based compensation expense"
                            }
                        }
                    },
                "localname":  "AllocatedShareBasedCompensationExpense",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofShareBasedCompensationExpensesbyOperatingFunctionDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent":  {
                "auth_ref":  [
                    "r32",
                    "r211",
                    "r222"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of allowance for credit loss on accounts receivable, classified as current.",
                            "label":  "Accounts Receivable, Allowance for Credit Loss, Current",
                            "terseLabel":  "Allowance for doubtful accounts"
                            }
                        }
                    },
                "localname":  "AllowanceForDoubtfulAccountsReceivableCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheetsParenthetical"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AmortizationOfFinancingCostsAndDiscounts":  {
                "auth_ref":  [
                    "r102",
                    "r479"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
                            "label":  "Amortization of Debt Issuance Costs and Discounts",
                            "terseLabel":  "Amortization of debt discount and issuance costs"
                            }
                        }
                    },
                "localname":  "AmortizationOfFinancingCostsAndDiscounts",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AmortizationOfIntangibleAssets":  {
                "auth_ref":  [
                    "r102",
                    "r233",
                    "r241"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        },
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations":  {
                        "order":  7.0,
                        "parentTag":  "us-gaap_CostsAndExpenses",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets.  As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
                            "label":  "Amortization of Intangible Assets",
                            "terseLabel":  "Amortization of intangible assets"
                            }
                        }
                    },
                "localname":  "AmortizationOfIntangibleAssets",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations",
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount":  {
                "auth_ref":  [
                    "r153"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
                            "label":  "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
                            "terseLabel":  "Weighted-average potentially dilutive shares excluded from calculation of diluted loss per share because effect would be antidilutive (in shares)"
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/NetLossPerShareAntidilutiveSecuritiesDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis":  {
                "auth_ref":  [
                    "r153"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of antidilutive security.",
                            "label":  "Antidilutive Securities [Axis]",
                            "terseLabel":  "Antidilutive Securities [Axis]"
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/NetLossPerShareAntidilutiveSecuritiesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
                            "terseLabel":  "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/NetLossPerShareAntidilutiveSecuritiesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AntidilutiveSecuritiesNameDomain":  {
                "auth_ref":  [
                    "r153"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
                            "label":  "Antidilutive Securities, Name [Domain]",
                            "terseLabel":  "Antidilutive Securities, Name [Domain]"
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/NetLossPerShareAntidilutiveSecuritiesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_Assets":  {
                "auth_ref":  [
                    "r115",
                    "r188",
                    "r194",
                    "r200",
                    "r215",
                    "r447",
                    "r453",
                    "r466",
                    "r529",
                    "r547"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized.  Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
                            "label":  "Assets",
                            "totalLabel":  "Total assets"
                            }
                        }
                    },
                "localname":  "Assets",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AssetsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Assets [Abstract]",
                            "terseLabel":  "Assets"
                            }
                        }
                    },
                "localname":  "AssetsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AssetsCurrent":  {
                "auth_ref":  [
                    "r4",
                    "r5",
                    "r57",
                    "r115",
                    "r215",
                    "r447",
                    "r453",
                    "r466"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer).  Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
                            "label":  "Assets, Current",
                            "totalLabel":  "Total current assets"
                            }
                        }
                    },
                "localname":  "AssetsCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AssetsCurrentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Assets, Current [Abstract]",
                            "terseLabel":  "Current assets:"
                            }
                        }
                    },
                "localname":  "AssetsCurrentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AwardTypeAxis":  {
                "auth_ref":  [
                    "r337",
                    "r361"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of award under share-based payment arrangement.",
                            "label":  "Award Type [Axis]",
                            "terseLabel":  "Award Type [Axis]"
                            }
                        }
                    },
                "localname":  "AwardTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofProfitUnitsandRSUsIssuedtoEmployeesDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofValuationAssumptionsOptionsDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofValuationAssumptionsProfitUnitsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_BasisOfAccountingPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
                            "label":  "Basis of Accounting, Policy [Policy Text Block]",
                            "terseLabel":  "Basis of Presentation and Significant Accounting Policies"
                            }
                        }
                    },
                "localname":  "BasisOfAccountingPolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_BusinessAcquisitionAcquireeDomain":  {
                "auth_ref":  [
                    "r329",
                    "r331"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
                            "label":  "Business Acquisition, Acquiree [Domain]",
                            "terseLabel":  "Business Acquisition, Acquiree [Domain]"
                            }
                        }
                    },
                "localname":  "BusinessAcquisitionAcquireeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails",
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails",
                    "http://www.gohealth.com/role/AcquisitionsSummaryofPurchaseConsiderationDetails",
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_BusinessAcquisitionAxis":  {
                "auth_ref":  [
                    "r329",
                    "r331",
                    "r419",
                    "r420"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by business combination or series of individually immaterial business combinations.",
                            "label":  "Business Acquisition [Axis]",
                            "terseLabel":  "Business Acquisition [Axis]"
                            }
                        }
                    },
                "localname":  "BusinessAcquisitionAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails",
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails",
                    "http://www.gohealth.com/role/AcquisitionsSummaryofPurchaseConsiderationDetails",
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued":  {
                "auth_ref":  [
                    "r435"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares of equity interests issued or issuable to acquire entity.",
                            "label":  "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
                            "terseLabel":  "Business combination equity interest Issued (in shares)"
                            }
                        }
                    },
                "localname":  "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_BusinessAcquisitionLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Business Acquisition [Line Items]",
                            "terseLabel":  "Business Acquisition [Line Items]"
                            }
                        }
                    },
                "localname":  "BusinessAcquisitionLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails",
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired":  {
                "auth_ref":  [
                    "r415"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
                            "label":  "Business Acquisition, Percentage of Voting Interests Acquired",
                            "terseLabel":  "Percentage of voting interest acquired"
                            }
                        }
                    },
                "localname":  "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss":  {
                "auth_ref":  [
                    "r416",
                    "r417"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
                            "label":  "Business Acquisition, Pro Forma Net Income (Loss)",
                            "terseLabel":  "Pro forma net loss"
                            }
                        }
                    },
                "localname":  "BusinessAcquisitionsProFormaNetIncomeLoss",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_BusinessCombinationConsiderationTransferred1":  {
                "auth_ref":  [
                    "r429",
                    "r430",
                    "r432"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/AcquisitionsSummaryofPurchaseConsiderationDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
                            "label":  "Business Combination, Consideration Transferred",
                            "totalLabel":  "Total consideration"
                            }
                        }
                    },
                "localname":  "BusinessCombinationConsiderationTransferred1",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsSummaryofPurchaseConsiderationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable":  {
                "auth_ref":  [
                    "r429",
                    "r430"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/AcquisitionsSummaryofPurchaseConsiderationDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_BusinessCombinationConsiderationTransferred1",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
                            "label":  "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
                            "terseLabel":  "Consideration payable as shares",
                            "verboseLabel":  "Fair value of GHH, LLC Class A and B common units issued"
                            }
                        }
                    },
                "localname":  "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails",
                    "http://www.gohealth.com/role/AcquisitionsSummaryofPurchaseConsiderationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred":  {
                "auth_ref":  [
                    "r427",
                    "r429",
                    "r430",
                    "r434"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/AcquisitionsSummaryofPurchaseConsiderationDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_BusinessCombinationConsiderationTransferred1",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.",
                            "label":  "Business Combination, Consideration Transferred, Liabilities Incurred",
                            "terseLabel":  "Fair value of contingent consideration liability"
                            }
                        }
                    },
                "localname":  "BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsSummaryofPurchaseConsiderationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1":  {
                "auth_ref":  [
                    "r101",
                    "r438"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        },
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_CostsAndExpenses",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
                            "label":  "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
                            "terseLabel":  "Change in fair value of contingent consideration liability",
                            "verboseLabel":  "Change in fair value of contingent consideration"
                            }
                        }
                    },
                "localname":  "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations",
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh":  {
                "auth_ref":  [
                    "r437"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
                            "label":  "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
                            "terseLabel":  "Maximum contingent consideration"
                            }
                        }
                    },
                "localname":  "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_BusinessCombinationContingentConsiderationLiability":  {
                "auth_ref":  [
                    "r428",
                    "r431",
                    "r436"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_LiabilitiesNoncurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of liability recognized arising from contingent consideration in a business combination.",
                            "label":  "Business Combination, Contingent Consideration, Liability",
                            "terseLabel":  "Contingent consideration"
                            }
                        }
                    },
                "localname":  "BusinessCombinationContingentConsiderationLiability",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails",
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_BusinessCombinationDisclosureTextBlock":  {
                "auth_ref":  [
                    "r439"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.  The disclosure may include leverage buyout transactions (as applicable).",
                            "label":  "Business Combination Disclosure [Text Block]",
                            "terseLabel":  "Acquisitions"
                            }
                        }
                    },
                "localname":  "BusinessCombinationDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Acquisitions"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther":  {
                "auth_ref":  [
                    "r422"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.",
                            "label":  "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other",
                            "terseLabel":  "Net working capital"
                            }
                        }
                    },
                "localname":  "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill":  {
                "auth_ref":  [
                    "r422"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
                            "label":  "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
                            "terseLabel":  "Finite-lived intangibles"
                            }
                        }
                    },
                "localname":  "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther":  {
                "auth_ref":  [
                    "r422"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
                            "label":  "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
                            "negatedLabel":  "Other non-current liabilities"
                            }
                        }
                    },
                "localname":  "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets":  {
                "auth_ref":  [
                    "r422"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
                            "label":  "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
                            "terseLabel":  "Other non-current assets"
                            }
                        }
                    },
                "localname":  "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment":  {
                "auth_ref":  [
                    "r421",
                    "r422"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of property, plant, and equipment recognized as of the acquisition date.",
                            "label":  "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
                            "terseLabel":  "Property and equipment"
                            }
                        }
                    },
                "localname":  "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet":  {
                "auth_ref":  [
                    "r422"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
                            "label":  "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
                            "totalLabel":  "Total consideration transferred"
                            }
                        }
                    },
                "localname":  "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_BusinessCombinationsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Business Combinations [Abstract]"
                            }
                        }
                    },
                "localname":  "BusinessCombinationsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_BusinessCombinationsPolicy":  {
                "auth_ref":  [
                    "r111",
                    "r414"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control).  This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof.  An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
                            "label":  "Business Combinations Policy [Policy Text Block]",
                            "terseLabel":  "Business Combinations"
                            }
                        }
                    },
                "localname":  "BusinessCombinationsPolicy",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock":  {
                "auth_ref":  [
                    "r125",
                    "r174"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for the business description and accounting policies concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Accounting policies describe all significant accounting policies of the reporting entity.",
                            "label":  "Business Description and Accounting Policies [Text Block]",
                            "terseLabel":  "Description of Business and Significant Accounting Policies"
                            }
                        }
                    },
                "localname":  "BusinessDescriptionAndAccountingPoliciesTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_BusinessDevelopment":  {
                "auth_ref":  [
                    "r79"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_CostsAndExpenses",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Business development involves the development of products and services, their delivery, design and their implementation.  Business development includes a number of techniques designed to grow an economic enterprise.  Such techniques include, but are not limited to, assessments of marketing opportunities and target markets, intelligence gathering on customers and competitors, generating leads for possible sales, follow-up sales activity, formal proposal writing and business model design.  Business development involves evaluating a business and then realizing its full potential, using such tools as marketing, sales, information management and customer service.",
                            "label":  "Business Development",
                            "terseLabel":  "Customer care and enrollment"
                            }
                        }
                    },
                "localname":  "BusinessDevelopment",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CapitalExpendituresIncurredButNotYetPaid":  {
                "auth_ref":  [
                    "r107",
                    "r108",
                    "r109"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Future cash outflow to pay for purchases of fixed assets that have occurred.",
                            "label":  "Capital Expenditures Incurred but Not yet Paid",
                            "terseLabel":  "Purchases of property, equipment and software included in accounts payable"
                            }
                        }
                    },
                "localname":  "CapitalExpendituresIncurredButNotYetPaid",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CapitalLeaseObligationsCurrent":  {
                "auth_ref":  [
                    "r16",
                    "r487",
                    "r489"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of capital lease obligation due within one year or the normal operating cycle, if longer.",
                            "label":  "Capital Lease Obligations, Current",
                            "negatedTerseLabel":  "Less: current portion of the present value of minimum lease payments"
                            }
                        }
                    },
                "localname":  "CapitalLeaseObligationsCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CapitalLeaseObligationsIncurred":  {
                "auth_ref":  [
                    "r107",
                    "r108"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase in lease obligation from new lease.",
                            "label":  "Lease Obligation Incurred",
                            "terseLabel":  "Purchases of property, equipment and software under capital leases"
                            }
                        }
                    },
                "localname":  "CapitalLeaseObligationsIncurred",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CapitalLeaseObligationsNoncurrent":  {
                "auth_ref":  [
                    "r47",
                    "r487",
                    "r489"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.",
                            "label":  "Capital Lease Obligations, Noncurrent",
                            "terseLabel":  "Non-current liabilities, net of current portion"
                            }
                        }
                    },
                "localname":  "CapitalLeaseObligationsNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CapitalLeasedAssetsGross":  {
                "auth_ref":  [
                    "r486"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before accumulated depreciation of leased physical assets used in the normal conduct of business to produce goods and services.",
                            "label":  "Capital Leased Assets, Gross",
                            "terseLabel":  "Assets acquired under capital leases"
                            }
                        }
                    },
                "localname":  "CapitalLeasedAssetsGross",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentsandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CapitalLeasesBalanceSheetAssetsByMajorClassNet":  {
                "auth_ref":  [
                    "r488"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The total gross amount less the charge for the use of the long-lived depreciable assets subject to a lease meeting the criteria for capitalization.",
                            "label":  "Capital Leases, Balance Sheet, Assets by Major Class, Net",
                            "terseLabel":  "Net book value of assets under capital leases"
                            }
                        }
                    },
                "localname":  "CapitalLeasesBalanceSheetAssetsByMajorClassNet",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentsandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CapitalLeasesFutureMinimumPaymentsDue":  {
                "auth_ref":  [
                    "r489"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of minimum lease payments for capital leases.",
                            "label":  "Capital Leases, Future Minimum Payments Due",
                            "totalLabel":  "Total minimum lease payments"
                            }
                        }
                    },
                "localname":  "CapitalLeasesFutureMinimumPaymentsDue",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent":  {
                "auth_ref":  [
                    "r489"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_CapitalLeasesFutureMinimumPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of minimum lease payments for capital leases due in the next fiscal year following the latest fiscal year.  Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
                            "label":  "Capital Leases, Future Minimum Payments Due, Next Twelve Months",
                            "terseLabel":  "2021"
                            }
                        }
                    },
                "localname":  "CapitalLeasesFutureMinimumPaymentsDueCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears":  {
                "auth_ref":  [
                    "r489"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_CapitalLeasesFutureMinimumPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of minimum lease payments for capital leases due in the fifth fiscal year following the latest fiscal year.  Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
                            "label":  "Capital Leases, Future Minimum Payments Due in Five Years",
                            "terseLabel":  "2025"
                            }
                        }
                    },
                "localname":  "CapitalLeasesFutureMinimumPaymentsDueInFiveYears",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears":  {
                "auth_ref":  [
                    "r489"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_CapitalLeasesFutureMinimumPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of minimum lease payments for capital leases due in the fourth fiscal year following the latest fiscal year.  Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
                            "label":  "Capital Leases, Future Minimum Payments Due in Four Years",
                            "terseLabel":  "2024"
                            }
                        }
                    },
                "localname":  "CapitalLeasesFutureMinimumPaymentsDueInFourYears",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears":  {
                "auth_ref":  [
                    "r489"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_CapitalLeasesFutureMinimumPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of minimum lease payments for capital leases due in the third fiscal year following the latest fiscal year.  Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
                            "label":  "Capital Leases, Future Minimum Payments Due in Three Years",
                            "terseLabel":  "2023"
                            }
                        }
                    },
                "localname":  "CapitalLeasesFutureMinimumPaymentsDueInThreeYears",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears":  {
                "auth_ref":  [
                    "r489"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_CapitalLeasesFutureMinimumPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of minimum lease payments for capital leases due in the second fiscal year following the latest fiscal year.  Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
                            "label":  "Capital Leases, Future Minimum Payments Due in Two Years",
                            "terseLabel":  "2022"
                            }
                        }
                    },
                "localname":  "CapitalLeasesFutureMinimumPaymentsDueInTwoYears",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter":  {
                "auth_ref":  [
                    "r489"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_CapitalLeasesFutureMinimumPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of minimum lease payments for capital leases due after the fifth fiscal year following the latest fiscal year.  Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
                            "label":  "Capital Leases, Future Minimum Payments Due Thereafter",
                            "terseLabel":  "Thereafter"
                            }
                        }
                    },
                "localname":  "CapitalLeasesFutureMinimumPaymentsDueThereafter",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CapitalLeasesFutureMinimumPaymentsNetPresentValueAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Capital Leases, Future Minimum Payments, Net Present Value [Abstract]",
                            "terseLabel":  "Capital Leases"
                            }
                        }
                    },
                "localname":  "CapitalLeasesFutureMinimumPaymentsNetPresentValueAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CapitalUnitClassDomain":  {
                "auth_ref":  [
                    "r580"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Description of the type or class of capital units or capital shares.",
                            "label":  "Capital Unit, Class [Domain]",
                            "terseLabel":  "Capital Unit, Class [Domain]"
                            }
                        }
                    },
                "localname":  "CapitalUnitClassDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_CapitalUnitsByClassAxis":  {
                "auth_ref":  [
                    "r579",
                    "r581"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type or class of the entity's capital units.",
                            "label":  "Capital Units by Class [Axis]",
                            "terseLabel":  "Capital Units by Class [Axis]"
                            }
                        }
                    },
                "localname":  "CapitalUnitsByClassAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CapitalizedComputerSoftwareAmortization1":  {
                "auth_ref":  [
                    "r587",
                    "r588"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of expense for amortization of capitalized computer software costs.",
                            "label":  "Capitalized Computer Software, Amortization",
                            "terseLabel":  "Amortization expense related to computer software"
                            }
                        }
                    },
                "localname":  "CapitalizedComputerSoftwareAmortization1",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashAndCashEquivalentsAtCarryingValue":  {
                "auth_ref":  [
                    "r2",
                    "r36",
                    "r104"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of currency on hand as well as demand deposits with banks or financial institutions.  Includes other kinds of accounts that have the general characteristics of demand deposits.  Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.  Excludes cash and cash equivalents within disposal group and discontinued operation.",
                            "label":  "Cash and Cash Equivalents, at Carrying Value",
                            "terseLabel":  "Cash and cash equivalents"
                            }
                        }
                    },
                "localname":  "CashAndCashEquivalentsAtCarryingValue",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashAndCashEquivalentsPolicyTextBlock":  {
                "auth_ref":  [
                    "r13",
                    "r105",
                    "r111"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents.  Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
                            "label":  "Cash and Cash Equivalents, Policy [Policy Text Block]",
                            "terseLabel":  "Cash and Cash Equivalents"
                            }
                        }
                    },
                "localname":  "CashAndCashEquivalentsPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents":  {
                "auth_ref":  [
                    "r96",
                    "r104",
                    "r110"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage.  Excludes amount for disposal group and discontinued operations.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
                            "periodEndLabel":  "Cash and cash equivalents at end of period",
                            "periodStartLabel":  "Cash and cash equivalents at beginning of period"
                            }
                        }
                    },
                "localname":  "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect":  {
                "auth_ref":  [
                    "r96",
                    "r467"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
                            "totalLabel":  "Increase (decrease) in cash and cash equivalents"
                            }
                        }
                    },
                "localname":  "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
                            "terseLabel":  "Non-cash investing and financing activities:"
                            }
                        }
                    },
                "localname":  "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ClassOfStockDomain":  {
                "auth_ref":  [
                    "r113",
                    "r115",
                    "r146",
                    "r147",
                    "r148",
                    "r150",
                    "r152",
                    "r159",
                    "r161",
                    "r162",
                    "r215",
                    "r466"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share of stock differentiated by the voting rights the holder receives.  Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
                            "label":  "Class of Stock [Domain]",
                            "terseLabel":  "Class of Stock [Domain]",
                            "verboseLabel":  "Class of Stock [Domain]"
                            }
                        }
                    },
                "localname":  "ClassOfStockDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets",
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheetsParenthetical",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity",
                    "http://www.gohealth.com/role/Cover",
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails",
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails",
                    "http://www.gohealth.com/role/StockholdersEquityandMembersEquityDetails",
                    "http://www.gohealth.com/role/SubsequentEventsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ClassOfStockLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Class of Stock [Line Items]",
                            "terseLabel":  "Class of Stock [Line Items]"
                            }
                        }
                    },
                "localname":  "ClassOfStockLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails",
                    "http://www.gohealth.com/role/StockholdersEquityandMembersEquityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CommitmentsAndContingencies":  {
                "auth_ref":  [
                    "r49",
                    "r259",
                    "r535",
                    "r554"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
                            "label":  "Commitments and Contingencies",
                            "terseLabel":  "Commitments and Contingencies (Note 12)"
                            }
                        }
                    },
                "localname":  "CommitmentsAndContingencies",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CommitmentsAndContingenciesDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Commitments and Contingencies Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "CommitmentsAndContingenciesDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock":  {
                "auth_ref":  [
                    "r256",
                    "r257",
                    "r258",
                    "r267"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for commitments and contingencies.",
                            "label":  "Commitments and Contingencies Disclosure [Text Block]",
                            "terseLabel":  "Commitments and Contingencies"
                            }
                        }
                    },
                "localname":  "CommitmentsAndContingenciesDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentsandContingencies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_CommitmentsAndContingenciesPolicyTextBlock":  {
                "auth_ref":  [
                    "r111",
                    "r270",
                    "r582",
                    "r583"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
                            "label":  "Commitments and Contingencies, Policy [Policy Text Block]",
                            "terseLabel":  "Contingencies"
                            }
                        }
                    },
                "localname":  "CommitmentsAndContingenciesPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_CommonClassAMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Classification of common stock representing ownership interest in a corporation.",
                            "label":  "Common Class A [Member]",
                            "terseLabel":  "Class A Common Stock"
                            }
                        }
                    },
                "localname":  "CommonClassAMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets",
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheetsParenthetical",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity",
                    "http://www.gohealth.com/role/Cover",
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails",
                    "http://www.gohealth.com/role/StockholdersEquityandMembersEquityDetails",
                    "http://www.gohealth.com/role/SubsequentEventsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_CommonClassBMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
                            "label":  "Common Class B [Member]",
                            "terseLabel":  "Class B common stock",
                            "verboseLabel":  "Class B Common Stock"
                            }
                        }
                    },
                "localname":  "CommonClassBMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets",
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheetsParenthetical",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity",
                    "http://www.gohealth.com/role/Cover",
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails",
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails",
                    "http://www.gohealth.com/role/NetLossPerShareAntidilutiveSecuritiesDetails",
                    "http://www.gohealth.com/role/StockholdersEquityandMembersEquityDetails",
                    "http://www.gohealth.com/role/SubsequentEventsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance":  {
                "auth_ref":  [
                    "r51"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate number of common shares reserved for future issuance.",
                            "label":  "Common Stock, Capital Shares Reserved for Future Issuance",
                            "terseLabel":  "Shares reserved for issuance (in shares)"
                            }
                        }
                    },
                "localname":  "CommonStockCapitalSharesReservedForFutureIssuance",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockMember":  {
                "auth_ref":  [
                    "r126",
                    "r127"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock that is subordinate to all other stock of the issuer.",
                            "label":  "Common Stock [Member]",
                            "terseLabel":  "Common Stock"
                            }
                        }
                    },
                "localname":  "CommonStockMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity",
                    "http://www.gohealth.com/role/SubsequentEventsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_CommonStockParOrStatedValuePerShare":  {
                "auth_ref":  [
                    "r24"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Face amount or stated value per share of common stock.",
                            "label":  "Common Stock, Par or Stated Value Per Share",
                            "terseLabel":  "Common stock, par value (in dollars per share)"
                            }
                        }
                    },
                "localname":  "CommonStockParOrStatedValuePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheetsParenthetical",
                    "http://www.gohealth.com/role/StockholdersEquityandMembersEquityDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_CommonStockSharesAuthorized":  {
                "auth_ref":  [
                    "r24"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
                            "label":  "Common Stock, Shares Authorized",
                            "terseLabel":  "Common stock, shares authorized (in shares)"
                            }
                        }
                    },
                "localname":  "CommonStockSharesAuthorized",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheetsParenthetical",
                    "http://www.gohealth.com/role/StockholdersEquityandMembersEquityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockSharesIssued":  {
                "auth_ref":  [
                    "r24"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury).  These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized.  Shares issued include shares outstanding and shares held in the treasury.",
                            "label":  "Common Stock, Shares, Issued",
                            "terseLabel":  "Common stock, shares issued (in shares)"
                            }
                        }
                    },
                "localname":  "CommonStockSharesIssued",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheetsParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockSharesOutstanding":  {
                "auth_ref":  [
                    "r24",
                    "r281"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares of common stock outstanding.  Common stock represent the ownership interest in a corporation.",
                            "label":  "Common Stock, Shares, Outstanding",
                            "periodEndLabel":  "Ending balance (in shares)",
                            "terseLabel":  "Common stock, shares outstanding (in shares)"
                            }
                        }
                    },
                "localname":  "CommonStockSharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheetsParenthetical",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockValue":  {
                "auth_ref":  [
                    "r24"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer).  This item includes treasury stock repurchased by the entity.  Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
                            "label":  "Common Stock, Value, Issued",
                            "terseLabel":  "Common stock"
                            }
                        }
                    },
                "localname":  "CommonStockValue",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ComponentsOfDeferredTaxAssetsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Components of Deferred Tax Assets [Abstract]",
                            "terseLabel":  "Deferred tax assets:"
                            }
                        }
                    },
                "localname":  "ComponentsOfDeferredTaxAssetsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Components of Deferred Tax Liabilities [Abstract]",
                            "terseLabel":  "Deferred tax liabilities:"
                            }
                        }
                    },
                "localname":  "ComponentsOfDeferredTaxLiabilitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ComprehensiveIncomeNetOfTax":  {
                "auth_ref":  [
                    "r67",
                    "r69",
                    "r70",
                    "r77",
                    "r540",
                    "r558"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity.  Excludes changes in equity resulting from investments by owners and distributions to owners.",
                            "label":  "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
                            "totalLabel":  "Comprehensive income (loss) attributable to GoHealth, Inc."
                            }
                        }
                    },
                "localname":  "ComprehensiveIncomeNetOfTax",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest":  {
                "auth_ref":  [
                    "r67",
                    "r69",
                    "r76",
                    "r443",
                    "r444",
                    "r457",
                    "r539",
                    "r557"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_ComprehensiveIncomeNetOfTax",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests.  Excludes changes in equity resulting from investments by owners and distributions to owners.",
                            "label":  "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
                            "terseLabel":  "Comprehensive loss attributable to non-controlling interests"
                            }
                        }
                    },
                "localname":  "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest":  {
                "auth_ref":  [
                    "r67",
                    "r69",
                    "r75",
                    "r442",
                    "r457",
                    "r538",
                    "r556"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_ComprehensiveIncomeNetOfTax",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income.  Excludes changes in equity resulting from investments by owners and distributions to owners.",
                            "label":  "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
                            "totalLabel":  "Comprehensive income (loss)"
                            }
                        }
                    },
                "localname":  "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ComputerEquipmentMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
                            "label":  "Computer Equipment [Member]",
                            "terseLabel":  "Computer equipment"
                            }
                        }
                    },
                "localname":  "ComputerEquipmentMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsSummaryofPropertyEquipmentandCapitalizedSoftwareNetDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ConcentrationRiskBenchmarkDomain":  {
                "auth_ref":  [
                    "r169",
                    "r170",
                    "r207",
                    "r464",
                    "r465"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The denominator in a calculation of a disclosed concentration risk percentage.",
                            "label":  "Concentration Risk Benchmark [Domain]",
                            "terseLabel":  "Concentration Risk Benchmark [Domain]"
                            }
                        }
                    },
                "localname":  "ConcentrationRiskBenchmarkDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails",
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofRevenuebyMajorCustomersbyReportingSegmentsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ConcentrationRiskByBenchmarkAxis":  {
                "auth_ref":  [
                    "r169",
                    "r170",
                    "r207",
                    "r464",
                    "r465",
                    "r578"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by benchmark of concentration risk.",
                            "label":  "Concentration Risk Benchmark [Axis]",
                            "terseLabel":  "Concentration Risk Benchmark [Axis]"
                            }
                        }
                    },
                "localname":  "ConcentrationRiskByBenchmarkAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails",
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofRevenuebyMajorCustomersbyReportingSegmentsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ConcentrationRiskByTypeAxis":  {
                "auth_ref":  [
                    "r169",
                    "r170",
                    "r207",
                    "r464",
                    "r465",
                    "r578"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
                            "label":  "Concentration Risk Type [Axis]",
                            "terseLabel":  "Concentration Risk Type [Axis]"
                            }
                        }
                    },
                "localname":  "ConcentrationRiskByTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails",
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofRevenuebyMajorCustomersbyReportingSegmentsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ConcentrationRiskCreditRisk":  {
                "auth_ref":  [
                    "r165",
                    "r544"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for credit risk.",
                            "label":  "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
                            "terseLabel":  "Concentration of Credit Risk"
                            }
                        }
                    },
                "localname":  "ConcentrationRiskCreditRisk",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ConcentrationRiskPercentage1":  {
                "auth_ref":  [
                    "r169",
                    "r170",
                    "r207",
                    "r464",
                    "r465"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
                            "label":  "Concentration Risk, Percentage",
                            "terseLabel":  "Revenue reported by segment, percent",
                            "verboseLabel":  "Concentration risk, percentage"
                            }
                        }
                    },
                "localname":  "ConcentrationRiskPercentage1",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails",
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofRevenuebyMajorCustomersbyReportingSegmentsDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ConcentrationRiskTypeDomain":  {
                "auth_ref":  [
                    "r169",
                    "r170",
                    "r207",
                    "r464",
                    "r465"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
                            "label":  "Concentration Risk Type [Domain]",
                            "terseLabel":  "Concentration Risk Type [Domain]"
                            }
                        }
                    },
                "localname":  "ConcentrationRiskTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails",
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofRevenuebyMajorCustomersbyReportingSegmentsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ContingentConsiderationByTypeAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of contingent consideration.",
                            "label":  "Contingent Consideration by Type [Axis]",
                            "terseLabel":  "Contingent Consideration by Type [Axis]"
                            }
                        }
                    },
                "localname":  "ContingentConsiderationByTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails",
                    "http://www.gohealth.com/role/FairValueMeasurementsNarrativeDetails",
                    "http://www.gohealth.com/role/FairValueMeasurementsSummaryofFairvalueoftheContingentConsiderationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ContingentConsiderationTypeDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Description of contingent payment arrangement.",
                            "label":  "Contingent Consideration Type [Domain]",
                            "terseLabel":  "Contingent Consideration Type [Domain]"
                            }
                        }
                    },
                "localname":  "ContingentConsiderationTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails",
                    "http://www.gohealth.com/role/FairValueMeasurementsNarrativeDetails",
                    "http://www.gohealth.com/role/FairValueMeasurementsSummaryofFairvalueoftheContingentConsiderationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock":  {
                "auth_ref":  [
                    "r294"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer.  Includes, but is not limited to, change in contract asset and contract liability.",
                            "label":  "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
                            "terseLabel":  "Summary of Commissions Receivable Activity"
                            }
                        }
                    },
                "localname":  "ContractWithCustomerAssetAndLiabilityTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ContractWithCustomerAssetCreditLossExpense":  {
                "auth_ref":  [
                    "r223",
                    "r293",
                    "r311"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
                            "label":  "Contract with Customer, Asset, Credit Loss Expense (Reversal)",
                            "terseLabel":  "Commissions receivable impairment loss"
                            }
                        }
                    },
                "localname":  "ContractWithCustomerAssetCreditLossExpense",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ContractWithCustomerAssetNet":  {
                "auth_ref":  [
                    "r290",
                    "r291",
                    "r313"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/BalanceSheetAccountsCommissionsReceivableDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
                            "label":  "Contract with Customer, Asset, after Allowance for Credit Loss",
                            "periodEndLabel":  "Ending balance",
                            "periodStartLabel":  "Beginning balance"
                            }
                        }
                    },
                "localname":  "ContractWithCustomerAssetNet",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsCommissionsReceivableDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ContractWithCustomerAssetNetCurrent":  {
                "auth_ref":  [
                    "r290",
                    "r291",
                    "r313"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/BalanceSheetAccountsCommissionsReceivableDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_ContractWithCustomerAssetNet",
                        "weight":  1.0
                        },
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
                            "label":  "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
                            "terseLabel":  "Commissions receivable - current",
                            "verboseLabel":  "Less:  Commissions receivable \u2013 current"
                            }
                        }
                    },
                "localname":  "ContractWithCustomerAssetNetCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsCommissionsReceivableDetails",
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ContractWithCustomerAssetNetNoncurrent":  {
                "auth_ref":  [
                    "r290",
                    "r291",
                    "r313"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/BalanceSheetAccountsCommissionsReceivableDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_ContractWithCustomerAssetNet",
                        "weight":  1.0
                        },
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as noncurrent.",
                            "label":  "Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent",
                            "terseLabel":  "Commissions receivable - non-current",
                            "verboseLabel":  "Commissions receivable \u2013 non-current"
                            }
                        }
                    },
                "localname":  "ContractWithCustomerAssetNetNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsCommissionsReceivableDetails",
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice":  {
                "auth_ref":  [
                    "r292"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in estimate of transaction price which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due.  Includes, but is not limited to, change in assessment of whether estimate of variable consideration is constrained.",
                            "label":  "Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price",
                            "terseLabel":  "Revenue adjustment relating to performance obligations satisfied n prior periods"
                            }
                        }
                    },
                "localname":  "ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/RevenueNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ContractWithCustomerLiabilityRevenueRecognized":  {
                "auth_ref":  [
                    "r314"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
                            "label":  "Contract with Customer, Liability, Revenue Recognized",
                            "terseLabel":  "Revenue recognized that was previously deferred"
                            }
                        }
                    },
                "localname":  "ContractWithCustomerLiabilityRevenueRecognized",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/RevenueNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CostOfRevenue":  {
                "auth_ref":  [
                    "r81",
                    "r115",
                    "r215",
                    "r466"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_CostsAndExpenses",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
                            "label":  "Cost of Revenue",
                            "terseLabel":  "Cost of revenue"
                            }
                        }
                    },
                "localname":  "CostOfRevenue",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CostsAndExpenses":  {
                "auth_ref":  [
                    "r80"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total costs of sales and operating expenses for the period.",
                            "label":  "Costs and Expenses",
                            "totalLabel":  "Total operating expenses"
                            }
                        }
                    },
                "localname":  "CostsAndExpenses",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CreditFacilityAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of credit facility.  Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
                            "label":  "Credit Facility [Axis]",
                            "terseLabel":  "Credit Facility [Axis]"
                            }
                        }
                    },
                "localname":  "CreditFacilityAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CreditFacilityDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Type of credit facility.  Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
                            "label":  "Credit Facility [Domain]",
                            "terseLabel":  "Credit Facility [Domain]"
                            }
                        }
                    },
                "localname":  "CreditFacilityDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_CurrentFederalTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r116",
                    "r397",
                    "r404"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_CurrentIncomeTaxExpenseBenefit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
                            "label":  "Current Federal Tax Expense (Benefit)",
                            "terseLabel":  "Federal"
                            }
                        }
                    },
                "localname":  "CurrentFederalTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CurrentForeignTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r122",
                    "r397"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_CurrentIncomeTaxExpenseBenefit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
                            "label":  "Current Foreign Tax Expense (Benefit)",
                            "terseLabel":  "Foreign"
                            }
                        }
                    },
                "localname":  "CurrentForeignTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CurrentIncomeTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r116",
                    "r397",
                    "r404",
                    "r406"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_IncomeTaxExpenseBenefit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
                            "label":  "Current Income Tax Expense (Benefit)",
                            "totalLabel":  "Total current income taxes"
                            }
                        }
                    },
                "localname":  "CurrentIncomeTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
                            "terseLabel":  "Current income taxes:"
                            }
                        }
                    },
                "localname":  "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CurrentStateAndLocalTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r116",
                    "r397",
                    "r404"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_CurrentIncomeTaxExpenseBenefit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
                            "label":  "Current State and Local Tax Expense (Benefit)",
                            "terseLabel":  "State and local"
                            }
                        }
                    },
                "localname":  "CurrentStateAndLocalTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CustomerConcentrationRiskMember":  {
                "auth_ref":  [
                    "r168",
                    "r207"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues.  The risk is the materially adverse effects of loss of a significant customer.",
                            "label":  "Customer Concentration Risk [Member]",
                            "terseLabel":  "Customer concentration risk"
                            }
                        }
                    },
                "localname":  "CustomerConcentrationRiskMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails",
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofRevenuebyMajorCustomersbyReportingSegmentsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_CustomerRelationshipsMember":  {
                "auth_ref":  [
                    "r425"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
                            "label":  "Customer Relationships [Member]",
                            "terseLabel":  "Customer relationships"
                            }
                        }
                    },
                "localname":  "CustomerRelationshipsMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails",
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails",
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetSummaryofDefinitelivedandIndefinitelivedIntangibleAssetsDetails",
                    "http://www.gohealth.com/role/GoodwillandIntangibleAssetsNetSummaryofExpectedFutureAmortizationExpenseRelatedtoIntangibleAssetsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_DebtConversionConvertedInstrumentAmount1":  {
                "auth_ref":  [
                    "r107",
                    "r109"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
                            "label":  "Debt Conversion, Converted Instrument, Amount",
                            "terseLabel":  "Issuance of equity to settle contingent consideration liability"
                            }
                        }
                    },
                "localname":  "DebtConversionConvertedInstrumentAmount1",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DebtDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Debt Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "DebtDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtInstrumentAxis":  {
                "auth_ref":  [
                    "r16",
                    "r17",
                    "r18",
                    "r530",
                    "r532",
                    "r546"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
                            "label":  "Debt Instrument [Axis]",
                            "terseLabel":  "Debt Instrument [Axis]"
                            }
                        }
                    },
                "localname":  "DebtInstrumentAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
                            "label":  "Debt Instrument, Basis Spread on Variable Rate",
                            "terseLabel":  "Debt instrument variable interest rate spread"
                            }
                        }
                    },
                "localname":  "DebtInstrumentBasisSpreadOnVariableRate1",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_DebtInstrumentCarryingAmount":  {
                "auth_ref":  [
                    "r18",
                    "r272",
                    "r532",
                    "r546"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/LongTermDebtMaturitiesofLongtermDebtDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        },
                    "http://www.gohealth.com/role/LongTermDebtSummaryofLongTermDebtDetails_1":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LongTermDebt",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt.  Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
                            "label":  "Long-term Debt, Gross",
                            "terseLabel":  "Credit facility",
                            "totalLabel":  "Total debt"
                            }
                        }
                    },
                "localname":  "DebtInstrumentCarryingAmount",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtMaturitiesofLongtermDebtDetails",
                    "http://www.gohealth.com/role/LongTermDebtSummaryofLongTermDebtDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DebtInstrumentInterestRateEffectivePercentage":  {
                "auth_ref":  [
                    "r46",
                    "r275",
                    "r478"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
                            "label":  "Debt Instrument, Interest Rate, Effective Percentage",
                            "terseLabel":  "Debt Instrument, effective interest rate"
                            }
                        }
                    },
                "localname":  "DebtInstrumentInterestRateEffectivePercentage",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_DebtInstrumentLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Debt Instrument [Line Items]",
                            "terseLabel":  "Debt Instrument [Line Items]"
                            }
                        }
                    },
                "localname":  "DebtInstrumentLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtInstrumentNameDomain":  {
                "auth_ref":  [
                    "r47"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
                            "label":  "Debt Instrument, Name [Domain]",
                            "terseLabel":  "Debt Instrument, Name [Domain]"
                            }
                        }
                    },
                "localname":  "DebtInstrumentNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_DebtInstrumentTable":  {
                "auth_ref":  [
                    "r47",
                    "r119",
                    "r282",
                    "r285",
                    "r286",
                    "r287",
                    "r477",
                    "r478",
                    "r480",
                    "r543"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation.  These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
                            "label":  "Schedule of Long-term Debt Instruments [Table]",
                            "terseLabel":  "Schedule of Long-term Debt Instruments [Table]"
                            }
                        }
                    },
                "localname":  "DebtInstrumentTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet":  {
                "auth_ref":  [
                    "r273",
                    "r479"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/LongTermDebtSummaryofLongTermDebtDetails_1":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LongTermDebt",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of unamortized debt discount (premium) and debt issuance costs.",
                            "label":  "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
                            "negatedLabel":  "Less:  Unamortized debt discount and issuance costs"
                            }
                        }
                    },
                "localname":  "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtSummaryofLongTermDebtDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredFederalIncomeTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r116",
                    "r398",
                    "r404"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_DeferredIncomeTaxExpenseBenefit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
                            "label":  "Deferred Federal Income Tax Expense (Benefit)",
                            "terseLabel":  "Federal"
                            }
                        }
                    },
                "localname":  "DeferredFederalIncomeTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredFinanceCostsGross":  {
                "auth_ref":  [
                    "r479"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, before accumulated amortization, of debt issuance costs.  Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
                            "label":  "Debt Issuance Costs, Gross",
                            "terseLabel":  "Debt issuance costs"
                            }
                        }
                    },
                "localname":  "DeferredFinanceCostsGross",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredForeignIncomeTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r116",
                    "r398",
                    "r404"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_DeferredIncomeTaxExpenseBenefit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
                            "label":  "Deferred Foreign Income Tax Expense (Benefit)",
                            "terseLabel":  "Foreign"
                            }
                        }
                    },
                "localname":  "DeferredForeignIncomeTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredIncomeTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r102",
                    "r116",
                    "r398",
                    "r404",
                    "r405",
                    "r406"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_IncomeTaxExpenseBenefit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
                            "label":  "Deferred Income Tax Expense (Benefit)",
                            "totalLabel":  "Total deferred income taxes"
                            }
                        }
                    },
                "localname":  "DeferredIncomeTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
                            "terseLabel":  "Deferred income taxes:"
                            }
                        }
                    },
                "localname":  "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DeferredIncomeTaxLiabilities":  {
                "auth_ref":  [
                    "r20",
                    "r21",
                    "r387",
                    "r531",
                    "r545"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsLiabilitiesNet",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of deferred tax liability attributable to taxable temporary differences.",
                            "label":  "Deferred Tax Liabilities, Gross",
                            "negatedTotalLabel":  "Total gross deferred tax liabilities"
                            }
                        }
                    },
                "localname":  "DeferredIncomeTaxLiabilities",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r116",
                    "r398",
                    "r404"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_DeferredIncomeTaxExpenseBenefit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
                            "label":  "Deferred State and Local Income Tax Expense (Benefit)",
                            "terseLabel":  "State and local"
                            }
                        }
                    },
                "localname":  "DeferredStateAndLocalIncomeTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetInterestCarryforward":  {
                "auth_ref":  [
                    "r395"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsGross",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward.",
                            "label":  "Deferred Tax Asset, Interest Carryforward",
                            "terseLabel":  "Disallowed business interest"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetInterestCarryforward",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsGross":  {
                "auth_ref":  [
                    "r388"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
                            "label":  "Deferred Tax Assets, Gross",
                            "totalLabel":  "Total gross deferred tax assets"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsGross",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsInvestments":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsGross",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments (excludes investments in subsidiaries and equity method investments).",
                            "label":  "Deferred Tax Assets, Investments",
                            "terseLabel":  "Basis in partnership investment"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsInvestments",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsLiabilitiesNet":  {
                "auth_ref":  [
                    "r390"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
                            "label":  "Deferred Tax Assets, Net",
                            "totalLabel":  "Net deferred tax assets"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsLiabilitiesNet",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsNet":  {
                "auth_ref":  [
                    "r390"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsLiabilitiesNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
                            "label":  "Deferred Tax Assets, Net of Valuation Allowance",
                            "totalLabel":  "Total deferred tax assets, net of valuation allowance"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsNet",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards":  {
                "auth_ref":  [
                    "r395",
                    "r396"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsGross",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
                            "label":  "Deferred Tax Assets, Operating Loss Carryforwards",
                            "terseLabel":  "Net operating losses"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsOperatingLossCarryforwards",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsOther":  {
                "auth_ref":  [
                    "r395",
                    "r396"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsGross",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
                            "label":  "Deferred Tax Assets, Other",
                            "terseLabel":  "Other"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsOther",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign":  {
                "auth_ref":  [
                    "r393",
                    "r395",
                    "r396"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsGross",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards.",
                            "label":  "Deferred Tax Assets, Tax Credit Carryforwards, Foreign",
                            "terseLabel":  "Foreign tax credits"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsTaxCreditCarryforwardsForeign",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities":  {
                "auth_ref":  [
                    "r395",
                    "r396"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsGross",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
                            "label":  "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
                            "terseLabel":  "Accrued liabilities"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsValuationAllowance":  {
                "auth_ref":  [
                    "r389"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsNet",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
                            "label":  "Deferred Tax Assets, Valuation Allowance",
                            "negatedTerseLabel":  "Valuation allowance",
                            "terseLabel":  "Valuation allowance"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsValuationAllowance",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
                    "http://www.gohealth.com/role/IncomeTaxesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxLiabilitiesOther":  {
                "auth_ref":  [
                    "r395",
                    "r396"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_DeferredIncomeTaxLiabilities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
                            "label":  "Deferred Tax Liabilities, Other",
                            "negatedTerseLabel":  "Other"
                            }
                        }
                    },
                "localname":  "DeferredTaxLiabilitiesOther",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment":  {
                "auth_ref":  [
                    "r395",
                    "r396"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_DeferredIncomeTaxLiabilities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
                            "label":  "Deferred Tax Liabilities, Property, Plant and Equipment",
                            "negatedTerseLabel":  "Fixed assets"
                            }
                        }
                    },
                "localname":  "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DefinedContributionPlanCostRecognized":  {
                "auth_ref":  [
                    "r327"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cost for defined contribution plan.",
                            "label":  "Defined Contribution Plan, Cost",
                            "terseLabel":  "Defined contribution plan expense"
                            }
                        }
                    },
                "localname":  "DefinedContributionPlanCostRecognized",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.",
                            "label":  "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
                            "terseLabel":  "Employer matching contribution, percent of employees' gross pay"
                            }
                        }
                    },
                "localname":  "DefinedContributionPlanEmployerMatchingContributionPercent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage employer matches of the employee's percentage contribution matched.",
                            "label":  "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
                            "terseLabel":  "Employer contribution, percent of match"
                            }
                        }
                    },
                "localname":  "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of employer's matching contributions to a defined contribution plan that vests in a given year.",
                            "label":  "Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage",
                            "terseLabel":  "Employer matching contribution, annual vesting percentage"
                            }
                        }
                    },
                "localname":  "DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_Depreciation":  {
                "auth_ref":  [
                    "r102",
                    "r248"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives.  Includes production and non-production related depreciation.",
                            "label":  "Depreciation",
                            "terseLabel":  "Depreciation expense"
                            }
                        }
                    },
                "localname":  "Depreciation",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DepreciationDepletionAndAmortization":  {
                "auth_ref":  [
                    "r102",
                    "r183"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
                            "label":  "Depreciation, Depletion and Amortization",
                            "terseLabel":  "Depreciation and amortization"
                            }
                        }
                    },
                "localname":  "DepreciationDepletionAndAmortization",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DevelopedTechnologyRightsMember":  {
                "auth_ref":  [
                    "r426"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
                            "label":  "Developed Technology Rights [Member]",
                            "terseLabel":  "Developed technology"
                            }
                        }
                    },
                "localname":  "DevelopedTechnologyRightsMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails",
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails",
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetSummaryofDefinitelivedandIndefinitelivedIntangibleAssetsDetails",
                    "http://www.gohealth.com/role/GoodwillandIntangibleAssetsNetSummaryofExpectedFutureAmortizationExpenseRelatedtoIntangibleAssetsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_DisaggregationOfRevenueLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Disaggregation of Revenue [Line Items]",
                            "terseLabel":  "Disaggregation of Revenue [Line Items]"
                            }
                        }
                    },
                "localname":  "DisaggregationOfRevenueLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsCommissionsReceivableDetails",
                    "http://www.gohealth.com/role/RevenueSummaryofDisaggregationofRevenueDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DisaggregationOfRevenueTable":  {
                "auth_ref":  [
                    "r312",
                    "r316",
                    "r317",
                    "r318",
                    "r319",
                    "r320",
                    "r321",
                    "r322"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
                            "label":  "Disaggregation of Revenue [Table]",
                            "terseLabel":  "Disaggregation of Revenue [Table]"
                            }
                        }
                    },
                "localname":  "DisaggregationOfRevenueTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsCommissionsReceivableDetails",
                    "http://www.gohealth.com/role/RevenueSummaryofDisaggregationofRevenueDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DisaggregationOfRevenueTableTextBlock":  {
                "auth_ref":  [
                    "r312"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
                            "label":  "Disaggregation of Revenue [Table Text Block]",
                            "terseLabel":  "Summary of Disaggregation of Revenue"
                            }
                        }
                    },
                "localname":  "DisaggregationOfRevenueTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/RevenueTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock":  {
                "auth_ref":  [
                    "r374"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for share-based payment arrangement.",
                            "label":  "Share-based Payment Arrangement [Text Block]",
                            "terseLabel":  "Share-Based Compensation Plans"
                            }
                        }
                    },
                "localname":  "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlans"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-based Payment Arrangement [Abstract]"
                            }
                        }
                    },
                "localname":  "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DomesticCountryMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
                            "label":  "Domestic Tax Authority [Member]",
                            "terseLabel":  "U.S. federal"
                            }
                        }
                    },
                "localname":  "DomesticCountryMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_DueFromAffiliateCurrent":  {
                "auth_ref":  [
                    "r54",
                    "r123",
                    "r494",
                    "r496",
                    "r501"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of receivables due from an entity that is affiliated with the reporting entity by means of direct or indirect ownership, due within 1 year (or 1 business cycle).",
                            "label":  "Due from Affiliate, Current",
                            "terseLabel":  "Receivable from NVX Holdings, Inc."
                            }
                        }
                    },
                "localname":  "DueFromAffiliateCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets",
                    "http://www.gohealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_EarningsPerShareAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Earnings Per Share [Abstract]"
                            }
                        }
                    },
                "localname":  "EarningsPerShareAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_EarningsPerShareBasicAndDiluted":  {
                "auth_ref":  [
                    "r151"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
                            "label":  "Earnings Per Share, Basic and Diluted",
                            "terseLabel":  "Net loss per share of Class A common stock\u2014basic and diluted (in dollars per share)"
                            }
                        }
                    },
                "localname":  "EarningsPerShareBasicAndDiluted",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations",
                    "http://www.gohealth.com/role/NetLossPerShareReconciliationoftheNumeratorandDenominatorUsedintheCalculationofBasicandDilutedNetLossPerShareDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_EarningsPerShareProFormaAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Earnings Per Share, Pro Forma [Abstract]",
                            "terseLabel":  "Net loss per share (Note 9):"
                            }
                        }
                    },
                "localname":  "EarningsPerShareProFormaAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_EarningsPerShareTextBlock":  {
                "auth_ref":  [
                    "r153",
                    "r154",
                    "r155",
                    "r157"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for earnings per share.",
                            "label":  "Earnings Per Share [Text Block]",
                            "verboseLabel":  "Net Loss Per Share"
                            }
                        }
                    },
                "localname":  "EarningsPerShareTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/NetLossPerShare"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents":  {
                "auth_ref":  [
                    "r467"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies.  Excludes amounts for disposal group and discontinued operations.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
                            "terseLabel":  "Effect of exchange rate changes on cash and cash equivalents"
                            }
                        }
                    },
                "localname":  "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateContinuingOperations":  {
                "auth_ref":  [
                    "r381"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesReconciliationofStatutoryTaxRatetoOurEffectiveTaxRateDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
                            "label":  "Effective Income Tax Rate Reconciliation, Percent",
                            "terseLabel":  "Effective tax rate",
                            "totalLabel":  "Effective tax rate"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateContinuingOperations",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesNarrativeDetails",
                    "http://www.gohealth.com/role/IncomeTaxesReconciliationofStatutoryTaxRatetoOurEffectiveTaxRateDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate":  {
                "auth_ref":  [
                    "r381",
                    "r408"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesReconciliationofStatutoryTaxRatetoOurEffectiveTaxRateDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
                        "weight":  1.0
                        }
                    },
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
                            "label":  "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
                            "terseLabel":  "U.S. statutory tax rate"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesReconciliationofStatutoryTaxRatetoOurEffectiveTaxRateDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance":  {
                "auth_ref":  [
                    "r381",
                    "r408"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesReconciliationofStatutoryTaxRatetoOurEffectiveTaxRateDetails":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
                        "weight":  1.0
                        }
                    },
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
                            "label":  "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
                            "terseLabel":  "Change in valuation allowance"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesReconciliationofStatutoryTaxRatetoOurEffectiveTaxRateDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense":  {
                "auth_ref":  [
                    "r381",
                    "r408"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesReconciliationofStatutoryTaxRatetoOurEffectiveTaxRateDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
                        "weight":  -1.0
                        }
                    },
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.",
                            "label":  "Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent",
                            "negatedTerseLabel":  "Loss attributable to non-controlling interest"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesReconciliationofStatutoryTaxRatetoOurEffectiveTaxRateDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense":  {
                "auth_ref":  [
                    "r381",
                    "r408"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesReconciliationofStatutoryTaxRatetoOurEffectiveTaxRateDetails":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
                        "weight":  1.0
                        }
                    },
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
                            "label":  "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent",
                            "terseLabel":  "Non-deductible expenses"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesReconciliationofStatutoryTaxRatetoOurEffectiveTaxRateDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments":  {
                "auth_ref":  [
                    "r381",
                    "r408"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesReconciliationofStatutoryTaxRatetoOurEffectiveTaxRateDetails":  {
                        "order":  7.0,
                        "parentTag":  "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
                        "weight":  1.0
                        }
                    },
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
                            "label":  "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
                            "terseLabel":  "Other"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesReconciliationofStatutoryTaxRatetoOurEffectiveTaxRateDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes":  {
                "auth_ref":  [
                    "r381",
                    "r408"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesReconciliationofStatutoryTaxRatetoOurEffectiveTaxRateDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
                        "weight":  1.0
                        }
                    },
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
                            "label":  "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
                            "terseLabel":  "State taxes, net of the federal benefit"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesReconciliationofStatutoryTaxRatetoOurEffectiveTaxRateDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome":  {
                "auth_ref":  [
                    "r381",
                    "r408"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesReconciliationofStatutoryTaxRatetoOurEffectiveTaxRateDetails":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
                        "weight":  -1.0
                        }
                    },
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income (loss) exempt from income taxes.",
                            "label":  "Effective Income Tax Rate Reconciliation, Tax Exempt Income, Percent",
                            "negatedTerseLabel":  "Flow-through structure"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationTaxExemptIncome",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesReconciliationofStatutoryTaxRatetoOurEffectiveTaxRateDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized":  {
                "auth_ref":  [
                    "r360"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
                            "label":  "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
                            "terseLabel":  "Unamortized share-based compensation expense"
                            }
                        }
                    },
                "localname":  "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1":  {
                "auth_ref":  [
                    "r360"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
                            "terseLabel":  "Unamortized share-based compensation expense, weighted average period of recognition"
                            }
                        }
                    },
                "localname":  "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions":  {
                "auth_ref":  [
                    "r360"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cost to be recognized for nonvested award under share-based payment arrangement.  Excludes share and unit options.",
                            "label":  "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
                            "terseLabel":  "Unamortized share-based compensation expense"
                            }
                        }
                    },
                "localname":  "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_EmployeeStockMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
                            "label":  "Employee Stock [Member]",
                            "terseLabel":  "Employee Stock"
                            }
                        }
                    },
                "localname":  "EmployeeStockMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_EmployeeStockOptionMember":  {
                "auth_ref":  [
                    "r357"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
                            "label":  "Share-based Payment Arrangement, Option [Member]",
                            "terseLabel":  "Stock options"
                            }
                        }
                    },
                "localname":  "EmployeeStockOptionMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofValuationAssumptionsOptionsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_EntityWideRevenueMajorCustomerLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Revenue, Major Customer [Line Items]",
                            "terseLabel":  "Revenue, Major Customer [Line Items]"
                            }
                        }
                    },
                "localname":  "EntityWideRevenueMajorCustomerLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofRevenuebyMajorCustomersbyReportingSegmentsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_EquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Equity [Abstract]"
                            }
                        }
                    },
                "localname":  "EquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_EquityComponentDomain":  {
                "auth_ref":  [
                    "r126",
                    "r127",
                    "r129",
                    "r131",
                    "r140",
                    "r143",
                    "r158",
                    "r219",
                    "r281",
                    "r288",
                    "r366",
                    "r367",
                    "r368",
                    "r400",
                    "r401",
                    "r468",
                    "r469",
                    "r470",
                    "r471",
                    "r472",
                    "r473",
                    "r568",
                    "r569",
                    "r570"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
                            "label":  "Equity Component [Domain]",
                            "terseLabel":  "Equity Component [Domain]"
                            }
                        }
                    },
                "localname":  "EquityComponentDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity",
                    "http://www.gohealth.com/role/SubsequentEventsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_EquityMethodInvestmentOwnershipPercentage":  {
                "auth_ref":  [
                    "r214"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
                            "label":  "Equity Method Investment, Ownership Percentage",
                            "terseLabel":  "Equity method investment ownership percentage"
                            }
                        }
                    },
                "localname":  "EquityMethodInvestmentOwnershipPercentage",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
                            "terseLabel":  "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
                            }
                        }
                    },
                "localname":  "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/FairValueMeasurementsNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable":  {
                "auth_ref":  [
                    "r458"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
                            "label":  "Fair Value Measurement Inputs and Valuation Techniques [Table]",
                            "terseLabel":  "Fair Value Measurement Inputs and Valuation Techniques [Table]"
                            }
                        }
                    },
                "localname":  "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/FairValueMeasurementsNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueByLiabilityClassAxis":  {
                "auth_ref":  [
                    "r462",
                    "r463"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by class of liability.",
                            "label":  "Liability Class [Axis]",
                            "terseLabel":  "Liability Class [Axis]"
                            }
                        }
                    },
                "localname":  "FairValueByLiabilityClassAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/FairValueMeasurementsNarrativeDetails",
                    "http://www.gohealth.com/role/FairValueMeasurementsSummaryofFairvalueoftheContingentConsiderationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueDisclosuresAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Fair Value Disclosures [Abstract]"
                            }
                        }
                    },
                "localname":  "FairValueDisclosuresAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueDisclosuresTextBlock":  {
                "auth_ref":  [
                    "r462"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities.  Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
                            "label":  "Fair Value Disclosures [Text Block]",
                            "terseLabel":  "Fair Value Measurements"
                            }
                        }
                    },
                "localname":  "FairValueDisclosuresTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/FairValueMeasurements"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain":  {
                "auth_ref":  [
                    "r459"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Represents classes of liabilities measured and disclosed at fair value.",
                            "label":  "Fair Value by Liability Class [Domain]",
                            "terseLabel":  "Fair Value by Liability Class [Domain]"
                            }
                        }
                    },
                "localname":  "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/FairValueMeasurementsNarrativeDetails",
                    "http://www.gohealth.com/role/FairValueMeasurementsSummaryofFairvalueoftheContingentConsiderationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
                            "label":  "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
                            "terseLabel":  "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
                            }
                        }
                    },
                "localname":  "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/FairValueMeasurementsSummaryofFairvalueoftheContingentConsiderationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
                            "terseLabel":  "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
                            }
                        }
                    },
                "localname":  "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/FairValueMeasurementsSummaryofFairvalueoftheContingentConsiderationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable":  {
                "auth_ref":  [
                    "r459",
                    "r463"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3).  Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.",
                            "label":  "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
                            "terseLabel":  "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
                            }
                        }
                    },
                "localname":  "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/FairValueMeasurementsSummaryofFairvalueoftheContingentConsiderationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock":  {
                "auth_ref":  [
                    "r459",
                    "r463"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
                            "label":  "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
                            "terseLabel":  "Changes to the Fair value of the Contingent Consideration"
                            }
                        }
                    },
                "localname":  "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/FairValueMeasurementsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_FairValueMeasurementPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity.  Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
                            "label":  "Fair Value Measurement, Policy [Policy Text Block]",
                            "terseLabel":  "Fair Value of Financial Instruments"
                            }
                        }
                    },
                "localname":  "FairValueMeasurementPolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings":  {
                "auth_ref":  [
                    "r460"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
                            "label":  "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
                            "negatedTerseLabel":  "2020 earnout fair value adjustment"
                            }
                        }
                    },
                "localname":  "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/FairValueMeasurementsSummaryofFairvalueoftheContingentConsiderationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements":  {
                "auth_ref":  [
                    "r461"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
                            "label":  "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
                            "negatedTerseLabel":  "Settlement",
                            "terseLabel":  "Settlement"
                            }
                        }
                    },
                "localname":  "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/FairValueMeasurementsNarrativeDetails",
                    "http://www.gohealth.com/role/FairValueMeasurementsSummaryofFairvalueoftheContingentConsiderationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue":  {
                "auth_ref":  [
                    "r459"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
                            "label":  "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
                            "periodEndLabel":  "Ending balance",
                            "periodStartLabel":  "Beginning balance"
                            }
                        }
                    },
                "localname":  "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/FairValueMeasurementsSummaryofFairvalueoftheContingentConsiderationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinancialDesignationPredecessorAndSuccessorFixedList":  {
                "auth_ref":  [
                    "r500"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicates designation of financial information when substantially all business or separately identifiable line of business transfers from one entity to another entity.  Acceptable values are \"Predecessor\" and \"Successor\".",
                            "label":  "Financial Designation, Predecessor and Successor [Fixed List]",
                            "terseLabel":  "Financial Designation, Predecessor and Successor [Fixed List]"
                            }
                        }
                    },
                "localname":  "FinancialDesignationPredecessorAndSuccessorFixedList",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsCommissionsReceivableDetails",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations",
                    "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeLossBeforeIncomeTaxesDetails",
                    "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails",
                    "http://www.gohealth.com/role/IncomeTaxesReconciliationofStatutoryTaxRatetoOurEffectiveTaxRateDetails",
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofRevenuebyMajorCustomersbyReportingSegmentsDetails",
                    "http://www.gohealth.com/role/RevenueSummaryofDisaggregationofRevenueDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofShareBasedCompensationExpensesbyOperatingFunctionDetails"
                    ],
                "xbrltype":  "financialDesignationType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization":  {
                "auth_ref":  [
                    "r240"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetSummaryofDefinitelivedandIndefinitelivedIntangibleAssetsDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_FiniteLivedIntangibleAssetsNet",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
                            "label":  "Finite-Lived Intangible Assets, Accumulated Amortization",
                            "terseLabel":  "Accumulated Amortization"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsAccumulatedAmortization",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetSummaryofDefinitelivedandIndefinitelivedIntangibleAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/GoodwillandIntangibleAssetsNetSummaryofExpectedFutureAmortizationExpenseRelatedtoIntangibleAssetsDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_FiniteLivedIntangibleAssetsNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
                            "terseLabel":  "Thereafter"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillandIntangibleAssetsNetSummaryofExpectedFutureAmortizationExpenseRelatedtoIntangibleAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths":  {
                "auth_ref":  [
                    "r242"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/GoodwillandIntangibleAssetsNetSummaryofExpectedFutureAmortizationExpenseRelatedtoIntangibleAssetsDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_FiniteLivedIntangibleAssetsNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Finite-Lived Intangible Asset, Expected Amortization, Year One",
                            "terseLabel":  "2021"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillandIntangibleAssetsNetSummaryofExpectedFutureAmortizationExpenseRelatedtoIntangibleAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive":  {
                "auth_ref":  [
                    "r242"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/GoodwillandIntangibleAssetsNetSummaryofExpectedFutureAmortizationExpenseRelatedtoIntangibleAssetsDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_FiniteLivedIntangibleAssetsNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
                            "terseLabel":  "2025"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillandIntangibleAssetsNetSummaryofExpectedFutureAmortizationExpenseRelatedtoIntangibleAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour":  {
                "auth_ref":  [
                    "r242"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/GoodwillandIntangibleAssetsNetSummaryofExpectedFutureAmortizationExpenseRelatedtoIntangibleAssetsDetails":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_FiniteLivedIntangibleAssetsNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
                            "terseLabel":  "2024"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillandIntangibleAssetsNetSummaryofExpectedFutureAmortizationExpenseRelatedtoIntangibleAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree":  {
                "auth_ref":  [
                    "r242"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/GoodwillandIntangibleAssetsNetSummaryofExpectedFutureAmortizationExpenseRelatedtoIntangibleAssetsDetails":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_FiniteLivedIntangibleAssetsNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
                            "terseLabel":  "2023"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillandIntangibleAssetsNetSummaryofExpectedFutureAmortizationExpenseRelatedtoIntangibleAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo":  {
                "auth_ref":  [
                    "r242"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/GoodwillandIntangibleAssetsNetSummaryofExpectedFutureAmortizationExpenseRelatedtoIntangibleAssetsDetails":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_FiniteLivedIntangibleAssetsNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
                            "terseLabel":  "2022"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillandIntangibleAssetsNetSummaryofExpectedFutureAmortizationExpenseRelatedtoIntangibleAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis":  {
                "auth_ref":  [
                    "r234",
                    "r236",
                    "r240",
                    "r244",
                    "r513",
                    "r514"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by major type or class of finite-lived intangible assets.",
                            "label":  "Finite-Lived Intangible Assets by Major Class [Axis]",
                            "terseLabel":  "Finite-Lived Intangible Assets by Major Class [Axis]"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsByMajorClassAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails",
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails",
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetSummaryofDefinitelivedandIndefinitelivedIntangibleAssetsDetails",
                    "http://www.gohealth.com/role/GoodwillandIntangibleAssetsNetSummaryofExpectedFutureAmortizationExpenseRelatedtoIntangibleAssetsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsGross":  {
                "auth_ref":  [
                    "r240",
                    "r514"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetSummaryofDefinitelivedandIndefinitelivedIntangibleAssetsDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_FiniteLivedIntangibleAssetsNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
                            "label":  "Finite-Lived Intangible Assets, Gross",
                            "terseLabel":  "Gross Carrying Amount"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsGross",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetSummaryofDefinitelivedandIndefinitelivedIntangibleAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Finite-Lived Intangible Assets [Line Items]",
                            "terseLabel":  "Finite-Lived Intangible Assets [Line Items]"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetSummaryofDefinitelivedandIndefinitelivedIntangibleAssetsDetails",
                    "http://www.gohealth.com/role/GoodwillandIntangibleAssetsNetSummaryofExpectedFutureAmortizationExpenseRelatedtoIntangibleAssetsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain":  {
                "auth_ref":  [
                    "r234",
                    "r239"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
                            "label":  "Finite-Lived Intangible Assets, Major Class Name [Domain]",
                            "terseLabel":  "Finite-Lived Intangible Assets, Major Class Name [Domain]"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsMajorClassNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails",
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails",
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetSummaryofDefinitelivedandIndefinitelivedIntangibleAssetsDetails",
                    "http://www.gohealth.com/role/GoodwillandIntangibleAssetsNetSummaryofExpectedFutureAmortizationExpenseRelatedtoIntangibleAssetsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsNet":  {
                "auth_ref":  [
                    "r240",
                    "r513"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetSummaryofDefinitelivedandIndefinitelivedIntangibleAssetsDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_IntangibleAssetsNetExcludingGoodwill",
                        "weight":  1.0
                        },
                    "http://www.gohealth.com/role/GoodwillandIntangibleAssetsNetSummaryofExpectedFutureAmortizationExpenseRelatedtoIntangibleAssetsDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
                            "label":  "Finite-Lived Intangible Assets, Net",
                            "totalLabel":  "Net Carrying Amount"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsNet",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetSummaryofDefinitelivedandIndefinitelivedIntangibleAssetsDetails",
                    "http://www.gohealth.com/role/GoodwillandIntangibleAssetsNetSummaryofExpectedFutureAmortizationExpenseRelatedtoIntangibleAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1":  {
                "auth_ref":  [
                    "r513"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
                            "label":  "Finite-Lived Intangible Assets, Remaining Amortization Period",
                            "terseLabel":  "Remaining amortization period"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock":  {
                "auth_ref":  [
                    "r111",
                    "r475"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
                            "label":  "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
                            "terseLabel":  "Foreign Currency"
                            }
                        }
                    },
                "localname":  "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_GeneralAndAdministrativeExpense":  {
                "auth_ref":  [
                    "r82"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_CostsAndExpenses",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
                            "label":  "General and Administrative Expense",
                            "terseLabel":  "General and administrative"
                            }
                        }
                    },
                "localname":  "GeneralAndAdministrativeExpense",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_GeneralAndAdministrativeExpenseMember":  {
                "auth_ref":  [
                    "r78"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Primary financial statement caption encompassing general and administrative expense.",
                            "label":  "General and Administrative Expense [Member]",
                            "terseLabel":  "General and administrative"
                            }
                        }
                    },
                "localname":  "GeneralAndAdministrativeExpenseMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofShareBasedCompensationExpensesbyOperatingFunctionDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_Goodwill":  {
                "auth_ref":  [
                    "r224",
                    "r226",
                    "r528"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails":  {
                        "order":  7.0,
                        "parentTag":  "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
                        "weight":  1.0
                        },
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
                            "label":  "Goodwill",
                            "terseLabel":  "Goodwill"
                            }
                        }
                    },
                "localname":  "Goodwill",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails",
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_GoodwillAcquiredDuringPeriod":  {
                "auth_ref":  [
                    "r227"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
                            "label":  "Goodwill, Acquired During Period",
                            "terseLabel":  "Goodwill recorded"
                            }
                        }
                    },
                "localname":  "GoodwillAcquiredDuringPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Goodwill and Intangible Assets Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "GoodwillAndIntangibleAssetsDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock":  {
                "auth_ref":  [
                    "r247"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for goodwill and intangible assets.",
                            "label":  "Goodwill and Intangible Assets Disclosure [Text Block]",
                            "terseLabel":  "Goodwill and Intangible Assets, Net"
                            }
                        }
                    },
                "localname":  "GoodwillAndIntangibleAssetsDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNet"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock":  {
                "auth_ref":  [
                    "r111",
                    "r229",
                    "r237"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for goodwill and intangible assets.  This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
                            "label":  "Goodwill and Intangible Assets, Policy [Policy Text Block]",
                            "terseLabel":  "Goodwill and Intangible Assets"
                            }
                        }
                    },
                "localname":  "GoodwillAndIntangibleAssetsPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_GoodwillImpairmentLoss":  {
                "auth_ref":  [
                    "r102",
                    "r225",
                    "r228",
                    "r230"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
                            "label":  "Goodwill, Impairment Loss",
                            "terseLabel":  "Impairment of goodwill"
                            }
                        }
                    },
                "localname":  "GoodwillImpairmentLoss",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_GoodwillLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Goodwill [Line Items]",
                            "terseLabel":  "Goodwill [Line Items]"
                            }
                        }
                    },
                "localname":  "GoodwillLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IPOMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "First sale of stock by a private company to the public.",
                            "label":  "IPO [Member]",
                            "terseLabel":  "IPO"
                            }
                        }
                    },
                "localname":  "IPOMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill":  {
                "auth_ref":  [
                    "r102",
                    "r245"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
                            "label":  "Impairment of Intangible Assets (Excluding Goodwill)",
                            "terseLabel":  "Impairment of intangible assets"
                            }
                        }
                    },
                "localname":  "ImpairmentOfIntangibleAssetsExcludingGoodwill",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.",
                            "label":  "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]",
                            "terseLabel":  "Impairment of Long-Lived Assets"
                            }
                        }
                    },
                "localname":  "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic":  {
                "auth_ref":  [
                    "r121",
                    "r407"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeLossBeforeIncomeTaxesDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
                            "label":  "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
                            "terseLabel":  "Domestic"
                            }
                        }
                    },
                "localname":  "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeLossBeforeIncomeTaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest":  {
                "auth_ref":  [
                    "r73",
                    "r188",
                    "r193",
                    "r196",
                    "r199",
                    "r202",
                    "r527",
                    "r536",
                    "r542",
                    "r559"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_ProfitLoss",
                        "weight":  1.0
                        },
                    "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeLossBeforeIncomeTaxesDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
                            "label":  "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
                            "totalLabel":  "Income (loss) before income taxes"
                            }
                        }
                    },
                "localname":  "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations",
                    "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeLossBeforeIncomeTaxesDetails",
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign":  {
                "auth_ref":  [
                    "r121",
                    "r407"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeLossBeforeIncomeTaxesDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
                            "label":  "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
                            "terseLabel":  "Foreign"
                            }
                        }
                    },
                "localname":  "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeLossBeforeIncomeTaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeStatementAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Income Statement [Abstract]"
                            }
                        }
                    },
                "localname":  "IncomeStatementAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeStatementLocationAxis":  {
                "auth_ref":  [
                    "r252"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by location in the income statement.",
                            "label":  "Income Statement Location [Axis]",
                            "terseLabel":  "Income Statement Location [Axis]"
                            }
                        }
                    },
                "localname":  "IncomeStatementLocationAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofShareBasedCompensationExpensesbyOperatingFunctionDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeStatementLocationDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Location in the income statement.",
                            "label":  "Income Statement Location [Domain]",
                            "terseLabel":  "Income Statement Location [Domain]"
                            }
                        }
                    },
                "localname":  "IncomeStatementLocationDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofShareBasedCompensationExpensesbyOperatingFunctionDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_IncomeTaxAuthorityAxis":  {
                "auth_ref":  [
                    "r383"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by tax jurisdiction.",
                            "label":  "Income Tax Authority [Axis]",
                            "terseLabel":  "Income Tax Authority [Axis]"
                            }
                        }
                    },
                "localname":  "IncomeTaxAuthorityAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeTaxAuthorityDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
                            "label":  "Income Tax Authority [Domain]",
                            "terseLabel":  "Income Tax Authority [Domain]"
                            }
                        }
                    },
                "localname":  "IncomeTaxAuthorityDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_IncomeTaxDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Income Tax Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "IncomeTaxDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeTaxDisclosureTextBlock":  {
                "auth_ref":  [
                    "r382",
                    "r385",
                    "r392",
                    "r402",
                    "r409",
                    "r411",
                    "r412",
                    "r413"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for income taxes.  Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
                            "label":  "Income Tax Disclosure [Text Block]",
                            "terseLabel":  "Income Taxes"
                            }
                        }
                    },
                "localname":  "IncomeTaxDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxes"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_IncomeTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r116",
                    "r142",
                    "r143",
                    "r186",
                    "r380",
                    "r403",
                    "r410",
                    "r560"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_ProfitLoss",
                        "weight":  -1.0
                        },
                    "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
                            "label":  "Income Tax Expense (Benefit)",
                            "terseLabel":  "Income tax expense (benefit)",
                            "totalLabel":  "Income tax expense (benefit)"
                            }
                        }
                    },
                "localname":  "IncomeTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations",
                    "http://www.gohealth.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeTaxPolicyTextBlock":  {
                "auth_ref":  [
                    "r71",
                    "r111",
                    "r378",
                    "r379",
                    "r385",
                    "r386",
                    "r391",
                    "r399",
                    "r584"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
                            "label":  "Income Tax, Policy [Policy Text Block]",
                            "terseLabel":  "Income Taxes"
                            }
                        }
                    },
                "localname":  "IncomeTaxPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_IncomeTaxesPaid":  {
                "auth_ref":  [
                    "r99",
                    "r106"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
                            "label":  "Income Taxes Paid",
                            "terseLabel":  "Taxes paid"
                            }
                        }
                    },
                "localname":  "IncomeTaxesPaid",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInAccountsPayableTrade":  {
                "auth_ref":  [
                    "r101"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  11.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.",
                            "label":  "Increase (Decrease) in Accounts Payable, Trade",
                            "terseLabel":  "Accounts payable"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccountsPayableTrade",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInAccountsReceivable":  {
                "auth_ref":  [
                    "r101"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  8.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
                            "label":  "Increase (Decrease) in Accounts Receivable",
                            "negatedLabel":  "Accounts receivable"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccountsReceivable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInAccruedLiabilities":  {
                "auth_ref":  [
                    "r101"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  12.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
                            "label":  "Increase (Decrease) in Accrued Liabilities",
                            "terseLabel":  "Accrued liabilities"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccruedLiabilities",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInContractWithCustomerAsset":  {
                "auth_ref":  [
                    "r101"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  9.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
                            "label":  "Increase (Decrease) in Contract with Customer, Asset",
                            "negatedLabel":  "Commissions receivable"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInContractWithCustomerAsset",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Increase (Decrease) in Operating Capital [Abstract]",
                            "terseLabel":  "Changes in assets and liabilities, net of acquisition:"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInOperatingCapitalAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities":  {
                "auth_ref":  [
                    "r101"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  15.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in operating liabilities classified as other.",
                            "label":  "Increase (Decrease) in Other Operating Liabilities",
                            "terseLabel":  "Other liabilities"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInOtherOperatingLiabilities",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets":  {
                "auth_ref":  [
                    "r101"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  10.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
                            "label":  "Increase (Decrease) in Prepaid Expense and Other Assets",
                            "negatedLabel":  "Prepaid expenses and other assets"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
                            "label":  "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
                            "terseLabel":  "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInStockholdersEquityRollForward",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncreaseInCarryingAmountOfRedeemablePreferredStock":  {
                "auth_ref":  [
                    "r278"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Adjustment to retained earnings for the increase in carrying amount of redeemable preferred stock that is classified as temporary equity.",
                            "label":  "Increase in Carrying Amount of Redeemable Preferred Stock",
                            "negatedLabel":  "Redeemable Class B unit accretion"
                            }
                        }
                    },
                "localname":  "IncreaseInCarryingAmountOfRedeemablePreferredStock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis":  {
                "auth_ref":  [
                    "r235",
                    "r243"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
                            "label":  "Indefinite-lived Intangible Assets [Axis]",
                            "terseLabel":  "Indefinite-lived Intangible Assets [Axis]"
                            }
                        }
                    },
                "localname":  "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetSummaryofDefinitelivedandIndefinitelivedIntangibleAssetsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Indefinite-lived Intangible Assets [Line Items]",
                            "terseLabel":  "Indefinite-lived Intangible Assets [Line Items]"
                            }
                        }
                    },
                "localname":  "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetSummaryofDefinitelivedandIndefinitelivedIntangibleAssetsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill":  {
                "auth_ref":  [
                    "r243"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetSummaryofDefinitelivedandIndefinitelivedIntangibleAssetsDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_IntangibleAssetsNetExcludingGoodwill",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
                            "label":  "Indefinite-lived Intangible Assets (Excluding Goodwill)",
                            "terseLabel":  "Indefinite-lived trade names"
                            }
                        }
                    },
                "localname":  "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetSummaryofDefinitelivedandIndefinitelivedIntangibleAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain":  {
                "auth_ref":  [
                    "r235",
                    "r243"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill.  A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
                            "label":  "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
                            "terseLabel":  "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
                            }
                        }
                    },
                "localname":  "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetSummaryofDefinitelivedandIndefinitelivedIntangibleAssetsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_InformationTechnologyAndDataProcessing":  {
                "auth_ref":  [
                    "r83"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_CostsAndExpenses",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of expenses incurred in the period for information technology and data processing products and services.",
                            "label":  "Information Technology and Data Processing",
                            "terseLabel":  "Technology"
                            }
                        }
                    },
                "localname":  "InformationTechnologyAndDataProcessing",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IntangibleAssetsNetExcludingGoodwill":  {
                "auth_ref":  [
                    "r232",
                    "r238"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        },
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetSummaryofDefinitelivedandIndefinitelivedIntangibleAssetsDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
                            "label":  "Intangible Assets, Net (Excluding Goodwill)",
                            "terseLabel":  "Intangible assets, net",
                            "totalLabel":  "Net Carrying Amount"
                            }
                        }
                    },
                "localname":  "IntangibleAssetsNetExcludingGoodwill",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets",
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetSummaryofDefinitelivedandIndefinitelivedIntangibleAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Intangible Assets, Net (Excluding Goodwill) [Abstract]",
                            "terseLabel":  "Intangible Assets, Net (Excluding Goodwill) [Abstract]"
                            }
                        }
                    },
                "localname":  "IntangibleAssetsNetExcludingGoodwillAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetSummaryofDefinitelivedandIndefinitelivedIntangibleAssetsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_InterestExpense":  {
                "auth_ref":  [
                    "r72",
                    "r182",
                    "r476",
                    "r479",
                    "r541"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of the cost of borrowed funds accounted for as interest expense.",
                            "label":  "Interest Expense",
                            "terseLabel":  "Interest expense"
                            }
                        }
                    },
                "localname":  "InterestExpense",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations",
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InterestPaidNet":  {
                "auth_ref":  [
                    "r94",
                    "r98",
                    "r106"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity.  Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
                            "label":  "Interest Paid, Excluding Capitalized Interest, Operating Activities",
                            "terseLabel":  "Interest paid"
                            }
                        }
                    },
                "localname":  "InterestPaidNet",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InterestPayableCurrent":  {
                "auth_ref":  [
                    "r8",
                    "r9",
                    "r44"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/BalanceSheetAccountsSummaryofAccruedLiabilitiesDetails":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Interest Payable, Current",
                            "terseLabel":  "Interest expense"
                            }
                        }
                    },
                "localname":  "InterestPayableCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsSummaryofAccruedLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LeaseAndRentalExpense":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
                            "label":  "Operating Leases, Rent Expense",
                            "terseLabel":  "Rent expense"
                            }
                        }
                    },
                "localname":  "LeaseAndRentalExpense",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentsandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LeaseholdImprovementsMember":  {
                "auth_ref":  [
                    "r249"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Additions or improvements to assets held under a lease arrangement.",
                            "label":  "Leasehold Improvements [Member]",
                            "terseLabel":  "Leasehold improvements"
                            }
                        }
                    },
                "localname":  "LeaseholdImprovementsMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsSummaryofPropertyEquipmentandCapitalizedSoftwareNetDetails",
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_LesseeOperatingLeaseTermOfContract":  {
                "auth_ref":  [
                    "r490"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Lessee, Operating Lease, Term of Contract",
                            "terseLabel":  "Lease expiration period"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseTermOfContract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_LiabilitiesAndStockholdersEquity":  {
                "auth_ref":  [
                    "r31",
                    "r115",
                    "r215",
                    "r466",
                    "r534",
                    "r552"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
                            "label":  "Liabilities and Equity",
                            "totalLabel":  "Total liabilities and stockholders\u2019 / members\u2019 equity"
                            }
                        }
                    },
                "localname":  "LiabilitiesAndStockholdersEquity",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesAndStockholdersEquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Liabilities and Equity [Abstract]",
                            "terseLabel":  "Liabilities and Stockholders\u2019 / Members\u2019 Equity"
                            }
                        }
                    },
                "localname":  "LiabilitiesAndStockholdersEquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LiabilitiesCurrent":  {
                "auth_ref":  [
                    "r45",
                    "r115",
                    "r215",
                    "r448",
                    "r453",
                    "r454",
                    "r466"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
                            "label":  "Liabilities, Current",
                            "totalLabel":  "Total current liabilities"
                            }
                        }
                    },
                "localname":  "LiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesCurrentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Liabilities, Current [Abstract]",
                            "terseLabel":  "Current liabilities:"
                            }
                        }
                    },
                "localname":  "LiabilitiesCurrentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LiabilitiesNoncurrent":  {
                "auth_ref":  [
                    "r10",
                    "r11",
                    "r12",
                    "r18",
                    "r19",
                    "r115",
                    "r215",
                    "r448",
                    "r453",
                    "r454",
                    "r466"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
                            "label":  "Liabilities, Noncurrent",
                            "totalLabel":  "Total non-current liabilities"
                            }
                        }
                    },
                "localname":  "LiabilitiesNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesNoncurrentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Liabilities, Noncurrent [Abstract]",
                            "terseLabel":  "Non-current liabilities:"
                            }
                        }
                    },
                "localname":  "LiabilitiesNoncurrentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LineOfCredit":  {
                "auth_ref":  [
                    "r18",
                    "r532",
                    "r546"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount.  Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.  Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
                            "label":  "Long-term Line of Credit",
                            "verboseLabel":  "Amount outstanding"
                            }
                        }
                    },
                "localname":  "LineOfCredit",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity":  {
                "auth_ref":  [
                    "r42"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
                            "label":  "Line of Credit Facility, Current Borrowing Capacity",
                            "terseLabel":  "Line of credit current borrowing capacity"
                            }
                        }
                    },
                "localname":  "LineOfCreditFacilityCurrentBorrowingCapacity",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity":  {
                "auth_ref":  [
                    "r42"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
                            "label":  "Line of Credit Facility, Maximum Borrowing Capacity",
                            "verboseLabel":  "Credit facility, aggregate principal amount"
                            }
                        }
                    },
                "localname":  "LineOfCreditFacilityMaximumBorrowingCapacity",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity":  {
                "auth_ref":  [
                    "r42"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
                            "label":  "Line of Credit Facility, Remaining Borrowing Capacity",
                            "terseLabel":  "Line of credit remaining borrowing capacity"
                            }
                        }
                    },
                "localname":  "LineOfCreditFacilityRemainingBorrowingCapacity",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.",
                            "label":  "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
                            "terseLabel":  "Commitment fee percentage due to unused commitments"
                            }
                        }
                    },
                "localname":  "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_LineOfCreditMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
                            "label":  "Line of Credit [Member]",
                            "terseLabel":  "Credit Agreement"
                            }
                        }
                    },
                "localname":  "LineOfCreditMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_LitigationStatusAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by status of pending, threatened, or settled litigation.",
                            "label":  "Litigation Status [Axis]",
                            "terseLabel":  "Litigation Status [Axis]"
                            }
                        }
                    },
                "localname":  "LitigationStatusAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentsandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LitigationStatusDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Status of pending, threatened, or settled litigation.",
                            "label":  "Litigation Status [Domain]",
                            "terseLabel":  "Litigation Status [Domain]"
                            }
                        }
                    },
                "localname":  "LitigationStatusDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentsandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_LondonInterbankOfferedRateLIBORMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
                            "label":  "London Interbank Offered Rate (LIBOR) [Member]",
                            "terseLabel":  "LIBOR"
                            }
                        }
                    },
                "localname":  "LondonInterbankOfferedRateLIBORMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_LongTermDebt":  {
                "auth_ref":  [
                    "r18",
                    "r274",
                    "r532",
                    "r548"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/LongTermDebtSummaryofLongTermDebtDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        },
                    "http://www.gohealth.com/role/LongTermDebtSummaryofLongTermDebtDetails_1":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt.  Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper.  Excludes capital lease obligations.",
                            "label":  "Long-term Debt",
                            "totalLabel":  "Total debt"
                            }
                        }
                    },
                "localname":  "LongTermDebt",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtSummaryofLongTermDebtDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LongTermDebtCurrent":  {
                "auth_ref":  [
                    "r43"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        },
                    "http://www.gohealth.com/role/LongTermDebtSummaryofLongTermDebtDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LongTermDebt",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current.  Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper.  Excludes capital lease obligations.",
                            "label":  "Long-term Debt, Current Maturities",
                            "negatedLabel":  "Less:  Current portion of long-term debt",
                            "terseLabel":  "Current portion of long-term debt"
                            }
                        }
                    },
                "localname":  "LongTermDebtCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets",
                    "http://www.gohealth.com/role/LongTermDebtSummaryofLongTermDebtDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths":  {
                "auth_ref":  [
                    "r124",
                    "r271"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/LongTermDebtMaturitiesofLongtermDebtDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_DebtInstrumentCarryingAmount",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Long-Term Debt, Maturity, Year One",
                            "terseLabel":  "2021"
                            }
                        }
                    },
                "localname":  "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtMaturitiesofLongtermDebtDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive":  {
                "auth_ref":  [
                    "r124",
                    "r271"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/LongTermDebtMaturitiesofLongtermDebtDetails":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_DebtInstrumentCarryingAmount",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Long-Term Debt, Maturity, Year Five",
                            "terseLabel":  "2025"
                            }
                        }
                    },
                "localname":  "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtMaturitiesofLongtermDebtDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour":  {
                "auth_ref":  [
                    "r124",
                    "r271"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/LongTermDebtMaturitiesofLongtermDebtDetails":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_DebtInstrumentCarryingAmount",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Long-Term Debt, Maturity, Year Four",
                            "terseLabel":  "2024"
                            }
                        }
                    },
                "localname":  "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtMaturitiesofLongtermDebtDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree":  {
                "auth_ref":  [
                    "r124",
                    "r271"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/LongTermDebtMaturitiesofLongtermDebtDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_DebtInstrumentCarryingAmount",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Long-Term Debt, Maturity, Year Three",
                            "terseLabel":  "2023"
                            }
                        }
                    },
                "localname":  "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtMaturitiesofLongtermDebtDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo":  {
                "auth_ref":  [
                    "r124",
                    "r271"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/LongTermDebtMaturitiesofLongtermDebtDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_DebtInstrumentCarryingAmount",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Long-Term Debt, Maturity, Year Two",
                            "terseLabel":  "2022"
                            }
                        }
                    },
                "localname":  "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtMaturitiesofLongtermDebtDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LongTermDebtNoncurrent":  {
                "auth_ref":  [
                    "r47"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LiabilitiesNoncurrent",
                        "weight":  1.0
                        },
                    "http://www.gohealth.com/role/LongTermDebtSummaryofLongTermDebtDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LongTermDebt",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer.  Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper.  Excludes capital lease obligations.",
                            "label":  "Long-term Debt, Excluding Current Maturities",
                            "terseLabel":  "Long-term debt, net of current portion",
                            "verboseLabel":  "Total long-term-debt"
                            }
                        }
                    },
                "localname":  "LongTermDebtNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets",
                    "http://www.gohealth.com/role/LongTermDebtSummaryofLongTermDebtDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LongTermDebtTextBlock":  {
                "auth_ref":  [
                    "r276"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for long-term debt.",
                            "label":  "Long-term Debt [Text Block]",
                            "terseLabel":  "Long-Term Debt"
                            }
                        }
                    },
                "localname":  "LongTermDebtTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebt"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_LossContingenciesLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Loss Contingencies [Line Items]",
                            "terseLabel":  "Loss Contingencies [Line Items]"
                            }
                        }
                    },
                "localname":  "LossContingenciesLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentsandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LossContingenciesTable":  {
                "auth_ref":  [
                    "r259",
                    "r260",
                    "r261",
                    "r263",
                    "r264",
                    "r265",
                    "r266",
                    "r268",
                    "r269"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made.  Excludes environmental contingencies, warranties and unconditional purchase obligations.",
                            "label":  "Loss Contingencies [Table]",
                            "terseLabel":  "Loss Contingencies [Table]"
                            }
                        }
                    },
                "localname":  "LossContingenciesTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentsandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LossContingencyNewClaimsFiledNumber":  {
                "auth_ref":  [
                    "r262"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The total number of new claims filed pertaining to a loss contingency during the period.",
                            "label":  "Loss Contingency, New Claims Filed, Number",
                            "terseLabel":  "Number of securities class action complaints filed"
                            }
                        }
                    },
                "localname":  "LossContingencyNewClaimsFiledNumber",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentsandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "us-gaap_MarketingAndAdvertisingExpense":  {
                "auth_ref":  [
                    "r82"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_CostsAndExpenses",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The total expense recognized in the period for promotion, public relations, and brand or product advertising.",
                            "label":  "Marketing and Advertising Expense",
                            "terseLabel":  "Marketing and advertising"
                            }
                        }
                    },
                "localname":  "MarketingAndAdvertisingExpense",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_MemberUnitsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Ownership interest in limited liability company (LLC).",
                            "label":  "Member Units [Member]",
                            "terseLabel":  "Members\u2019 Equity"
                            }
                        }
                    },
                "localname":  "MemberUnitsMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_MembersCapital":  {
                "auth_ref":  [
                    "r288"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_MembersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of member capital in limited liability company (LLC).",
                            "label":  "Members' Capital",
                            "terseLabel":  "Members\u2019 interest"
                            }
                        }
                    },
                "localname":  "MembersCapital",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_MembersEquity":  {
                "auth_ref":  [
                    "r159",
                    "r160",
                    "r161",
                    "r162",
                    "r288"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of ownership interest in limited liability company (LLC), attributable to the parent entity.",
                            "label":  "Members' Equity",
                            "periodEndLabel":  "Ending balance",
                            "periodStartLabel":  "Beginning balance",
                            "totalLabel":  "Total members' equity"
                            }
                        }
                    },
                "localname":  "MembersEquity",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_MinorityInterest":  {
                "auth_ref":  [
                    "r56",
                    "r115",
                    "r215",
                    "r466",
                    "r533",
                    "r551"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
                            "label":  "Stockholders' Equity Attributable to Noncontrolling Interest",
                            "terseLabel":  "Non-controlling interests"
                            }
                        }
                    },
                "localname":  "MinorityInterest",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders":  {
                "auth_ref":  [
                    "r288"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
                            "label":  "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
                            "negatedTerseLabel":  "Member distributions non-controlling interests"
                            }
                        }
                    },
                "localname":  "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_MinorityInterestDecreaseFromRedemptions":  {
                "auth_ref":  [
                    "r288",
                    "r445",
                    "r446"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).",
                            "label":  "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
                            "negatedTerseLabel":  "Effect of purchase of LLC Interests/Acquisition of non-controlling interests"
                            }
                        }
                    },
                "localname":  "MinorityInterestDecreaseFromRedemptions",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
                            "label":  "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
                            "terseLabel":  "Noncontrolling interest ownership percentage held by the Continuing Equity Owners"
                            }
                        }
                    },
                "localname":  "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_MinorityInterestOwnershipPercentageByParent":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
                            "label":  "Noncontrolling Interest, Ownership Percentage by Parent",
                            "terseLabel":  "Noncontrolling interest ownership percentage held by the Company"
                            }
                        }
                    },
                "localname":  "MinorityInterestOwnershipPercentageByParent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_NetCashProvidedByUsedInFinancingActivities":  {
                "auth_ref":  [
                    "r96"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from financing activities, including discontinued operations.  Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
                            "label":  "Net Cash Provided by (Used in) Financing Activities",
                            "totalLabel":  "Net cash provided by (used in) financing activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInFinancingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net Cash Provided by (Used in) Financing Activities [Abstract]",
                            "terseLabel":  "Financing Activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInFinancingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetCashProvidedByUsedInInvestingActivities":  {
                "auth_ref":  [
                    "r96"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from investing activities, including discontinued operations.  Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
                            "label":  "Net Cash Provided by (Used in) Investing Activities",
                            "totalLabel":  "Net cash provided by (used in) investing activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInInvestingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net Cash Provided by (Used in) Investing Activities [Abstract]",
                            "terseLabel":  "Investing Activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInInvestingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetCashProvidedByUsedInOperatingActivities":  {
                "auth_ref":  [
                    "r96",
                    "r100",
                    "r103"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from operating activities, including discontinued operations.  Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
                            "label":  "Net Cash Provided by (Used in) Operating Activities",
                            "totalLabel":  "Net cash provided by (used in) operating activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInOperatingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net Cash Provided by (Used in) Operating Activities [Abstract]",
                            "terseLabel":  "Operating activities:"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInOperatingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetIncomeLoss":  {
                "auth_ref":  [
                    "r1",
                    "r66",
                    "r68",
                    "r74",
                    "r103",
                    "r115",
                    "r130",
                    "r134",
                    "r135",
                    "r136",
                    "r137",
                    "r142",
                    "r143",
                    "r149",
                    "r188",
                    "r193",
                    "r196",
                    "r199",
                    "r202",
                    "r215",
                    "r466",
                    "r537",
                    "r555"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
                            "label":  "Net Income (Loss) Attributable to Parent",
                            "totalLabel":  "Net income (loss) attributable to GoHealth, Inc."
                            }
                        }
                    },
                "localname":  "NetIncomeLoss",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest":  {
                "auth_ref":  [
                    "r66",
                    "r68",
                    "r142",
                    "r143",
                    "r450",
                    "r456"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetIncomeLoss",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of Net Income (Loss) attributable to noncontrolling interest.",
                            "label":  "Net Income (Loss) Attributable to Noncontrolling Interest",
                            "terseLabel":  "Net loss attributable to non-controlling interests",
                            "verboseLabel":  "Less:  Net loss attributable to non-controlling interests subsequent to the IPO"
                            }
                        }
                    },
                "localname":  "NetIncomeLossAttributableToNoncontrollingInterest",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations",
                    "http://www.gohealth.com/role/NetLossPerShareReconciliationoftheNumeratorandDenominatorUsedintheCalculationofBasicandDilutedNetLossPerShareDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]",
                            "terseLabel":  "Numerator:"
                            }
                        }
                    },
                "localname":  "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/NetLossPerShareReconciliationoftheNumeratorandDenominatorUsedintheCalculationofBasicandDilutedNetLossPerShareDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting.  Includes, but is not limited to, quantification of the expected or actual impact.",
                            "label":  "New Accounting Pronouncements, Policy [Policy Text Block]",
                            "terseLabel":  "Recent Accounting Pronouncements"
                            }
                        }
                    },
                "localname":  "NewAccountingPronouncementsPolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_NoncontrollingInterestMember":  {
                "auth_ref":  [
                    "r126",
                    "r127",
                    "r129",
                    "r288",
                    "r440"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent.  A noncontrolling interest is sometimes called a minority interest.",
                            "label":  "Noncontrolling Interest [Member]",
                            "terseLabel":  "Non-Controlling Interest"
                            }
                        }
                    },
                "localname":  "NoncontrollingInterestMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_NonrecurringAdjustmentAxis":  {
                "auth_ref":  [
                    "r418"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information about material and nonrecurring adjustment directly attributable to the business combination(s) included in the reported pro forma revenue and earnings (supplemental pro forma information).",
                            "label":  "Nonrecurring Adjustment [Axis]",
                            "terseLabel":  "Nonrecurring Adjustment [Axis]"
                            }
                        }
                    },
                "localname":  "NonrecurringAdjustmentAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NonrecurringAdjustmentDomain":  {
                "auth_ref":  [
                    "r418"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Material, nonrecurring adjustment(s) allocated (included) to (in) reported pro forma revenue and earnings (supplemental pro forma information).",
                            "label":  "Nonrecurring Adjustment [Domain]",
                            "terseLabel":  "Nonrecurring Adjustment [Domain]"
                            }
                        }
                    },
                "localname":  "NonrecurringAdjustmentDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_NumberOfOperatingSegments":  {
                "auth_ref":  [
                    "r176"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of operating segments.  An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available.  An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
                            "label":  "Number of Operating Segments",
                            "terseLabel":  "Number of operating segments"
                            }
                        }
                    },
                "localname":  "NumberOfOperatingSegments",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails",
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersNarrativeDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "us-gaap_NumberOfReportableSegments":  {
                "auth_ref":  [
                    "r176"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of segments reported by the entity.  A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
                            "label":  "Number of Reportable Segments",
                            "terseLabel":  "Number of reportable segments"
                            }
                        }
                    },
                "localname":  "NumberOfReportableSegments",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersNarrativeDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "us-gaap_NumberOfReportingUnits":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of reporting units tested for impairment of goodwill.  A reporting unit is an operating segment or one level below an operating segment.",
                            "label":  "Number of Reporting Units",
                            "terseLabel":  "Number of reporting units"
                            }
                        }
                    },
                "localname":  "NumberOfReportingUnits",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "us-gaap_OperatingExpensesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Operating Expenses [Abstract]",
                            "terseLabel":  "Operating expenses:"
                            }
                        }
                    },
                "localname":  "OperatingExpensesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OperatingIncomeLoss":  {
                "auth_ref":  [
                    "r188",
                    "r193",
                    "r196",
                    "r199",
                    "r202"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The net result for the period of deducting operating expenses from operating revenues.",
                            "label":  "Operating Income (Loss)",
                            "totalLabel":  "Income (loss) from operations",
                            "verboseLabel":  "Segment profit"
                            }
                        }
                    },
                "localname":  "OperatingIncomeLoss",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations",
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingIncomeLossAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Operating Income (Loss) [Abstract]",
                            "terseLabel":  "Segment profit (loss):"
                            }
                        }
                    },
                "localname":  "OperatingIncomeLossAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OperatingLeasesFutureMinimumPaymentsDue":  {
                "auth_ref":  [
                    "r482",
                    "r484"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.",
                            "label":  "Operating Leases, Future Minimum Payments Due",
                            "totalLabel":  "Total minimum lease payments"
                            }
                        }
                    },
                "localname":  "OperatingLeasesFutureMinimumPaymentsDue",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]",
                            "terseLabel":  "Operating Leases"
                            }
                        }
                    },
                "localname":  "OperatingLeasesFutureMinimumPaymentsDueAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent":  {
                "auth_ref":  [
                    "r482",
                    "r484"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year.  Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
                            "label":  "Operating Leases, Future Minimum Payments Due, Next Twelve Months",
                            "terseLabel":  "2021"
                            }
                        }
                    },
                "localname":  "OperatingLeasesFutureMinimumPaymentsDueCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears":  {
                "auth_ref":  [
                    "r482",
                    "r484"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year.  Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
                            "label":  "Operating Leases, Future Minimum Payments, Due in Five Years",
                            "terseLabel":  "2025"
                            }
                        }
                    },
                "localname":  "OperatingLeasesFutureMinimumPaymentsDueInFiveYears",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears":  {
                "auth_ref":  [
                    "r482",
                    "r484"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year.  Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
                            "label":  "Operating Leases, Future Minimum Payments, Due in Four Years",
                            "terseLabel":  "2024"
                            }
                        }
                    },
                "localname":  "OperatingLeasesFutureMinimumPaymentsDueInFourYears",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears":  {
                "auth_ref":  [
                    "r482",
                    "r484"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year.  Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
                            "label":  "Operating Leases, Future Minimum Payments, Due in Three Years",
                            "terseLabel":  "2023"
                            }
                        }
                    },
                "localname":  "OperatingLeasesFutureMinimumPaymentsDueInThreeYears",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears":  {
                "auth_ref":  [
                    "r482",
                    "r484"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year.  Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
                            "label":  "Operating Leases, Future Minimum Payments, Due in Two Years",
                            "terseLabel":  "2022"
                            }
                        }
                    },
                "localname":  "OperatingLeasesFutureMinimumPaymentsDueInTwoYears",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter":  {
                "auth_ref":  [
                    "r482",
                    "r484"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year.  Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
                            "label":  "Operating Leases, Future Minimum Payments, Due Thereafter",
                            "terseLabel":  "Thereafter"
                            }
                        }
                    },
                "localname":  "OperatingLeasesFutureMinimumPaymentsDueThereafter",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsUnderNoncancelableCapitalandOperatingLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeasesRentExpenseMinimumRentals":  {
                "auth_ref":  [
                    "r481",
                    "r482",
                    "r483"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "This element represents the payments that the lessee is obligated to make or can be required to make in connection with a property under the terms of an agreement classified as an operating lease, excluding contingent rentals and a guarantee by the lessee of the lessor's debt and the lessee's obligation to pay (apart from the rental payments) executory costs such as insurance, maintenance, and taxes.",
                            "label":  "Operating Leases, Rent Expense, Minimum Rentals",
                            "terseLabel":  "Initial base rent"
                            }
                        }
                    },
                "localname":  "OperatingLeasesRentExpenseMinimumRentals",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLossCarryforwards":  {
                "auth_ref":  [
                    "r393"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
                            "label":  "Operating Loss Carryforwards",
                            "terseLabel":  "Net operating loss carryforwards"
                            }
                        }
                    },
                "localname":  "OperatingLossCarryforwards",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLossCarryforwardsLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Operating Loss Carryforwards [Line Items]",
                            "terseLabel":  "Operating Loss Carryforwards [Line Items]"
                            }
                        }
                    },
                "localname":  "OperatingLossCarryforwardsLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OperatingLossCarryforwardsTable":  {
                "auth_ref":  [
                    "r394"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
                            "label":  "Operating Loss Carryforwards [Table]",
                            "terseLabel":  "Operating Loss Carryforwards [Table]"
                            }
                        }
                    },
                "localname":  "OperatingLossCarryforwardsTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OperatingSegmentsMember":  {
                "auth_ref":  [
                    "r192",
                    "r193",
                    "r194",
                    "r195",
                    "r196",
                    "r202"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
                            "label":  "Operating Segments [Member]",
                            "terseLabel":  "Operating Segments"
                            }
                        }
                    },
                "localname":  "OperatingSegmentsMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
                            }
                        }
                    },
                "localname":  "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OtherAccruedLiabilitiesCurrent":  {
                "auth_ref":  [
                    "r7",
                    "r8",
                    "r9",
                    "r44"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/BalanceSheetAccountsSummaryofAccruedLiabilitiesDetails":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
                            "label":  "Other Accrued Liabilities, Current",
                            "terseLabel":  "Other accrued expenses"
                            }
                        }
                    },
                "localname":  "OtherAccruedLiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsSummaryofAccruedLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherAssetsNoncurrent":  {
                "auth_ref":  [
                    "r40"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of noncurrent assets classified as other.",
                            "label":  "Other Assets, Noncurrent",
                            "terseLabel":  "Other long-term assets"
                            }
                        }
                    },
                "localname":  "OtherAssetsNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax":  {
                "auth_ref":  [
                    "r60"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
                            "label":  "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
                            "terseLabel":  "Foreign currency translation adjustments",
                            "verboseLabel":  "Foreign currency translation adjustment"
                            }
                        }
                    },
                "localname":  "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
                            "terseLabel":  "Other comprehensive income (loss):"
                            }
                        }
                    },
                "localname":  "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OtherLiabilitiesCurrent":  {
                "auth_ref":  [
                    "r6",
                    "r7",
                    "r44"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
                            "label":  "Other Liabilities, Current",
                            "terseLabel":  "Other current liabilities"
                            }
                        }
                    },
                "localname":  "OtherLiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherLiabilitiesNoncurrent":  {
                "auth_ref":  [
                    "r48"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_LiabilitiesNoncurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
                            "label":  "Other Liabilities, Noncurrent",
                            "terseLabel":  "Other non-current liabilities"
                            }
                        }
                    },
                "localname":  "OtherLiabilitiesNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherNoncashIncomeExpense":  {
                "auth_ref":  [
                    "r103"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  7.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
                            "label":  "Other Noncash Income (Expense)",
                            "negatedLabel":  "Other non-cash items"
                            }
                        }
                    },
                "localname":  "OtherNoncashIncomeExpense",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherNonoperatingIncomeExpense":  {
                "auth_ref":  [
                    "r84"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of income (expense) related to nonoperating activities, classified as other.",
                            "label":  "Other Nonoperating Income (Expense)",
                            "negatedTerseLabel":  "Other (income) expense"
                            }
                        }
                    },
                "localname":  "OtherNonoperatingIncomeExpense",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations",
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities":  {
                "auth_ref":  [
                    "r92"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
                            "label":  "Payment for Contingent Consideration Liability, Financing Activities",
                            "terseLabel":  "Payment of contingent consideration in cash"
                            }
                        }
                    },
                "localname":  "PaymentForContingentConsiderationLiabilityFinancingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsForRepurchaseOfPreferredStockAndPreferenceStock":  {
                "auth_ref":  [
                    "r89"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash outflow to reacquire preferred stock during the period.",
                            "label":  "Payments for Repurchase of Preferred Stock and Preference Stock",
                            "negatedTerseLabel":  "Settlement of Senior Preferred Earnout Units",
                            "terseLabel":  "Payments for equity instruments"
                            }
                        }
                    },
                "localname":  "PaymentsForRepurchaseOfPreferredStockAndPreferenceStock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows",
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsOfDebtIssuanceCosts":  {
                "auth_ref":  [
                    "r91"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  11.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
                            "label":  "Payments of Debt Issuance Costs",
                            "negatedLabel":  "Debt issuance cost payments"
                            }
                        }
                    },
                "localname":  "PaymentsOfDebtIssuanceCosts",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsToAcquireBusinessesGross":  {
                "auth_ref":  [
                    "r85",
                    "r433"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/AcquisitionsSummaryofPurchaseConsiderationDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_BusinessCombinationConsiderationTransferred1",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash outflow associated with the acquisition of business during the period.  The cash portion only of the acquisition price.",
                            "label":  "Payments to Acquire Businesses, Gross",
                            "terseLabel":  "Cash consideration paid",
                            "verboseLabel":  "Cash paid"
                            }
                        }
                    },
                "localname":  "PaymentsToAcquireBusinessesGross",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails",
                    "http://www.gohealth.com/role/AcquisitionsSummaryofPurchaseConsiderationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired":  {
                "auth_ref":  [
                    "r85"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
                            "label":  "Payments to Acquire Businesses, Net of Cash Acquired",
                            "negatedTerseLabel":  "Acquisition of business, net of cash"
                            }
                        }
                    },
                "localname":  "PaymentsToAcquireBusinessesNetOfCashAcquired",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsToAcquireProductiveAssets":  {
                "auth_ref":  [
                    "r86"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
                            "label":  "Payments to Acquire Productive Assets",
                            "negatedLabel":  "Purchases of property, equipment and software"
                            }
                        }
                    },
                "localname":  "PaymentsToAcquireProductiveAssets",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsToMinorityShareholders":  {
                "auth_ref":  [
                    "r93"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  13.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash outflow to a noncontrolling interest.  Includes, but not limited to, reduction of noncontrolling interest ownership.  Excludes dividends paid to the noncontrolling interest.",
                            "label":  "Payments to Noncontrolling Interests",
                            "negatedTerseLabel":  "Distributions to non-controlling interests"
                            }
                        }
                    },
                "localname":  "PaymentsToMinorityShareholders",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PendingLitigationMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
                            "label":  "Pending Litigation [Member]",
                            "terseLabel":  "Pending litigation"
                            }
                        }
                    },
                "localname":  "PendingLitigationMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentsandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_PensionAndOtherPostretirementPlansNonpensionBenefitsPolicy":  {
                "auth_ref":  [
                    "r111",
                    "r326",
                    "r328",
                    "r333"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for plans, other than pension plans, that provide postretirement benefits (including both defined benefit and defined contribution plans).  This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.",
                            "label":  "Pension and Other Postretirement Plans, Nonpension Benefits, Policy [Policy Text Block]",
                            "terseLabel":  "401(k) Plan"
                            }
                        }
                    },
                "localname":  "PensionAndOtherPostretirementPlansNonpensionBenefitsPolicy",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_PlanNameAxis":  {
                "auth_ref":  [
                    "r337",
                    "r361"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by plan name for share-based payment arrangement.",
                            "label":  "Plan Name [Axis]",
                            "terseLabel":  "Plan Name [Axis]"
                            }
                        }
                    },
                "localname":  "PlanNameAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PlanNameDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Plan name for share-based payment arrangement.",
                            "label":  "Plan Name [Domain]",
                            "terseLabel":  "Plan Name [Domain]"
                            }
                        }
                    },
                "localname":  "PlanNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_PreferredStockParOrStatedValuePerShare":  {
                "auth_ref":  [
                    "r23"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
                            "label":  "Preferred Stock, Par or Stated Value Per Share",
                            "terseLabel":  "Preferred stock, par value (in dollars per share)"
                            }
                        }
                    },
                "localname":  "PreferredStockParOrStatedValuePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheetsParenthetical",
                    "http://www.gohealth.com/role/StockholdersEquityandMembersEquityDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_PreferredStockSharesAuthorized":  {
                "auth_ref":  [
                    "r23"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
                            "label":  "Preferred Stock, Shares Authorized",
                            "terseLabel":  "Preferred stock, shares authorized (in shares)"
                            }
                        }
                    },
                "localname":  "PreferredStockSharesAuthorized",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheetsParenthetical",
                    "http://www.gohealth.com/role/StockholdersEquityandMembersEquityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_PreferredStockSharesIssued":  {
                "auth_ref":  [
                    "r23"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury).  May be all or portion of the number of preferred shares authorized.  Excludes preferred shares that are classified as debt.",
                            "label":  "Preferred Stock, Shares Issued",
                            "terseLabel":  "Preferred stock, shares issued (in shares)"
                            }
                        }
                    },
                "localname":  "PreferredStockSharesIssued",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheetsParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_PreferredStockSharesOutstanding":  {
                "auth_ref":  [
                    "r23"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders.  Does not include preferred shares that have been repurchased.",
                            "label":  "Preferred Stock, Shares Outstanding",
                            "terseLabel":  "Preferred stock, shares outstanding (in shares)"
                            }
                        }
                    },
                "localname":  "PreferredStockSharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheetsParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_PreferredStockValue":  {
                "auth_ref":  [
                    "r23"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer).  This item includes treasury stock repurchased by the entity.  Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
                            "label":  "Preferred Stock, Value, Issued",
                            "terseLabel":  "Preferred stock \u2013 $0.0001 par value; 20,000 shares authorized; no shares issued and outstanding at December 31, 2020"
                            }
                        }
                    },
                "localname":  "PreferredStockValue",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PrepaidExpenseAndOtherAssetsCurrent":  {
                "auth_ref":  [
                    "r4",
                    "r34",
                    "r35"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
                            "label":  "Prepaid Expense and Other Assets, Current",
                            "terseLabel":  "Prepaid expense and other current assets"
                            }
                        }
                    },
                "localname":  "PrepaidExpenseAndOtherAssetsCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PrimeRateMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Interest rate charged by financial institutions to their most creditworthy borrowers.",
                            "label":  "Prime Rate [Member]",
                            "terseLabel":  "Prime Rate"
                            }
                        }
                    },
                "localname":  "PrimeRateMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ProceedsFromCommissionsReceived":  {
                "auth_ref":  [
                    "r97"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Cash received for commissions during the current period.",
                            "label":  "Proceeds from Commissions Received",
                            "negatedLabel":  "Cash receipts for the period"
                            }
                        }
                    },
                "localname":  "ProceedsFromCommissionsReceived",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsCommissionsReceivableDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromIssuanceInitialPublicOffering":  {
                "auth_ref":  [
                    "r87"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
                            "label":  "Proceeds from Issuance Initial Public Offering",
                            "terseLabel":  "Proceeds from issuance of Class A common stock sold in initial public offering, net of offering costs",
                            "verboseLabel":  "Proceeds from initial public offering"
                            }
                        }
                    },
                "localname":  "ProceedsFromIssuanceInitialPublicOffering",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows",
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromIssuanceOfCommonStock":  {
                "auth_ref":  [
                    "r87"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow from the additional capital contribution to the entity.",
                            "label":  "Proceeds from Issuance of Common Stock",
                            "terseLabel":  "Proceeds received upon issuance of common units"
                            }
                        }
                    },
                "localname":  "ProceedsFromIssuanceOfCommonStock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromIssuanceOfPreferredLimitedPartnersUnits":  {
                "auth_ref":  [
                    "r87"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow from the issuance of preferred limited partners units during the period.",
                            "label":  "Proceeds from Issuance of Preferred Limited Partners Units",
                            "terseLabel":  "Proceeds received upon issuance of preferred units"
                            }
                        }
                    },
                "localname":  "ProceedsFromIssuanceOfPreferredLimitedPartnersUnits",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromLinesOfCredit":  {
                "auth_ref":  [
                    "r88",
                    "r120"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  9.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
                            "label":  "Proceeds from Lines of Credit",
                            "terseLabel":  "Borrowings under revolving credit facilities"
                            }
                        }
                    },
                "localname":  "ProceedsFromLinesOfCredit",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromLongTermLinesOfCredit":  {
                "auth_ref":  [
                    "r88"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  7.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
                            "label":  "Proceeds from Long-term Lines of Credit",
                            "terseLabel":  "Borrowings under term loans"
                            }
                        }
                    },
                "localname":  "ProceedsFromLongTermLinesOfCredit",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProfitLoss":  {
                "auth_ref":  [
                    "r1",
                    "r66",
                    "r68",
                    "r95",
                    "r115",
                    "r130",
                    "r142",
                    "r143",
                    "r188",
                    "r193",
                    "r196",
                    "r199",
                    "r202",
                    "r215",
                    "r442",
                    "r449",
                    "r451",
                    "r456",
                    "r457",
                    "r466",
                    "r542"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        },
                    "http://www.gohealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                        "weight":  1.0
                        },
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetIncomeLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
                            "label":  "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
                            "negatedNetLabel":  "Non-recurring pro forma adjustments",
                            "terseLabel":  "Net income (loss)",
                            "totalLabel":  "Net income (loss)",
                            "verboseLabel":  "Net loss"
                            }
                        }
                    },
                "localname":  "ProfitLoss",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations",
                    "http://www.gohealth.com/role/NetLossPerShareReconciliationoftheNumeratorandDenominatorUsedintheCalculationofBasicandDilutedNetLossPerShareDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentByTypeAxis":  {
                "auth_ref":  [
                    "r39",
                    "r251"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
                            "label":  "Long-Lived Tangible Asset [Axis]",
                            "terseLabel":  "Long-Lived Tangible Asset [Axis]"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentByTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsSummaryofPropertyEquipmentandCapitalizedSoftwareNetDetails",
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentGross":  {
                "auth_ref":  [
                    "r38",
                    "r249"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale.  Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
                            "label":  "Property, Plant and Equipment, Gross",
                            "terseLabel":  "Property and equipment"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentGross",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsSummaryofPropertyEquipmentandCapitalizedSoftwareNetDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Property, Plant and Equipment [Line Items]",
                            "terseLabel":  "Property, Plant and Equipment [Line Items]"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsSummaryofPropertyEquipmentandCapitalizedSoftwareNetDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentNet":  {
                "auth_ref":  [
                    "r14",
                    "r15",
                    "r251",
                    "r553"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale.  Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
                            "label":  "Property, Plant and Equipment, Net",
                            "terseLabel":  "Property, equipment, and capitalized software, net"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentNet",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsSummaryofPropertyEquipmentandCapitalizedSoftwareNetDetails",
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock":  {
                "auth_ref":  [
                    "r37",
                    "r111",
                    "r251",
                    "r585",
                    "r586"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale.  Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
                            "label":  "Property, Plant and Equipment, Policy [Policy Text Block]",
                            "terseLabel":  "Property Equipment, and Capitalized Software, Net"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentTextBlock":  {
                "auth_ref":  [
                    "r14",
                    "r251"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale.  Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
                            "label":  "Property, Plant and Equipment [Table Text Block]",
                            "terseLabel":  "Summary of Property, Equipment and Capitalized Software, Net",
                            "verboseLabel":  "Summary of Property, Equipment and Capitalized Software Estimated Useful Lives"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsTables",
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentTypeDomain":  {
                "auth_ref":  [
                    "r14",
                    "r249"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.  Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
                            "label":  "Long-Lived Tangible Asset [Domain]",
                            "terseLabel":  "Long-Lived Tangible Asset [Domain]"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsSummaryofPropertyEquipmentandCapitalizedSoftwareNetDetails",
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentUsefulLife":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.  Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
                            "label":  "Property, Plant and Equipment, Useful Life",
                            "terseLabel":  "Estimated useful life"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentUsefulLife",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_ReceivablesBillingStatusDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amounts due from customers (or dealers) within the next year (or operating cycle, if longer) for goods or services that have been delivered or used, but not yet paid.",
                            "label":  "Receivables Billing Status [Domain]",
                            "terseLabel":  "Receivables Billing Status [Domain]"
                            }
                        }
                    },
                "localname":  "ReceivablesBillingStatusDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy":  {
                "auth_ref":  [
                    "r33",
                    "r111",
                    "r212"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.",
                            "label":  "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]",
                            "terseLabel":  "Accounts Receivable and Allowance for Doubtful Accounts"
                            }
                        }
                    },
                "localname":  "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable":  {
                "auth_ref":  [
                    "r193",
                    "r196"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations.  Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
                            "label":  "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]",
                            "terseLabel":  "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]"
                            }
                        }
                    },
                "localname":  "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock":  {
                "auth_ref":  [
                    "r193",
                    "r196"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations.  Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
                            "label":  "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
                            "terseLabel":  "Summary of Reconciliation of Operating Profit (Loss) From Segments to Consolidated"
                            }
                        }
                    },
                "localname":  "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_RelatedPartyDomain":  {
                "auth_ref":  [
                    "r325",
                    "r493",
                    "r494"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families.  It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
                            "label":  "Related Party [Domain]",
                            "terseLabel":  "Related Party [Domain]"
                            }
                        }
                    },
                "localname":  "RelatedPartyDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RelatedPartyTransactionAxis":  {
                "auth_ref":  [
                    "r325",
                    "r493",
                    "r494",
                    "r497"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of related party transaction.",
                            "label":  "Related Party Transaction [Axis]",
                            "terseLabel":  "Related Party Transaction [Axis]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RelatedPartyTransactionDomain":  {
                "auth_ref":  [
                    "r325"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Transaction between related party.",
                            "label":  "Related Party Transaction [Domain]",
                            "terseLabel":  "Related Party Transaction [Domain]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty":  {
                "auth_ref":  [
                    "r493"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
                            "label":  "Related Party Transaction, Expenses from Transactions with Related Party",
                            "terseLabel":  "Lease expenses incurred"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RelatedPartyTransactionLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Related Party Transaction [Line Items]",
                            "terseLabel":  "Related Party Transaction [Line Items]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RelatedPartyTransactionsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Related Party Transactions [Abstract]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis":  {
                "auth_ref":  [
                    "r325",
                    "r493",
                    "r497",
                    "r515",
                    "r516",
                    "r517",
                    "r518",
                    "r519",
                    "r520",
                    "r521",
                    "r522",
                    "r523",
                    "r524",
                    "r525",
                    "r526"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of related party.  Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families.  It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
                            "label":  "Related Party [Axis]",
                            "terseLabel":  "Related Party [Axis]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionsByRelatedPartyAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RelatedPartyTransactionsDisclosureTextBlock":  {
                "auth_ref":  [
                    "r491",
                    "r492",
                    "r494",
                    "r498",
                    "r499"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for related party transactions.  Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
                            "label":  "Related Party Transactions Disclosure [Text Block]",
                            "terseLabel":  "Related Party Transactions"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionsDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/RelatedPartyTransactions"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_RepaymentsOfLinesOfCredit":  {
                "auth_ref":  [
                    "r90",
                    "r120"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  10.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
                            "label":  "Repayments of Lines of Credit",
                            "negatedLabel":  "Payments under revolving credit facilities"
                            }
                        }
                    },
                "localname":  "RepaymentsOfLinesOfCredit",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RepaymentsOfLongTermCapitalLeaseObligations":  {
                "auth_ref":  [
                    "r90"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  12.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).",
                            "label":  "Repayments of Long-term Capital Lease Obligations",
                            "negatedLabel":  "Principal payments under capital lease obligations"
                            }
                        }
                    },
                "localname":  "RepaymentsOfLongTermCapitalLeaseObligations",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RepaymentsOfLongTermLinesOfCredit":  {
                "auth_ref":  [
                    "r90"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  8.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
                            "label":  "Repayments of Long-term Lines of Credit",
                            "negatedLabel":  "Principal payments under term loans"
                            }
                        }
                    },
                "localname":  "RepaymentsOfLongTermLinesOfCredit",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RestrictedStockUnitsRSUMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
                            "label":  "Restricted Stock Units (RSUs) [Member]",
                            "terseLabel":  "RSUs"
                            }
                        }
                    },
                "localname":  "RestrictedStockUnitsRSUMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofProfitUnitsandRSUsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RetainedEarningsAccumulatedDeficit":  {
                "auth_ref":  [
                    "r27",
                    "r288",
                    "r369",
                    "r550",
                    "r572",
                    "r577"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
                            "label":  "Retained Earnings (Accumulated Deficit)",
                            "terseLabel":  "Accumulated deficit"
                            }
                        }
                    },
                "localname":  "RetainedEarningsAccumulatedDeficit",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RetainedEarningsMember":  {
                "auth_ref":  [
                    "r126",
                    "r127",
                    "r129",
                    "r131",
                    "r140",
                    "r143",
                    "r219",
                    "r366",
                    "r367",
                    "r368",
                    "r400",
                    "r401",
                    "r568",
                    "r570"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
                            "label":  "Retained Earnings [Member]",
                            "terseLabel":  "Accumulated Deficit"
                            }
                        }
                    },
                "localname":  "RetainedEarningsMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RevenueFromContractWithCustomerAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Revenue from Contract with Customer [Abstract]"
                            }
                        }
                    },
                "localname":  "RevenueFromContractWithCustomerAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax":  {
                "auth_ref":  [
                    "r179",
                    "r180",
                    "r192",
                    "r197",
                    "r198",
                    "r204",
                    "r205",
                    "r207",
                    "r310",
                    "r312",
                    "r512"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer.  Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
                            "label":  "Revenue from Contract with Customer, Including Assessed Tax",
                            "netLabel":  "Commission revenue for the period",
                            "verboseLabel":  "Net revenues"
                            }
                        }
                    },
                "localname":  "RevenueFromContractWithCustomerIncludingAssessedTax",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsCommissionsReceivableDetails",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations",
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
                    "http://www.gohealth.com/role/RevenueSummaryofDisaggregationofRevenueDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock":  {
                "auth_ref":  [
                    "r112",
                    "r302",
                    "r303",
                    "r304",
                    "r305",
                    "r306",
                    "r307",
                    "r308",
                    "r309",
                    "r323"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for revenue from contract with customer.",
                            "label":  "Revenue from Contract with Customer [Policy Text Block]",
                            "terseLabel":  "Commissions Receivable, Commissions Payable, Revenue Recognition, Deferred Revenue and Cost of Revenue"
                            }
                        }
                    },
                "localname":  "RevenueFromContractWithCustomerPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_RevenueFromContractWithCustomerTextBlock":  {
                "auth_ref":  [
                    "r294",
                    "r295",
                    "r296",
                    "r297",
                    "r298",
                    "r299",
                    "r300",
                    "r301",
                    "r315",
                    "r323"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset.  Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer.  Excludes insurance and lease contracts.",
                            "label":  "Revenue from Contract with Customer [Text Block]",
                            "verboseLabel":  "Revenue"
                            }
                        }
                    },
                "localname":  "RevenueFromContractWithCustomerTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/Revenue"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_RevenuesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Revenues [Abstract]",
                            "verboseLabel":  "Revenues:"
                            }
                        }
                    },
                "localname":  "RevenuesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RevolvingCreditFacilityMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
                            "label":  "Revolving Credit Facility [Member]",
                            "terseLabel":  "Revolving Credit Facility"
                            }
                        }
                    },
                "localname":  "RevolvingCreditFacilityMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SaleOfStockNameOfTransactionDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
                            "label":  "Sale of Stock [Domain]",
                            "terseLabel":  "Sale of Stock [Domain]"
                            }
                        }
                    },
                "localname":  "SaleOfStockNameOfTransactionDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SalesRevenueNetMember":  {
                "auth_ref":  [
                    "r169",
                    "r207"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
                            "label":  "Revenue Benchmark [Member]",
                            "terseLabel":  "Revenue"
                            }
                        }
                    },
                "localname":  "SalesRevenueNetMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofRevenuebyMajorCustomersbyReportingSegmentsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the components of accrued liabilities.",
                            "label":  "Schedule of Accrued Liabilities [Table Text Block]",
                            "terseLabel":  "Summary of Accrued Liabilities"
                            }
                        }
                    },
                "localname":  "ScheduleOfAccruedLiabilitiesTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable":  {
                "auth_ref":  [
                    "r153"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
                            "label":  "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
                            "terseLabel":  "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/NetLossPerShareAntidilutiveSecuritiesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock":  {
                "auth_ref":  [
                    "r153"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
                            "label":  "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
                            "terseLabel":  "Schedule of Antidilutive Securities Excluded From Calculation of Diluted Loss Per Share"
                            }
                        }
                    },
                "localname":  "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/NetLossPerShareTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable":  {
                "auth_ref":  [
                    "r419",
                    "r420"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
                            "label":  "Schedule of Business Acquisitions, by Acquisition [Table]",
                            "terseLabel":  "Schedule of Business Acquisitions, by Acquisition [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsNarrativeDetails",
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock":  {
                "auth_ref":  [
                    "r399"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
                            "label":  "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
                            "terseLabel":  "Schedule of Components of Income Tax Expense (Benefit)"
                            }
                        }
                    },
                "localname":  "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfDebtInstrumentsTextBlock":  {
                "auth_ref":  [
                    "r47",
                    "r119",
                    "r282",
                    "r285",
                    "r286",
                    "r287",
                    "r477",
                    "r478",
                    "r480",
                    "r543"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation.  These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
                            "label":  "Schedule of Long-term Debt Instruments [Table Text Block]",
                            "verboseLabel":  "Summary of Long-Term Debt"
                            }
                        }
                    },
                "localname":  "ScheduleOfDebtInstrumentsTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock":  {
                "auth_ref":  [
                    "r390"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
                            "label":  "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
                            "terseLabel":  "Schedule of Deferred Tax Assets and Liabilities"
                            }
                        }
                    },
                "localname":  "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock":  {
                "auth_ref":  [
                    "r152"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
                            "label":  "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
                            "terseLabel":  "Summary of Reconciliation of the Numerator and Denominator Used in the Calculation of Basic and Diluted Net Loss Per Share"
                            }
                        }
                    },
                "localname":  "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/NetLossPerShareTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock":  {
                "auth_ref":  [
                    "r381"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
                            "label":  "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
                            "terseLabel":  "Reconciliation of the Statutory Tax Rate to Our Effective Tax Rate"
                            }
                        }
                    },
                "localname":  "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable":  {
                "auth_ref":  [
                    "r336",
                    "r358",
                    "r371"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about amount recognized for award under share-based payment arrangement.  Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
                            "label":  "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
                            "terseLabel":  "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofShareBasedCompensationExpensesbyOperatingFunctionDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock":  {
                "auth_ref":  [
                    "r336",
                    "r358",
                    "r371"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position.  Includes, but is not limited to, corresponding line item in financial statement.",
                            "label":  "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
                            "terseLabel":  "Summary of Share-Based Compensation Expenses by Operating Function"
                            }
                        }
                    },
                "localname":  "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable":  {
                "auth_ref":  [
                    "r207"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure about the extent of the entity's reliance on its major customers.",
                            "label":  "Schedule of Revenue by Major Customers, by Reporting Segments [Table]",
                            "terseLabel":  "Schedule of Revenue by Major Customers, by Reporting Segments [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofRevenuebyMajorCustomersbyReportingSegmentsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable":  {
                "auth_ref":  [
                    "r234",
                    "r239",
                    "r513"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
                            "label":  "Schedule of Finite-Lived Intangible Assets [Table]",
                            "terseLabel":  "Schedule of Finite-Lived Intangible Assets [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfFiniteLivedIntangibleAssetsTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetSummaryofDefinitelivedandIndefinitelivedIntangibleAssetsDetails",
                    "http://www.gohealth.com/role/GoodwillandIntangibleAssetsNetSummaryofExpectedFutureAmortizationExpenseRelatedtoIntangibleAssetsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock":  {
                "auth_ref":  [
                    "r234",
                    "r239"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
                            "label":  "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
                            "terseLabel":  "Schedule of Definite-lived Amortizable Intangible Assets"
                            }
                        }
                    },
                "localname":  "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock":  {
                "auth_ref":  [
                    "r489"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of future minimum lease payments as of the date of the latest balance sheet presented, in aggregate and for each of the five years succeeding fiscal years, with separate deductions from the total for the amount representing executor costs, including any profit thereon, included in the minimum lease payments and for the amount of the imputed interest necessary to reduce the net minimum lease payments to present value.",
                            "label":  "Schedule of Future Minimum Lease Payments for Capital Leases [Table Text Block]",
                            "terseLabel":  "Schedule of Future Minimum Lease Payments Under Non-cancelable Capital Leases"
                            }
                        }
                    },
                "localname":  "ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentandContingenciesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock":  {
                "auth_ref":  [
                    "r485"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.",
                            "label":  "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]",
                            "terseLabel":  "Schedule of Future Minimum Rental Payments Under Non-cancelable Operating Leases"
                            }
                        }
                    },
                "localname":  "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/CommitmentandContingenciesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfGoodwillTable":  {
                "auth_ref":  [
                    "r229",
                    "r231"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
                            "label":  "Schedule of Goodwill [Table]",
                            "terseLabel":  "Schedule of Goodwill [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfGoodwillTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock":  {
                "auth_ref":  [
                    "r121"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
                            "label":  "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
                            "terseLabel":  "Schedule of Components of Income (Loss) Before Income Taxes"
                            }
                        }
                    },
                "localname":  "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable":  {
                "auth_ref":  [
                    "r243",
                    "r246"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.",
                            "label":  "Schedule of Indefinite-Lived Intangible Assets [Table]",
                            "terseLabel":  "Schedule of Indefinite-Lived Intangible Assets [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetSummaryofDefinitelivedandIndefinitelivedIntangibleAssetsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock":  {
                "auth_ref":  [
                    "r243",
                    "r246"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
                            "label":  "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
                            "terseLabel":  "Schedule of Indefinite-lived Intangible Trade Names"
                            }
                        }
                    },
                "localname":  "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock":  {
                "auth_ref":  [
                    "r271"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
                            "label":  "Schedule of Maturities of Long-term Debt [Table Text Block]",
                            "terseLabel":  "Schedule of Maturities of Long-Term Debt"
                            }
                        }
                    },
                "localname":  "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock":  {
                "auth_ref":  [
                    "r345"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
                            "label":  "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
                            "terseLabel":  "Schedule of RSUs Issued"
                            }
                        }
                    },
                "localname":  "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock":  {
                "auth_ref":  [
                    "r345"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of activity for outstanding award under share-based payment arrangement excluding share and unit options and nonvested award.",
                            "label":  "Share-based Payment Arrangement, Outstanding Award, Activity, Excluding Option [Table Text Block]",
                            "terseLabel":  "Summary of Non-option Equity Awards Issued to Employees"
                            }
                        }
                    },
                "localname":  "ScheduleOfOtherShareBasedCompensationActivityTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable":  {
                "auth_ref":  [
                    "r39",
                    "r251"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale.  Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
                            "label":  "Property, Plant and Equipment [Table]",
                            "terseLabel":  "Property, Plant and Equipment [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfPropertyPlantAndEquipmentTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsSummaryofPropertyEquipmentandCapitalizedSoftwareNetDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock":  {
                "auth_ref":  [
                    "r423"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed.  May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
                            "label":  "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
                            "terseLabel":  "Summary of Purchase Price Allocation"
                            }
                        }
                    },
                "localname":  "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable":  {
                "auth_ref":  [
                    "r117",
                    "r495",
                    "r497"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule of quantitative and qualitative information pertaining to related party transactions.  Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
                            "label":  "Schedule of Related Party Transactions, by Related Party [Table]",
                            "terseLabel":  "Schedule of Related Party Transactions, by Related Party [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues.  The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer.  For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.",
                            "label":  "Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]",
                            "terseLabel":  "Summary of Revenue by Major Customers by Reporting Segments"
                            }
                        }
                    },
                "localname":  "ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable":  {
                "auth_ref":  [
                    "r337",
                    "r361"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about share-based payment arrangement.",
                            "label":  "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
                            "terseLabel":  "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofProfitUnitsandRSUsIssuedtoEmployeesDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofValuationAssumptionsOptionsDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofValuationAssumptionsProfitUnitsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock":  {
                "auth_ref":  [
                    "r352"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
                            "label":  "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
                            "terseLabel":  "Schedule of Stock Options Valuation Assumptions"
                            }
                        }
                    },
                "localname":  "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfStockByClassTable":  {
                "auth_ref":  [
                    "r50",
                    "r113",
                    "r159",
                    "r161",
                    "r277",
                    "r279",
                    "r280",
                    "r282",
                    "r283",
                    "r284",
                    "r285",
                    "r286",
                    "r287",
                    "r288"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule detailing information related to equity by class of stock.  Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer.  It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
                            "label":  "Schedule of Stock by Class [Table]",
                            "terseLabel":  "Schedule of Stock by Class [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfStockByClassTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails",
                    "http://www.gohealth.com/role/StockholdersEquityandMembersEquityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the change in stock options.",
                            "label":  "Schedule of Stock Options Roll Forward [Table Text Block]",
                            "terseLabel":  "Summary of Stock Options Issued to Employees"
                            }
                        }
                    },
                "localname":  "ScheduleOfStockOptionsRollForwardTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock":  {
                "auth_ref":  [
                    "r239"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
                            "label":  "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
                            "terseLabel":  "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense"
                            }
                        }
                    },
                "localname":  "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SecuredDebtMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
                            "label":  "Secured Debt [Member]",
                            "terseLabel":  "Secured debt"
                            }
                        }
                    },
                "localname":  "SecuredDebtMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SegmentDomain":  {
                "auth_ref":  [
                    "r175",
                    "r179",
                    "r180",
                    "r181",
                    "r182",
                    "r183",
                    "r184",
                    "r185",
                    "r186",
                    "r187",
                    "r188",
                    "r189",
                    "r190",
                    "r192",
                    "r193",
                    "r194",
                    "r195",
                    "r196",
                    "r197",
                    "r198",
                    "r199",
                    "r200",
                    "r202",
                    "r207",
                    "r561"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
                            "label":  "Segments [Domain]",
                            "terseLabel":  "Segments [Domain]"
                            }
                        }
                    },
                "localname":  "SegmentDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails",
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
                    "http://www.gohealth.com/role/RevenueSummaryofDisaggregationofRevenueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SegmentReportingAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Segment Reporting [Abstract]"
                            }
                        }
                    },
                "localname":  "SegmentReportingAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SegmentReportingDisclosureTextBlock":  {
                "auth_ref":  [
                    "r175",
                    "r177",
                    "r178",
                    "r188",
                    "r191",
                    "r196",
                    "r200",
                    "r201",
                    "r202",
                    "r203",
                    "r204",
                    "r206",
                    "r207",
                    "r208"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for reporting segments including data and tables.  Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
                            "label":  "Segment Reporting Disclosure [Text Block]",
                            "terseLabel":  "Operating Segments and Significant Customers"
                            }
                        }
                    },
                "localname":  "SegmentReportingDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomers"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]",
                            "terseLabel":  "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]"
                            }
                        }
                    },
                "localname":  "SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SellingAndMarketingExpenseMember":  {
                "auth_ref":  [
                    "r78"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Primary financial statement caption encompassing selling and marketing expense.",
                            "label":  "Selling and Marketing Expense [Member]",
                            "terseLabel":  "Marketing and advertising"
                            }
                        }
                    },
                "localname":  "SellingAndMarketingExpenseMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofShareBasedCompensationExpensesbyOperatingFunctionDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock":  {
                "auth_ref":  [
                    "r111",
                    "r375"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.",
                            "label":  "Selling, General and Administrative Expenses, Policy [Policy Text Block]",
                            "terseLabel":  "General and Administrative Expenses"
                            }
                        }
                    },
                "localname":  "SellingGeneralAndAdministrativeExpensesPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ShareBasedCompensation":  {
                "auth_ref":  [
                    "r101"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of noncash expense for share-based payment arrangement.",
                            "label":  "Share-based Payment Arrangement, Noncash Expense",
                            "terseLabel":  "Share-based compensation"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of additional cost recognized for award under share-based payment arrangement from occurrence of event accelerating recognition of cost.",
                            "label":  "Share-based Payment Arrangement, Accelerated Cost",
                            "terseLabel":  "Accelerated vesting, related compensation expense"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1":  {
                "auth_ref":  [
                    "r338"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period",
                            "terseLabel":  "Requisite service period"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1":  {
                "auth_ref":  [
                    "r338"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.  Includes, but is not limited to, combination of market, performance or service condition.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
                            "terseLabel":  "401(k) award vesting period"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod":  {
                "auth_ref":  [
                    "r344"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
                            "negatedTerseLabel":  "Forfeited (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofProfitUnitsandRSUsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue":  {
                "auth_ref":  [
                    "r349"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
                            "terseLabel":  "Forfeited (in dollars per share)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofProfitUnitsandRSUsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod":  {
                "auth_ref":  [
                    "r347"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
                            "terseLabel":  "Restricted stock units granted (in shares)",
                            "verboseLabel":  "Granted (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofProfitUnitsandRSUsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue":  {
                "auth_ref":  [
                    "r347"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
                            "terseLabel":  "Granted (in dollars per share)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofProfitUnitsandRSUsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber":  {
                "auth_ref":  [
                    "r346"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
                            "periodEndLabel":  "Unvested units at end of period (in shares)",
                            "periodStartLabel":  "Unvested units at beginning of period (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofProfitUnitsandRSUsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
                            "terseLabel":  "Number of Units"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofProfitUnitsandRSUsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue":  {
                "auth_ref":  [
                    "r346"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement.  Excludes share and unit options.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
                            "periodEndLabel":  "Unvested units at end of period (in dollars per share)",
                            "periodStartLabel":  "Unvested units at beginning of period (in dollars per share)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofProfitUnitsandRSUsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
                            "terseLabel":  "Weighted Average Grant Date Fair Value"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofProfitUnitsandRSUsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod":  {
                "auth_ref":  [
                    "r348"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
                            "negatedTerseLabel":  "Vested (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofProfitUnitsandRSUsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue":  {
                "auth_ref":  [
                    "r348"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
                            "terseLabel":  "Vested (in dollars per share)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofProfitUnitsandRSUsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate":  {
                "auth_ref":  [
                    "r355"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
                            "terseLabel":  "Expected dividend yield"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofValuationAssumptionsOptionsDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofValuationAssumptionsProfitUnitsDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate":  {
                "auth_ref":  [
                    "r354"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The estimated measure of the percentage by which a share price is expected to fluctuate during a period.  Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean.  The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period.  That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
                            "terseLabel":  "Expected volatility"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofValuationAssumptionsProfitUnitsDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period.  Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean.  The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period.  That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
                            "terseLabel":  "Expected volatility"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofValuationAssumptionsOptionsDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period.  Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean.  The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period.  That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
                            "terseLabel":  "Expected volatility"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofValuationAssumptionsOptionsDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate":  {
                "auth_ref":  [
                    "r356"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
                            "terseLabel":  "Risk free interest rate"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofValuationAssumptionsProfitUnitsDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
                            "terseLabel":  "Risk free interest rate"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofValuationAssumptionsOptionsDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
                            "terseLabel":  "Risk free interest rate"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofValuationAssumptionsOptionsDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
                            "terseLabel":  "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofProfitUnitsandRSUsIssuedtoEmployeesDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofShareBasedCompensationExpensesbyOperatingFunctionDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofValuationAssumptionsOptionsDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofValuationAssumptionsProfitUnitsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of additional shares authorized for issuance under share-based payment arrangement.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized",
                            "terseLabel":  "Number of additional shares authorized (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
                            "terseLabel":  "Stock Option Activity, Additional Disclosures"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofStockOptionsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber":  {
                "auth_ref":  [
                    "r342"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
                            "terseLabel":  "Exercisable (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofStockOptionsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod":  {
                "auth_ref":  [
                    "r344"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
                            "negatedTerseLabel":  "Forfeited (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofStockOptionsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Gross number of share options (or share units) granted during the period.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
                            "terseLabel":  "Stock options granted (in shares)",
                            "verboseLabel":  "Granted (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofStockOptionsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue":  {
                "auth_ref":  [
                    "r350"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
                            "terseLabel":  "Granted (in dollars per share)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofStockOptionsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue":  {
                "auth_ref":  [
                    "r361"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
                            "terseLabel":  "Outstanding, Aggregate Intrinsic Value"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofStockOptionsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber":  {
                "auth_ref":  [
                    "r341",
                    "r361"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of options outstanding, including both vested and non-vested options.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
                            "periodEndLabel":  "Outstanding at end of period (in shares)",
                            "periodStartLabel":  "Outstanding at beginning of period (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofStockOptionsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
                            "terseLabel":  "Stock Options"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofStockOptionsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum",
                            "terseLabel":  "Maximum annual increase in shares initially available for issuance, percentage of shares of Class A common stock outstanding"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain":  {
                "auth_ref":  [
                    "r335",
                    "r339"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Award under share-based payment arrangement.",
                            "label":  "Award Type [Domain]",
                            "terseLabel":  "Award Type [Domain]"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofProfitUnitsandRSUsIssuedtoEmployeesDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofValuationAssumptionsOptionsDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofValuationAssumptionsProfitUnitsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ShareBasedCompensationAwardTrancheOneMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
                            "label":  "Share-based Payment Arrangement, Tranche One [Member]",
                            "terseLabel":  "Vesting Installment One"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationAwardTrancheOneMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ShareBasedCompensationAwardTrancheThreeMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
                            "label":  "Share-based Payment Arrangement, Tranche Three [Member]",
                            "terseLabel":  "Vesting Installment Three"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationAwardTrancheThreeMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ShareBasedCompensationAwardTrancheTwoMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
                            "label":  "Share-based Payment Arrangement, Tranche Two [Member]",
                            "terseLabel":  "Vesting Installment Two"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationAwardTrancheTwoMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy":  {
                "auth_ref":  [
                    "r111",
                    "r337",
                    "r340"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for award under share-based payment arrangement.  Includes, but is not limited to, methodology and assumption used in measuring cost.",
                            "label":  "Share-based Payment Arrangement [Policy Text Block]",
                            "terseLabel":  "Share-Based Compensation Expense"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationOptionAndIncentivePlansPolicy",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage":  {
                "auth_ref":  [
                    "r338"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of vesting of award under share-based payment arrangement.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
                            "terseLabel":  "Vesting percentage"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1":  {
                "auth_ref":  [
                    "r353",
                    "r370"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
                            "terseLabel":  "Expected life (years)"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofValuationAssumptionsOptionsDetails",
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofValuationAssumptionsProfitUnitsDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1":  {
                "auth_ref":  [
                    "r361"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
                            "terseLabel":  "Exercisable, Aggregate Intrinsic Value"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofStockOptionsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1":  {
                "auth_ref":  [
                    "r361"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
                            "terseLabel":  "Exercisable, Weighted Average Remaining Contractual Term"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofStockOptionsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2":  {
                "auth_ref":  [
                    "r351"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
                            "terseLabel":  "Outstanding, Weighted Average Remaining Contractual Term"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofStockOptionsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_SharesIssuedPricePerShare":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Per share or per unit amount of equity securities issued.",
                            "label":  "Shares Issued, Price Per Share",
                            "verboseLabel":  "Share issue price (in dollars per share)"
                            }
                        }
                    },
                "localname":  "SharesIssuedPricePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
                            "label":  "Software and Software Development Costs [Member]",
                            "terseLabel":  "Capitalized software"
                            }
                        }
                    },
                "localname":  "SoftwareAndSoftwareDevelopmentCostsMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccountsSummaryofPropertyEquipmentandCapitalizedSoftwareNetDetails",
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_StateAndLocalJurisdictionMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
                            "label":  "State and Local Jurisdiction [Member]",
                            "terseLabel":  "State"
                            }
                        }
                    },
                "localname":  "StateAndLocalJurisdictionMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_StatementBusinessSegmentsAxis":  {
                "auth_ref":  [
                    "r0",
                    "r175",
                    "r179",
                    "r180",
                    "r181",
                    "r182",
                    "r183",
                    "r184",
                    "r185",
                    "r186",
                    "r187",
                    "r188",
                    "r189",
                    "r190",
                    "r192",
                    "r193",
                    "r194",
                    "r195",
                    "r196",
                    "r197",
                    "r198",
                    "r199",
                    "r200",
                    "r202",
                    "r207",
                    "r229",
                    "r253",
                    "r254",
                    "r255",
                    "r561"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by business segments.",
                            "label":  "Segments [Axis]",
                            "terseLabel":  "Segments [Axis]"
                            }
                        }
                    },
                "localname":  "StatementBusinessSegmentsAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails",
                    "http://www.gohealth.com/role/OperatingSegmentsandSignificantCustomersSummaryofReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
                    "http://www.gohealth.com/role/RevenueSummaryofDisaggregationofRevenueDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementClassOfStockAxis":  {
                "auth_ref":  [
                    "r22",
                    "r23",
                    "r24",
                    "r113",
                    "r115",
                    "r146",
                    "r147",
                    "r148",
                    "r150",
                    "r152",
                    "r159",
                    "r161",
                    "r162",
                    "r215",
                    "r281",
                    "r466"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by the different classes of stock of the entity.",
                            "label":  "Class of Stock [Axis]",
                            "terseLabel":  "Class of Stock [Axis]",
                            "verboseLabel":  "Class of Stock [Axis]"
                            }
                        }
                    },
                "localname":  "StatementClassOfStockAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets",
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheetsParenthetical",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity",
                    "http://www.gohealth.com/role/Cover",
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails",
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails",
                    "http://www.gohealth.com/role/StockholdersEquityandMembersEquityDetails",
                    "http://www.gohealth.com/role/SubsequentEventsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementEquityComponentsAxis":  {
                "auth_ref":  [
                    "r53",
                    "r126",
                    "r127",
                    "r129",
                    "r131",
                    "r140",
                    "r143",
                    "r158",
                    "r219",
                    "r281",
                    "r288",
                    "r366",
                    "r367",
                    "r368",
                    "r400",
                    "r401",
                    "r468",
                    "r469",
                    "r470",
                    "r471",
                    "r472",
                    "r473",
                    "r568",
                    "r569",
                    "r570"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by component of equity.",
                            "label":  "Equity Components [Axis]",
                            "terseLabel":  "Equity Components [Axis]"
                            }
                        }
                    },
                "localname":  "StatementEquityComponentsAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity",
                    "http://www.gohealth.com/role/SubsequentEventsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Statement [Line Items]",
                            "terseLabel":  "Statement [Line Items]",
                            "verboseLabel":  "Statement [Line Items]"
                            }
                        }
                    },
                "localname":  "StatementLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets",
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheetsParenthetical",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfCashFlowsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement of Cash Flows [Abstract]"
                            }
                        }
                    },
                "localname":  "StatementOfCashFlowsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfFinancialPositionAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement of Financial Position [Abstract]"
                            }
                        }
                    },
                "localname":  "StatementOfFinancialPositionAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement of Comprehensive Income [Abstract]"
                            }
                        }
                    },
                "localname":  "StatementOfIncomeAndComprehensiveIncomeAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfStockholdersEquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement of Stockholders' Equity [Abstract]"
                            }
                        }
                    },
                "localname":  "StatementOfStockholdersEquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementTable":  {
                "auth_ref":  [
                    "r126",
                    "r127",
                    "r129",
                    "r158",
                    "r512"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
                            "label":  "Statement [Table]",
                            "terseLabel":  "Statement [Table]",
                            "verboseLabel":  "Statement [Table]"
                            }
                        }
                    },
                "localname":  "StatementTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets",
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheetsParenthetical",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StockIssued1":  {
                "auth_ref":  [
                    "r107",
                    "r108",
                    "r109"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The fair value of stock issued in noncash financing activities.",
                            "label":  "Stock Issued",
                            "terseLabel":  "Net issuance of Class A and Class B common stock in connection with the Transactions"
                            }
                        }
                    },
                "localname":  "StockIssued1",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesAcquisitions":  {
                "auth_ref":  [
                    "r23",
                    "r24",
                    "r288"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares of stock issued during the period pursuant to acquisitions.",
                            "label":  "Stock Issued During Period, Shares, Acquisitions",
                            "terseLabel":  "Stock issued for continuing equity owners (in shares)"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesAcquisitions",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities":  {
                "auth_ref":  [
                    "r52",
                    "r281",
                    "r282",
                    "r288"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares issued during the period as a result of the conversion of convertible securities.",
                            "label":  "Stock Issued During Period, Shares, Conversion of Convertible Securities",
                            "terseLabel":  "Conversion of stock"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/SubsequentEventsDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesNewIssues":  {
                "auth_ref":  [
                    "r23",
                    "r24",
                    "r281",
                    "r288"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of new stock issued during the period.",
                            "label":  "Stock Issued During Period, Shares, New Issues",
                            "terseLabel":  "Issuance of common stock sold in IPO, net of offering costs (in shares)",
                            "verboseLabel":  "Shares issued during the period (in shares)"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesNewIssues",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity",
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails",
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross":  {
                "auth_ref":  [
                    "r281",
                    "r288"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.",
                            "label":  "Stock Issued During Period, Shares, Restricted Stock Award, Gross",
                            "terseLabel":  "Issuance of Class A common shares upon vesting of restricted stock units (in shares)"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised":  {
                "auth_ref":  [
                    "r23",
                    "r24",
                    "r281",
                    "r288",
                    "r343"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of share options (or share units) exercised during the current period.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
                            "negatedTerseLabel":  "Exercised (in shares)"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesStockOptionsExercised",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofStockOptionsIssuedtoEmployeesDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits":  {
                "auth_ref":  [
                    "r53",
                    "r281",
                    "r288"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value of stock issued during the period upon the conversion of units.  An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).",
                            "label":  "Stock Issued During Period, Value, Conversion of Units",
                            "terseLabel":  "Conversion of Redeemable Class B Units"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueConversionOfUnits",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueNewIssues":  {
                "auth_ref":  [
                    "r23",
                    "r24",
                    "r281",
                    "r288"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Equity impact of the value of new stock issued during the period.  Includes shares issued in an initial public offering or a secondary public offering.",
                            "label":  "Stock Issued During Period, Value, New Issues",
                            "terseLabel":  "Issuance of common stock sold in IPO, net of offering costs",
                            "verboseLabel":  "Shares issued during the period, value"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueNewIssues",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity",
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockholdersEquity":  {
                "auth_ref":  [
                    "r24",
                    "r29",
                    "r30",
                    "r115",
                    "r213",
                    "r215",
                    "r466"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent.  The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest).  This excludes temporary equity and is sometimes called permanent equity.",
                            "label":  "Stockholders' Equity Attributable to Parent",
                            "totalLabel":  "Total stockholders' equity attributable to GoHealth, Inc."
                            }
                        }
                    },
                "localname":  "StockholdersEquity",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockholdersEquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Stockholders' Equity Attributable to Parent [Abstract]",
                            "terseLabel":  "Stockholders\u2019 / members\u2019 equity:"
                            }
                        }
                    },
                "localname":  "StockholdersEquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StockholdersEquityChangeInReportingEntity":  {
                "auth_ref":  [
                    "r138"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Impact on total stockholders' equity of cumulative effect of change in reporting entity.  A change in reporting entity is considered as follows: (1) presenting consolidated statements in place of the financial statements of individual reporting entities; (2) changing the combination of subsidiaries that make up the group for which the consolidated financial statements are presented; and (3) changing the entities included in the combined financial statements.  A business combination accounted for under the purchase method and the consolidation of a variable interest entity are not considered a change in reporting entity.",
                            "label":  "Stockholders' Equity, Change in Reporting Entity",
                            "terseLabel":  "Effect of the Transactions"
                            }
                        }
                    },
                "localname":  "StockholdersEquityChangeInReportingEntity",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest":  {
                "auth_ref":  [
                    "r115",
                    "r126",
                    "r127",
                    "r129",
                    "r131",
                    "r140",
                    "r215",
                    "r219",
                    "r288",
                    "r366",
                    "r367",
                    "r368",
                    "r400",
                    "r401",
                    "r440",
                    "r441",
                    "r455",
                    "r466",
                    "r468",
                    "r469",
                    "r473",
                    "r569",
                    "r570"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests.  Amount excludes temporary equity.  Alternate caption for the concept is permanent equity.",
                            "label":  "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
                            "periodEndLabel":  "Ending balance",
                            "totalLabel":  "Total stockholders\u2019 equity"
                            }
                        }
                    },
                "localname":  "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedBalanceSheets",
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockholdersEquityNoteDisclosureTextBlock":  {
                "auth_ref":  [
                    "r114",
                    "r288",
                    "r289"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income.  Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
                            "label":  "Stockholders' Equity Note Disclosure [Text Block]",
                            "terseLabel":  "Stockholders' Equity and Members' Equity"
                            }
                        }
                    },
                "localname":  "StockholdersEquityNoteDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/StockholdersEquityandMembersEquity"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_StockholdersEquityOther":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
                            "label":  "Stockholders' Equity, Other",
                            "negatedTerseLabel":  "Partner distributions and other"
                            }
                        }
                    },
                "localname":  "StockholdersEquityOther",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SubsequentEventLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Detail information of subsequent event by type.  User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
                            "label":  "Subsequent Event [Line Items]",
                            "terseLabel":  "Subsequent Event [Line Items]"
                            }
                        }
                    },
                "localname":  "SubsequentEventLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/SubsequentEventsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SubsequentEventMember":  {
                "auth_ref":  [
                    "r474",
                    "r503"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
                            "label":  "Subsequent Event [Member]",
                            "terseLabel":  "Subsequent event"
                            }
                        }
                    },
                "localname":  "SubsequentEventMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails",
                    "http://www.gohealth.com/role/SubsequentEventsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SubsequentEventTable":  {
                "auth_ref":  [
                    "r474",
                    "r503"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
                            "label":  "Subsequent Event [Table]",
                            "terseLabel":  "Subsequent Event [Table]"
                            }
                        }
                    },
                "localname":  "SubsequentEventTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/SubsequentEventsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SubsequentEventTypeAxis":  {
                "auth_ref":  [
                    "r474",
                    "r503"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
                            "label":  "Subsequent Event Type [Axis]",
                            "terseLabel":  "Subsequent Event Type [Axis]"
                            }
                        }
                    },
                "localname":  "SubsequentEventTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails",
                    "http://www.gohealth.com/role/SubsequentEventsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SubsequentEventTypeDomain":  {
                "auth_ref":  [
                    "r474",
                    "r503"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
                            "label":  "Subsequent Event Type [Domain]",
                            "terseLabel":  "Subsequent Event Type [Domain]"
                            }
                        }
                    },
                "localname":  "SubsequentEventTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails",
                    "http://www.gohealth.com/role/SubsequentEventsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SubsequentEventsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Subsequent Events [Abstract]"
                            }
                        }
                    },
                "localname":  "SubsequentEventsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SubsequentEventsTextBlock":  {
                "auth_ref":  [
                    "r502",
                    "r504"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.  Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
                            "label":  "Subsequent Events [Text Block]",
                            "terseLabel":  "Subsequent Events"
                            }
                        }
                    },
                "localname":  "SubsequentEventsTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/SubsequentEvents"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SubsidiarySaleOfStockAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of sale of the entity's stock.",
                            "label":  "Sale of Stock [Axis]",
                            "terseLabel":  "Sale of Stock [Axis]"
                            }
                        }
                    },
                "localname":  "SubsidiarySaleOfStockAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock":  {
                "auth_ref":  [
                    "r59"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
                            "label":  "Supplemental Balance Sheet Disclosures [Text Block]",
                            "terseLabel":  "Balance Sheet Accounts"
                            }
                        }
                    },
                "localname":  "SupplementalBalanceSheetDisclosuresTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/BalanceSheetAccounts"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SupplementalCashFlowElementsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Supplemental Cash Flow Elements [Abstract]",
                            "terseLabel":  "Supplemental Disclosure of Cash Flow Information"
                            }
                        }
                    },
                "localname":  "SupplementalCashFlowElementsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_TaxCreditCarryforwardAmount":  {
                "auth_ref":  [
                    "r393"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
                            "label":  "Tax Credit Carryforward, Amount",
                            "terseLabel":  "Tax credits and incentives"
                            }
                        }
                    },
                "localname":  "TaxCreditCarryforwardAmount",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_TechnologyServiceMember":  {
                "auth_ref":  [
                    "r316"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Technology assistance, including but not limited to, training, installation, engineering, and software design.",
                            "label":  "Technology Service [Member]",
                            "terseLabel":  "Technology"
                            }
                        }
                    },
                "localname":  "TechnologyServiceMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansSummaryofShareBasedCompensationExpensesbyOperatingFunctionDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_TemporaryEquityLiquidationPreferencePerShare":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The per share liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares.  The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.  Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.  Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer.  If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity.  If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases.  Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
                            "label":  "Temporary Equity, Liquidation Preference Per Share",
                            "terseLabel":  "Liquidation proceeds per unit (in dollars per share)"
                            }
                        }
                    },
                "localname":  "TemporaryEquityLiquidationPreferencePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/StockholdersEquityandMembersEquityDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_TradeNamesMember":  {
                "auth_ref":  [
                    "r424"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
                            "label":  "Trade Names [Member]",
                            "terseLabel":  "Trade names"
                            }
                        }
                    },
                "localname":  "TradeNamesMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/AcquisitionsSummaryofAllocationofPurchasePriceDetails",
                    "http://www.gohealth.com/role/GoodwillAndIntangibleAssetsNetSummaryofDefinitelivedandIndefinitelivedIntangibleAssetsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_UnbilledRevenuesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Unbilled amounts due for services rendered or products shipped.  This element is distinct from unbilled contracts receivables because this is based on noncontract transactions.",
                            "label":  "Unbilled Revenues [Member]",
                            "terseLabel":  "Unbilled revenues"
                            }
                        }
                    },
                "localname":  "UnbilledRevenuesMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_UnrecognizedTaxBenefits":  {
                "auth_ref":  [
                    "r377",
                    "r384"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of unrecognized tax benefits.",
                            "label":  "Unrecognized Tax Benefits",
                            "terseLabel":  "Reserve for uncertain tax positions"
                            }
                        }
                    },
                "localname":  "UnrecognizedTaxBenefits",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/IncomeTaxesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_UseOfEstimates":  {
                "auth_ref":  [
                    "r163",
                    "r164",
                    "r166",
                    "r167",
                    "r171",
                    "r172",
                    "r173"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
                            "label":  "Use of Estimates, Policy [Policy Text Block]",
                            "terseLabel":  "Use of Estimates"
                            }
                        }
                    },
                "localname":  "UseOfEstimates",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/DescriptionofBusinessandSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_VariableRateAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of variable rate.",
                            "label":  "Variable Rate [Axis]",
                            "terseLabel":  "Variable Rate [Axis]"
                            }
                        }
                    },
                "localname":  "VariableRateAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_VariableRateDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
                            "label":  "Variable Rate [Domain]",
                            "terseLabel":  "Variable Rate [Domain]"
                            }
                        }
                    },
                "localname":  "VariableRateDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_VestingAxis":  {
                "auth_ref":  [
                    "r361"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by vesting schedule of award under share-based payment arrangement.",
                            "label":  "Vesting [Axis]",
                            "terseLabel":  "Vesting [Axis]"
                            }
                        }
                    },
                "localname":  "VestingAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_VestingDomain":  {
                "auth_ref":  [
                    "r361"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Vesting schedule of award under share-based payment arrangement.",
                            "label":  "Vesting [Domain]",
                            "terseLabel":  "Vesting [Domain]"
                            }
                        }
                    },
                "localname":  "VestingDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ShareBasedCompensationPlansNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment":  {
                "auth_ref":  [
                    "r152"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/NetLossPerShareReconciliationoftheNumeratorandDenominatorUsedintheCalculationofBasicandDilutedNetLossPerShareDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
                        "weight":  1.0
                        }
                    },
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
                            "label":  "Weighted Average Number Diluted Shares Outstanding Adjustment",
                            "terseLabel":  "Effect of dilutive securities (in shares)"
                            }
                        }
                    },
                "localname":  "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/NetLossPerShareReconciliationoftheNumeratorandDenominatorUsedintheCalculationofBasicandDilutedNetLossPerShareDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding":  {
                "auth_ref":  [
                    "r145",
                    "r152"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/NetLossPerShareReconciliationoftheNumeratorandDenominatorUsedintheCalculationofBasicandDilutedNetLossPerShareDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
                            "label":  "Weighted Average Number of Shares Outstanding, Diluted",
                            "totalLabel":  "Weighted-average shares of Class A common stock outstanding\u2014diluted (in shares)"
                            }
                        }
                    },
                "localname":  "WeightedAverageNumberOfDilutedSharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/NetLossPerShareReconciliationoftheNumeratorandDenominatorUsedintheCalculationofBasicandDilutedNetLossPerShareDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
                            "label":  "Weighted Average Number of Shares Outstanding, Basic and Diluted",
                            "terseLabel":  "Weighted-average shares of Class A common stock outstanding\u2014basic and diluted (in shares)"
                            }
                        }
                    },
                "localname":  "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/ConsolidatedStatementsofOperations"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic":  {
                "auth_ref":  [
                    "r144",
                    "r152"
                    ],
                "calculation":  {
                    "http://www.gohealth.com/role/NetLossPerShareReconciliationoftheNumeratorandDenominatorUsedintheCalculationofBasicandDilutedNetLossPerShareDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
                        "weight":  1.0
                        }
                    },
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
                            "label":  "Weighted Average Number of Shares Outstanding, Basic",
                            "terseLabel":  "Weighted-average shares of Class A common stock outstanding\u2014basic (in shares)"
                            }
                        }
                    },
                "localname":  "WeightedAverageNumberOfSharesOutstandingBasic",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/NetLossPerShareReconciliationoftheNumeratorandDenominatorUsedintheCalculationofBasicandDilutedNetLossPerShareDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
                            "terseLabel":  "Denominator:"
                            }
                        }
                    },
                "localname":  "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://www.gohealth.com/role/NetLossPerShareReconciliationoftheNumeratorandDenominatorUsedintheCalculationofBasicandDilutedNetLossPerShareDetails"
                    ],
                "xbrltype":  "stringItemType"
                }
            },
        "unitCount":  8
        }
    },
"std_ref":  {
    "r0":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)",
        "Topic":  "205",
        "URI":  "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
        },
    "r1":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "205",
        "URI":  "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
        },
    "r10":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 201.5-02(24))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r100":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
        },
    "r101":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
        },
    "r102":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
        },
    "r103":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
        },
    "r104":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
        },
    "r105":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
        },
    "r106":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
        },
    "r107":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
        },
    "r108":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
        },
    "r109":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
        },
    "r11":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 201.5-02(25))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r110":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
        },
    "r111":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
        },
    "r112":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
        },
    "r113":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(d))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r114":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(e)(1))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r115":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(g)(1)(ii))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r116":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(h))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r117":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(k))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r118":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(m)(1)(iii))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r119":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08.(e),(f))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r12":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 201.5-02(26))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r120":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08.(f))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r121":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08.(h)(1)(i))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r122":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08.(h))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r123":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08.(k)(1))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r124":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.12-04.(a))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
        },
    "r125":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/topic&trid=2122369"
        },
    "r126":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "23",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
        },
    "r127":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
        },
    "r128":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "27",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=115929471&loc=d3e22044-107793"
        },
    "r129":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
        },
    "r13":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(1))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r130":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)(2)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
        },
    "r131":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)(3)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
        },
    "r132":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)(4)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
        },
    "r133":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
        },
    "r134":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
        },
    "r135":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
        },
    "r136":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
        },
    "r137":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
        },
    "r138":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22624-107794"
        },
    "r139":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
        },
    "r14":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(13))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r140":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
        },
    "r141":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
        },
    "r142":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
        },
    "r143":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
        },
    "r144":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
        },
    "r145":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "16",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
        },
    "r146":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
        },
    "r147":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
        },
    "r148":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "55",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256"
        },
    "r149":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "60B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
        },
    "r15":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(14))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r150":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "60B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
        },
    "r151":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
        },
    "r152":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
        },
    "r153":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
        },
    "r154":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
        },
    "r155":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
        },
    "r156":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
        },
    "r157":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/topic&trid=2144383"
        },
    "r158":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "272",
        "URI":  "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
        },
    "r159":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "272",
        "URI":  "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
        },
    "r16":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(19))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r160":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "272",
        "URI":  "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70258-108054"
        },
    "r161":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "272",
        "URI":  "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
        },
    "r162":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "272",
        "URI":  "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
        },
    "r163":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
        },
    "r164":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
        },
    "r165":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
        },
    "r166":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
        },
    "r167":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
        },
    "r168":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
        },
    "r169":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
        },
    "r17":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(20))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r170":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
        },
    "r171":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
        },
    "r172":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
        },
    "r173":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
        },
    "r174":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/topic&trid=2134479"
        },
    "r175":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
        },
    "r176":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
        },
    "r177":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
        },
    "r178":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
        },
    "r179":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
        },
    "r18":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(22))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r180":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
        },
    "r181":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
        },
    "r182":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
        },
    "r183":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
        },
    "r184":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
        },
    "r185":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(g)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
        },
    "r186":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
        },
    "r187":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(j)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
        },
    "r188":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
        },
    "r189":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
        },
    "r19":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(23))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r190":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
        },
    "r191":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "26",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
        },
    "r192":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
        },
    "r193":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
        },
    "r194":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
        },
    "r195":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
        },
    "r196":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "31",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
        },
    "r197":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
        },
    "r198":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
        },
    "r199":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
        },
    "r2":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
        },
    "r20":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(26)(a))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r200":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
        },
    "r201":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
        },
    "r202":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
        },
    "r203":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "34",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
        },
    "r204":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "40",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
        },
    "r205":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "41",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
        },
    "r206":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "41",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
        },
    "r207":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "42",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
        },
    "r208":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/topic&trid=2134510"
        },
    "r209":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
        },
    "r21":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(26)(b))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r210":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
        },
    "r211":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
        },
    "r212":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5144-111524"
        },
    "r213":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 4.E)",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
        },
    "r214":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(1)",
        "Topic":  "323",
        "URI":  "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
        },
    "r215":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "323",
        "URI":  "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
        },
    "r216":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
        },
    "r217":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
        },
    "r218":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
        },
    "r219":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
        },
    "r22":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(27))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r220":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(e)(3)",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
        },
    "r221":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(e)(4)",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
        },
    "r222":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
        },
    "r223":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
        },
    "r224":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
        },
    "r225":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
        },
    "r226":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
        },
    "r227":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
        },
    "r228":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(e)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
        },
    "r229":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
        },
    "r23":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(28))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r230":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
        },
    "r231":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
        },
    "r232":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
        },
    "r233":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
        },
    "r234":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
        },
    "r235":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(b)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
        },
    "r236":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(d)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
        },
    "r237":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
        },
    "r238":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "((a)(1),(b))",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r239":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r24":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(29))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r240":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)(1)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r241":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)(2)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r242":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)(3)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r243":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(b)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r244":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(d)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r245":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(b)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
        },
    "r246":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(b),(d)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
        },
    "r247":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/topic&trid=2144416"
        },
    "r248":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r249":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r25":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(3))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r250":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r251":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r252":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
        },
    "r253":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
        },
    "r254":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "420",
        "URI":  "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
        },
    "r255":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 5.P.4(d))",
        "Topic":  "420",
        "URI":  "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
        },
    "r256":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "440",
        "URI":  "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
        },
    "r257":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "440",
        "URI":  "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
        },
    "r258":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "440",
        "URI":  "http://asc.fasb.org/topic&trid=2144648"
        },
    "r259":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
        },
    "r26":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30)(a)(1))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r260":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
        },
    "r261":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
        },
    "r262":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
        },
    "r263":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
        },
    "r264":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
        },
    "r265":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
        },
    "r266":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
        },
    "r267":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/topic&trid=2127136"
        },
    "r268":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "460",
        "URI":  "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
        },
    "r269":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "460",
        "URI":  "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
        },
    "r27":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30)(a)(3))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r270":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "460",
        "URI":  "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
        },
    "r271":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
        },
    "r272":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(1)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
        },
    "r273":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(2)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
        },
    "r274":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(3)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
        },
    "r275":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
        },
    "r276":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/topic&trid=2208564"
        },
    "r277":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(CFRR 211.02)",
        "Topic":  "480",
        "URI":  "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
        },
    "r278":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 3.C)",
        "Topic":  "480",
        "URI":  "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177168-122764"
        },
    "r279":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
        },
    "r28":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30)(a)(4))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r280":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
        },
    "r281":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
        },
    "r282":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
        },
    "r283":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
        },
    "r284":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
        },
    "r285":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
        },
    "r286":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
        },
    "r287":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
        },
    "r288":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.3-04)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
        },
    "r289":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/topic&trid=2208762"
        },
    "r29":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r290":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
        },
    "r291":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130533-203044"
        },
    "r292":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
        },
    "r293":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
        },
    "r294":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
        },
    "r295":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
        },
    "r296":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
        },
    "r297":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
        },
    "r298":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
        },
    "r299":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
        },
    "r3":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
        },
    "r30":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(31))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r300":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)(2)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
        },
    "r301":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045"
        },
    "r302":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045"
        },
    "r303":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
        },
    "r304":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
        },
    "r305":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "19",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045"
        },
    "r306":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
        },
    "r307":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
        },
    "r308":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
        },
    "r309":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
        },
    "r31":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(32))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r310":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
        },
    "r311":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
        },
    "r312":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
        },
    "r313":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
        },
    "r314":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
        },
    "r315":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045"
        },
    "r316":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "91",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
        },
    "r317":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "91",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
        },
    "r318":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "91",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
        },
    "r319":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "91",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
        },
    "r32":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(4)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r320":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "91",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
        },
    "r321":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "91",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
        },
    "r322":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "91",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Subparagraph":  "(g)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
        },
    "r323":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/topic&trid=49130388"
        },
    "r324":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(i)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
        },
    "r325":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(n)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
        },
    "r326":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "SubTopic":  "60",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/subtopic&trid=2235172"
        },
    "r327":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "70",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
        },
    "r328":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "SubTopic":  "70",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/subtopic&trid=2235116"
        },
    "r329":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "80",
        "Subparagraph":  "(a)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
        },
    "r33":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(4))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r330":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "80",
        "Subparagraph":  "(d)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
        },
    "r331":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "80",
        "Subparagraph":  "(a)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
        },
    "r332":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "80",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
        },
    "r333":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "SubTopic":  "80",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/subtopic&trid=2235144"
        },
    "r334":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "35",
        "SubTopic":  "10",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
        },
    "r335":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
        },
    "r336":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
        },
    "r337":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
        },
    "r338":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r339":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a),(g)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r34":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(7))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r340":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b),(f)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r341":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(i)-(ii)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r342":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iii)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r343":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r344":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(3)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r345":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r346":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(i)-(ii)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r347":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(iii)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r348":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(iii)(2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r349":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(iii)(3)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r35":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(8))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r350":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r351":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r352":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r353":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(i)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r354":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(ii)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r355":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(iii)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r356":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(iv)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r357":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(g)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r358":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r359":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)(1)(i)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r36":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.1)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r360":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(i)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r361":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r362":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
        },
    "r363":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
        },
    "r364":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
        },
    "r365":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
        },
    "r366":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
        },
    "r367":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
        },
    "r368":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
        },
    "r369":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(g)(2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
        },
    "r37":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.13(a))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r370":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 14.D.2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
        },
    "r371":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 14.F)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
        },
    "r372":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
        },
    "r373":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
        },
    "r374":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/topic&trid=2228938"
        },
    "r375":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "35",
        "Subparagraph":  "(a)",
        "Topic":  "720",
        "URI":  "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
        },
    "r376":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "35",
        "Subparagraph":  "(b)",
        "Topic":  "720",
        "URI":  "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
        },
    "r377":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
        },
    "r378":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318"
        },
    "r379":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318"
        },
    "r38":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.13)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r380":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
        },
    "r381":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
        },
    "r382":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
        },
    "r383":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
        },
    "r384":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
        },
    "r385":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
        },
    "r386":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "19",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
        },
    "r387":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
        },
    "r388":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
        },
    "r389":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
        },
    "r39":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.14)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r390":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
        },
    "r391":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
        },
    "r392":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
        },
    "r393":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
        },
    "r394":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
        },
    "r395":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
        },
    "r396":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
        },
    "r397":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
        },
    "r398":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
        },
    "r399":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
        },
    "r4":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
        },
    "r40":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.17)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r400":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(2)",
        "Topic":  "740"
        },
    "r401":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(3)",
        "Topic":  "740"
        },
    "r402":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB TOPIC 6.I.5.Q1)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
        },
    "r403":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB TOPIC 6.I.7)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
        },
    "r404":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 6.I.7)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
        },
    "r405":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 6.I.Fact.1)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
        },
    "r406":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 6.I.Fact.2)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
        },
    "r407":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 6.I.Fact.3)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
        },
    "r408":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 6.I.Fact.4)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
        },
    "r409":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 11.C)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
        },
    "r41":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19(a))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r410":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
        },
    "r411":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "270",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
        },
    "r412":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
        },
    "r413":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/topic&trid=2144680"
        },
    "r414":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "05",
        "SubTopic":  "10",
        "Subparagraph":  "(a)-(d)",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457"
        },
    "r415":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
        },
    "r416":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)(2)",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
        },
    "r417":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)(3)",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
        },
    "r418":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)(4)",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
        },
    "r419":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
        },
    "r42":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19(b),22(b))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r420":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
        },
    "r421":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "37",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
        },
    "r422":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
        },
    "r423":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
        },
    "r424":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
        },
    "r425":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473"
        },
    "r426":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "38",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473"
        },
    "r427":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "30",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476"
        },
    "r428":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "30",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
        },
    "r429":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "30",
        "SubTopic":  "30",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
        },
    "r43":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19,20)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r430":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "30",
        "SubTopic":  "30",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
        },
    "r431":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "35",
        "SubTopic":  "30",
        "Subparagraph":  "(b)",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
        },
    "r432":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(b)",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
        },
    "r433":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(b)(1)",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
        },
    "r434":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(b)(3)",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
        },
    "r435":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(b)(4)",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
        },
    "r436":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(c)(1)",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
        },
    "r437":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(c)(3)",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
        },
    "r438":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)(1)",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
        },
    "r439":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/topic&trid=2303972"
        },
    "r44":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.20)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r440":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
        },
    "r441":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "16",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
        },
    "r442":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "19",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
        },
    "r443":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
        },
    "r444":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683"
        },
    "r445":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "23",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569655-111683"
        },
    "r446":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=108774443&loc=SL4616395-111683"
        },
    "r447":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
        },
    "r448":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
        },
    "r449":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(1)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
        },
    "r45":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.21)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r450":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(2)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
        },
    "r451":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
        },
    "r452":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c),(3)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
        },
    "r453":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(bb)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
        },
    "r454":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
        },
    "r455":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4I",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
        },
    "r456":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4J",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
        },
    "r457":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4K",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
        },
    "r458":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(bbb)",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
        },
    "r459":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
        },
    "r46":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.22(a)(1))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r460":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
        },
    "r461":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
        },
    "r462":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
        },
    "r463":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
        },
    "r464":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "825",
        "URI":  "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611"
        },
    "r465":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "825",
        "URI":  "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
        },
    "r466":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "825",
        "URI":  "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
        },
    "r467":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "230",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
        },
    "r468":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
        },
    "r469":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r47":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.22)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r470":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(b)",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r471":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(c)",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r472":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(d)",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r473":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
        },
    "r474":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
        },
    "r475":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/topic&trid=2175825"
        },
    "r476":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "835",
        "URI":  "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
        },
    "r477":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
        },
    "r478":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
        },
    "r479":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
        },
    "r48":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.24)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r480":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
        },
    "r481":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "10",
        "Topic":  "840",
        "URI":  "http://asc.fasb.org/extlink&oid=121595440&loc=d3e34039-112682"
        },
    "r482":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "40",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Subparagraph":  "(Note 3)",
        "Topic":  "840",
        "URI":  "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697"
        },
    "r483":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "840",
        "URI":  "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41499-112717"
        },
    "r484":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "840",
        "URI":  "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41502-112717"
        },
    "r485":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "840",
        "URI":  "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41502-112717"
        },
    "r486":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "840",
        "URI":  "http://asc.fasb.org/extlink&oid=121569800&loc=d3e45014-112735"
        },
    "r487":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "840",
        "URI":  "http://asc.fasb.org/extlink&oid=121569800&loc=d3e45023-112735"
        },
    "r488":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "840",
        "URI":  "http://asc.fasb.org/extlink&oid=121616839&loc=d3e45280-112737"
        },
    "r489":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(b)",
        "Topic":  "840",
        "URI":  "http://asc.fasb.org/extlink&oid=121616839&loc=d3e45280-112737"
        },
    "r49":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.25)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r490":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)(3)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
        },
    "r491":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r492":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r493":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r494":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r495":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r496":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
        },
    "r497":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
        },
    "r498":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
        },
    "r499":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/topic&trid=2122745"
        },
    "r5":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
        },
    "r50":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.28,29)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r500":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "27",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "852",
        "URI":  "http://asc.fasb.org/extlink&oid=116635682&loc=SL2890601-112764"
        },
    "r501":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "852",
        "URI":  "http://asc.fasb.org/extlink&oid=120604989&loc=d3e56071-112765"
        },
    "r502":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "855",
        "URI":  "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
        },
    "r503":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "855",
        "URI":  "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
        },
    "r504":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "855",
        "URI":  "http://asc.fasb.org/topic&trid=2122774"
        },
    "r505":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(1)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r506":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(2)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r507":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(3)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r508":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(1)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
        },
    "r509":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(2)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
        },
    "r51":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.29)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r510":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(3)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
        },
    "r511":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "910",
        "URI":  "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
        },
    "r512":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 11.L)",
        "Topic":  "924",
        "URI":  "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
        },
    "r513":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "926",
        "URI":  "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
        },
    "r514":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "340",
        "Topic":  "928",
        "URI":  "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
        },
    "r515":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
        },
    "r516":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
        },
    "r517":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
        },
    "r518":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
        },
    "r519":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
        },
    "r52":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.29-30)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r520":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
        },
    "r521":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "33",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
        },
    "r522":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "33",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
        },
    "r523":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "35A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
        },
    "r524":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "35A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
        },
    "r525":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(c)(1)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
        },
    "r526":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(c)(2)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
        },
    "r527":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "20",
        "Topic":  "940",
        "URI":  "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
        },
    "r528":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(10)(1))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r529":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(11))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r53":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.29-31)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r530":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(13))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r531":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(15)(2))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r532":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(16))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r533":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(22))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r534":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(23))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r535":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03.17)",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r536":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(15))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
        },
    "r537":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(22))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
        },
    "r538":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(24))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
        },
    "r539":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(25))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
        },
    "r54":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.3(a)(2))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r540":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(26))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
        },
    "r541":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04.9)",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
        },
    "r542":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "235",
        "Subparagraph":  "(SX 210.9-05(b)(2))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
        },
    "r543":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "470",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
        },
    "r544":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "825",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788"
        },
    "r545":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(15)(b)(2))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r546":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(16))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r547":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(12))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r548":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(16))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r549":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(23)(a)(3))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r55":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.3,4)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r550":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(23)(a)(4))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r551":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(24))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r552":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(25))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r553":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(8))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r554":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03.(a),19)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r555":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(18))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r556":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(20))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r557":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(21))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r558":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(22))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r559":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(8))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r56":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.31)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r560":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(9))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r561":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4H",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "40",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
        },
    "r562":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "40",
        "Subparagraph":  "(d)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
        },
    "r563":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13H",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "40",
        "Subparagraph":  "(a)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
        },
    "r564":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13H",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "40",
        "Subparagraph":  "(c)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
        },
    "r565":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "29F",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "40",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
        },
    "r566":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(a)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
        },
    "r567":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(b)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
        },
    "r568":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(e)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
        },
    "r569":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(f)(1)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
        },
    "r57":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.9)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r570":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(f)(2)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
        },
    "r571":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(g)(1)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
        },
    "r572":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(g)(2)(i)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
        },
    "r573":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(g)(2)(ii)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
        },
    "r574":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(g)(2)(iii)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
        },
    "r575":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(g)(2)(iv)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
        },
    "r576":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(h)(1)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
        },
    "r577":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(h)(2)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
        },
    "r578":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "825",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
        },
    "r579":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "205",
        "Topic":  "946",
        "URI":  "http://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837"
        },
    "r58":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "16",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
        },
    "r580":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.6-04.16(a))",
        "Topic":  "946",
        "URI":  "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
        },
    "r581":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.6-04.16)",
        "Topic":  "946",
        "URI":  "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
        },
    "r582":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "450",
        "Topic":  "954",
        "URI":  "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624"
        },
    "r583":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "450",
        "Topic":  "954",
        "URI":  "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6052-115624"
        },
    "r584":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "740",
        "Topic":  "954",
        "URI":  "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
        },
    "r585":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "360",
        "Subparagraph":  "(d)",
        "Topic":  "958",
        "URI":  "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
        },
    "r586":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "360",
        "Topic":  "958",
        "URI":  "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
        },
    "r587":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(1)",
        "Topic":  "985",
        "URI":  "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
        },
    "r588":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "985",
        "URI":  "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128487-111756"
        },
    "r589":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "b"
        },
    "r59":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/topic&trid=2122208"
        },
    "r590":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "b-23"
        },
    "r591":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "d1-1"
        },
    "r592":  {
        "Name":  "Form 10-K",
        "Number":  "249",
        "Publisher":  "SEC",
        "Section":  "310"
        },
    "r593":  {
        "Name":  "Form 20-F",
        "Number":  "249",
        "Publisher":  "SEC",
        "Section":  "220",
        "Subsection":  "f"
        },
    "r594":  {
        "Name":  "Form 40-F",
        "Number":  "249",
        "Publisher":  "SEC",
        "Section":  "240",
        "Subsection":  "f"
        },
    "r595":  {
        "Name":  "Forms 10-K, 10-Q, 20-F",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "13",
        "Subsection":  "a-1"
        },
    "r596":  {
        "Name":  "Regulation 12B",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "b-2"
        },
    "r597":  {
        "Name":  "Regulation S-T",
        "Number":  "232",
        "Publisher":  "SEC",
        "Section":  "405"
        },
    "r598":  {
        "Name":  "Securities Act",
        "Number":  "7A",
        "Publisher":  "SEC",
        "Section":  "B",
        "Subsection":  "2"
        },
    "r6":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6904-107765"
        },
    "r60":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
        },
    "r61":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
        },
    "r62":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
        },
    "r63":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
        },
    "r64":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
        },
    "r65":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
        },
    "r66":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
        },
    "r67":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
        },
    "r68":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
        },
    "r69":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
        },
    "r7":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
        },
    "r70":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
        },
    "r71":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
        },
    "r72":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(210.5-03(11))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
        },
    "r73":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(10))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
        },
    "r74":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(20))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
        },
    "r75":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(22))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
        },
    "r76":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(23))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
        },
    "r77":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(24))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
        },
    "r78":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(4))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
        },
    "r79":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(6))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
        },
    "r8":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
        },
    "r80":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
        },
    "r81":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.2)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
        },
    "r82":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.4)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
        },
    "r83":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.6)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
        },
    "r84":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.9)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
        },
    "r85":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
        },
    "r86":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
        },
    "r87":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
        },
    "r88":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
        },
    "r89":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
        },
    "r9":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
        },
    "r90":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
        },
    "r91":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
        },
    "r92":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
        },
    "r93":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
        },
    "r94":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
        },
    "r95":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
        },
    "r96":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
        },
    "r97":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
        },
    "r98":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
        },
    "r99":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
        }
    },
"version":  "2.1"
}

7 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/14/24  GoHealth, Inc.                    10-K       12/31/23   92:125M
11/09/23  GoHealth, Inc.                    10-Q        9/30/23   74:7.4M
 8/10/23  GoHealth, Inc.                    10-Q        6/30/23   72:11M
 5/09/23  GoHealth, Inc.                    10-Q        3/31/23   70:6.5M
 3/23/23  GoHealth, Inc.                    10-K       12/31/22   95:11M
 3/16/22  GoHealth, Inc.                    10-K       12/31/21   96:28M
12/20/21  GoHealth, Inc.                    S-8        12/20/21    6:291K                                   Donnelley … Solutions/FA

5 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/20/20  GoHealth, Inc.                    10-Q        6/30/20   75:8.6M                                   Donnelley … Solutions/FA
 7/17/20  GoHealth, Inc.                    8-K:1,9     7/15/20    5:893K                                   Donnelley … Solutions/FA
 7/08/20  GoHealth, Inc.                    S-1/A                 17:6.9M                                   Donnelley … Solutions/FA
 7/06/20  GoHealth, Inc.                    S-1/A       7/02/20   14:1.4M                                   Donnelley … Solutions/FA
 6/19/20  GoHealth, Inc.                    S-1                    8:6.8M                                   Donnelley … Solutions/FA

↑Top

Filing Submission 0001808220-21-000010 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

GoHealth, Inc. – ‘10-K’ for 12/31/20 – ‘JSON’

On: Tuesday, 3/16/21, at 4:25pm ET · For: 12/31/20 · Accession #: 1808220-21-10 · File #: 1-39390

Annual Report — Form 10-KFiling Table of Contents

‘JSON’ — XBRL Instance as JSON Data — MetaLinks

This File is an XBRL Instance as JavaScript Object Notation (JSON) Data.

7 Subsequent Filings that Reference this Filing

5 Previous Filings that this Filing References

Annual Report — Form 10-K
Filing Table of Contents